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Abstract 
 
Properties and Interactions of Type III Intermediate Filaments with CRYAB 
Jayne L Elliott 
Glial fibrillary acidic protein is a type three intermediate filament found within 
astrocytes in the central nervous system and mutations have been found as the cause 
of Alexander disease, resulting in protein aggregates of Rosenthal fibers with αB-
crystallin.  Here two glial fibrillary acidic protein mutants of R79C and R239H, 
located in the LNDR and rod 2A domain respectively, were assembled in vitro and 
their morphology, assembly competence and interactions with αB-crystallin were 
assessed.  Both mutants were unable to form usual filament lengths but instead were 
similar to unit length filaments with R239H forming aggregates due to such high 
protein interactions and the R79C mutant having much lower assembly competent 
protein interactions.  R239H had a much greater affinity for αB-crystallin, likely a 
reflection that it has one of the most severe phenotypes.  An absence of divalent 
cations equally affected GFAP assembly resulting in compromised compaction and 
increased filament-filament interactions.  The R120G αB-crystallin mutant results in 
cardiomyopathy and cataract due to aberrant interactions with desmin intermediate 
filaments, due to an increased oligomer size and therefore these interactions were 
studied and compared to wild-type interactions.  Temperature and pH also alter the 
oligomer size of αB-crystallin and were therefore investigated with αB-crystallin-
type III intermediate filament interactions.  It was found that ischemic conditions and 
increased temperatures promote their association, demonstrated by increased co-
pelleting under high speed sedimentations.  There was a preference for binding to 
desmin filaments thus showing how desmin-wild-type αB-crystallin interactions are 
important for homeostasis in muscle.  Passive microrheology was used to 
complement this and investigate how αB-crystallin may be modulating desmin 
filaments under equilibrium.  From these experiments wild-type αB-crystallin 
reduced the frequency-dependent passive viscosity η(f) and the G’, whereas the 
cardiomyopathy- and cataract- causing R120G mutant increased the η(f).  
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1 
Chapter 1; Introduction 
1.1 Intermediate filament (IF) structure. 
There are three main cytoskeleton networks found within metazoan cells that consist 
of actin microfilaments (MFs) responsible for cell motility, microtubules (MTs) that 
enable cell division and IFs (Bayless and Johnson, 2011).  IFs were initially 
identified by Ishikawa et al. in 1968 within myogenic cells localised between 
myofibrils and this was also the first IF to be sequenced fully as the desmin IF 
(Geisler and Weber, 1982, Ishikawa et al., 1968).  There are about 70 different genes 
that encode for IFs highlighting that it is a large protein family (Szeverenyi et al., 
2008).  IFs were originally considered as being just scaffolds within cells but now it 
appears that they are also involved with bearing stress and thus also act to provide 
the cell with support against mechanical stress.  There are six well known main types 
of IF I-VI (Omary, 2009) with type VII and VIII having filaments that share similar 
characteristics with previous types and they are very dynamic structures with 
variable mass-per-lengths (Engel A, 1985).  IFs share a common structure of a 
central α-helical rod domain with an N-terminal head domain and C-terminal tail 
region, both of which are non-α-helical.  The rod domain is composed of four major 
units of 1A, 1B, 2A and 2B, with three linker domains of L1, L1-2 and L2 to connect 
them, as shown in Figure 1.1 (Parry and Steinert, 1995).  LNDR and YRKLLEGE 
motifs are located at the beginning of rod 1 and the end of rod 2, respectively.  These 
are conserved across all IFs and are essential for assembly competence.  Found 
within the type III IFs there is an RP box (RLSL-RM-PP) located at the end of the 
head domain that contains phosphorylation and proteolytic cleavage sites (Ralton et 
al., 1994).  A pre-coil domain is also found within glial fibrillary acidic protein 
(GFAP) at the beginning of the rod 1A region, in common with the other IFs 
(Strelkov et al., 2002).  In contrast to other IFs, nuclear lamins contain a nuclear 
localisation sequence (NLS) that accommodates interactions with chromatin and a 
globular domain at its centre, which is in addition to the chromatin binding site 
present in the rod domain (Glass et al., 1993).  These features are common to all 
lamins except the CaaX sequence is present only in lamins A, B1 and B2 since lamin 
C is a truncated splice variant of lamin A with an alternative ending.  There are two 
other minor forms of lamins, which include lamin C2 and AΔ10 (Nakajima and Abe, 
1995, Machiels et al., 1996).  The globular domain has Ig folds consisting of nine β-
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strands and binds to chromatin, however it works in concert with the NLS and itself 
requires a positive charge.  Mutations in the globular domain have been linked to 
Dunnigan-type familial partial lipodystrophy (FPLD) (Stierle et al., 2003).  There are 
six additional heptad repeats in coil 1B which makes the rod domain 42 amino acids 
longer in all of the lamins (Conway and Parry, 1988).  A variant of chick CP49 
known as CP49ins has been discovered with a similar 41 amino acid insertion in coil 
1B which is the first discovery of a vertebrate IF with a lamin-like insertion resulting 
in a 5-6 nm extension of the rod domain (Sawada et al., 1995).	  	  Lamins also have a 
predicted rod domain, which is entirely α-helical, unlike IF types I-IV, which are 
predicted to have non-α-helical linkers in the rod domain (Conway and Parry, 1988).  
The N-terminal head domain of lamins is also different to other IFs with a lower 
quantity of basic amino acids in a shorter spanning length. 
Nestin and synemin, as with lamins, have a longer C-terminal tail domain, with 
synemin also having a shortened head domain.  NF-M and NF-H also have a long tail 
domain although unlike the tail in lamins containing many domains for specialised 
interactions, neurofilament (NF) tail regions do not appear to have such specific 
binding regions however NF-M and NF-H have repeats of Lys-Ser-Pro, which are 
sites for phosphorylation from Erk1 and 2 (Veeranna et al., 1998).  Synemin has 
similarities to type III IFs but the beginning of the 2A rod domain and the head 
domain are different, with a very short head domain.  NFs consist of three main 
groups of NF light (NF-L), NF medium (NF-M) and NF heavy (NF-H) chains.  Their 
structures differ to other IFs with having a much longer tail region and the chain 
weight corresponds to the length of the tails with NF-L having the shortest and NF-H 
having the longest.  Type VII IFs include filensin and CP49.  CP49 is closely related 
to type I keratins, specifically K18 (Pittenger et al., 2007), despite having a 
divergence from conserved motifs with cytokeratins and the absence of a C-terminal 
tail region, although keratin 19 also lacks a C-terminal tail.  However filensin is 
likely to be a novel IF, although is most closely related to type II keratins (Hess et 
al., 1998).  Filensin also differs from other IFs with a shortened rod domain, by 29 
amino acids, within helix 2 and a much shorter head domain (Gounari et al., 1993). 
Nematodes and mollusks of protostomes have an extended 1B coil domain and a 
lamin-homologous section within their C-terminal tail, which lacks the usual NLS 
and CaaX box observed in lamins (Bovenshulte et al., 1995).  Thus, protostomic 
invertebrate (p-INV) IFs have a longer rod domain due to extra amino acids in the 
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1B domain, in common with nuclear lamins, compared to other IFs (Geisler et al., 
1998).  
 
Type Proteins 
I Acidic keratins 
simple epithelial (K18-21, K23-28) 
stratified epithelial (K9-17) 
hair keratins (K31-40) 
II Neutral and basic keratins 
simple epithelial (K7-8, K71-75) 
stratified epithelial (K1-7, K76-80) 
hair keratins (K81-86) 
III GFAP, desmin, vimentin, peripherin, 
syncoilin 
IV NFs, α-internexin 
V Lamins 
VI Nestin, synemin 
VII Filensin/beaded filament structural 
protein 1 (BFSP1) and CP49/ beaded 
filament structural protein 2 (BFSP2) 
VIII 
 
Invertebrate IF proteins (both 
protostomic and deuterostomic) 
Table 1.1 IF types.   
 
BFSP1 and 2 are categorised in an “orphan” class VII and invertebrate IFs have been 
placed in class VIII.  Keratins are the only IFs spanning two different classes (I and 
II). 
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Figure 1.1 General structures of IF proteins.   
IF monomers are comprised of a rod domain with four left-handed coiled coils of 
1A, 1B, 2A and 2B, separated by linkers of L1, L1-2 and L2.  Region 2B also 
contains a centralised stutter, which is conserved across all IFs (Conway and Parry, 
1988).  An N-terminal head and C-terminal tail region, both of which are globular 
structures, flank the rod domain.  Each monomer forms a right-handed α-helix.  Two 
monomers form a dimer with a left-handed α-helix and the tetramers (protofilaments) 
form left-handed coils.  Finally the tetramers anneal to produce an overall right-
handed coiled-coil structure (Parry and Steinert, 1995).  A) The general structure of 
IFs in groups I-IV is shown (NF-L is represented but NF-M and NF-H have longer 
C-terminal tails) alongside B) the general structure of group V lamins with the 42 
amino acid extension of coil 1B, a globular C-terminal tail domain, a CaaX box and 
a NLS, C) group VI nestin with a long tail region which is 1306 amino acids in the 
human sequence and synemin is similar with a tail domain of approximately 1250 
amino acids in humans and a very short head domain of 11 amino acids and thus 
both proteins have a C-terminal tail 8-10 times longer than other IFs apart from NF-
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H and also D) i BFSP1 with a shortened helix 2 and long tail and ii BFSP2 with the 
absence of a C-terminal tail domain and a long head domain.  The different domains 
within each IF type are to approximate proportions, within each individual IF class. 
 
1.2 IFs; locations, functions and disease. 
Type III IFs are the main focus of this study and will be discussed initially, looking 
specifically at GFAP, desmin and vimentin, alongside overviews of the other types 
of IFs.  GFAP mutants and the CRYAB mutant that are studied in this thesis will 
also be mentioned.  All IFs are tissue-specific and as demonstrated in the following 
sections, mutations in IFs are useful for diagnostic pathology (Omary, 2009). 
GFAP is usually found within glial cells but has other locations such as in retinal 
astrocytes (Bozˇanic´ et al., 2006, Bongcam-Rudloff E, 1991).  Its stage of initial 
expression within the nervous system occurs in radial glia that are responsible for 
dendrite and axon growth and neuronal migration, replacing vimentin near the end of 
gestation and then in astrocytes where it also gradually replaces vimentin levels 
(Middeldorp and Hol, 2011, McCall et al., 1996).  Its function is not fully understood 
although it has been linked to regulating many different aspects within the central 
nervous system (CNS), such as blood brain barrier maintenance and involvement in 
plasticity of the brain such as with decreases in the strength of synapses known as 
long-term depression (LTD) and increases in the strength of synapses, known as 
long-term potentiation (LTP) (Hughes et al., 2004).  Both LTD and LTP are involved 
in loss and gain of memory and learning processes, respectively.  LTD can be 
activated by many different receptors; metabotropic glutamate receptors (mGluRs) 
are a common mechanism and are activated by paired-pulse low-frequency 
stimulation (LFS) in the hippocampus and in the cerebellum requires the 
combination of parallel and climbing fibre stimulation leading to parallel fibre-
Purkinje cell LTD (Ito and Kano, 1982, Brasno and Otis, 2001).  LTP results from 
pre-synaptic high-frequency stimulation (HFS) where calcium enters the post 
synapse and binds to calmodulin thus activating calcium/calmodulin-dependent 
protein kinase II (CaMKII), resulting in phosphorylation of AMPA-type glutamate 
receptors (AMPARs).  This increases conductivity and also phosphorylation of 
stargazin, which enables more AMPARs to traffic to the synapse (Lengyel et al., 
2004).  When GFAP is absent in astrocytes, there is an increase in synaptic plasticity 
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(changes in structure and function of synapses) and LTP, shown in GFAP null mice.  
However CNS morphology and development are the same as wild-type (WT) control 
mice (McCall et al., 1996). There is a reduction in cerebellar LTD in GFAP null 
mice, which is likely due to an increase in the astrocytic excitatory amino-acid 
transporter 2 (EAAT2) protein, responsible for glutamate uptake from synapses 
(Hughes et al., 2004).  However in the hippocampus there is not the same increase in 
EAAT2 protein (glutamate transporter) expression at synapses, despite EAAT2 total 
protein levels having been increased, thus showing that the absence of GFAP has 
inhibited the usual trafficking of EAAT2 to the surface of the cells (Hughes et al., 
2004).  GFAP levels are also altered in reactive gliosis, which is associated with an 
upregulation in GFAP levels, in response to brain insult (Vargova and Sykova, 
2009).  As well as the levels of GFAP protein being linked to different pathological 
states, mutations in GFAP have been linked to Alexander disease (AxD), which is 
discussed in more detail in section 1.5.  GFAP filaments have also been linked to 
inhibition of GTP-dependent chaperone-mediated autophagy and potential 
upregulation of macroautophagy, as seen with AxD when GFAP levels are high 
(Bandyopadhyay et al., 2010).  The presence of GFAP within astrocytes is important 
for modifying the extracellular matrix (ECM) and its absence leads to a more 
homogenous laminin distribution, contrasting +/+ cells that have laminin expressed 
in only certain cells, which influences astroglial differentiation (Menet et al., 2001).  
Within reactive astrocytes (injured astrocytes found in glial scars), GFAP is 
responsible for their positioning during prion disease.  Demonstrated by the irregular 
constricted processes in reactive astrocytes with few glial filaments compared to 
extended processes in normal astrocytes rich in glial filaments (Gomi et al., 2010).  
GFAP is also always an assembly partner of vimentin and in its absence leads to 
collapse of vimentin networks (Eliasson et al., 1999). 
Desmin is found within muscle fibers and acts to provide mechanical support and 
integrity (Chen et al., 2003).  One of the main roles is to provide force transmission 
within striated muscle fibers by attaching and aligning sarcomeres (Shah et al., 
2012).  It also aids in positioning of costameres, which are the sites where the 
sarcolemma makes contact with the internal myofibrils (Pardo et al., 1983).  
Mutations in desmin have been linked with myopathies, including skeletal and 
cardiac and the mutant protein is seen to form aggregates as opposed to normal 10 
nm filaments in some cases and other mutations result in assembly-incompetent 
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protein.  Desminopathies are classed as part of the myofibrillar myopathies and result 
in weakening of muscles, including respiratory and heart if cardiomyopathy is 
present, in patients and is characterised by accumulated protein aggregates (Selcen et 
al., 2004).  Some of the most severe mutations occur in the N-terminal head domain 
in the nonapeptide motif “SSYRRTFGG”, which is highly conserved between 
vimentin and desmin, as shown by aggregate formation for the S13F and R16C 
desmin mutants (Sharma et al., 2009).  K8 and 19 also form filaments at costameres, 
which they organise but are distinct from desmin as they are more important for 
sarcolemmal stability, whereas desmin is primarily involved in force transmission 
(Lovering et al., 2011).  Desmin interacts with many other cytoskeletal proteins at 
the costameres, such as plectin and syncoilin (Moorwood, 2008).  Importantly, 
desmin interacts with αB-crystallin	  (CRYAB) and mutations in CRYAB such as the 
R120G mutant are also responsible for cardiomyopathy and lead to aggregates of 
desmin, which phenocopies the pathology caused by desmin mutations (Perng et al., 
2004, Vicart et al., 1998).  As well as helping to mediate interactions between 
myofibrils and other proteins, such as with the dystroglycan protein complex, desmin 
has been implicated in helping to position nuclei and mitochondria (Shah et al., 
2004).  Desmin knock-out mice display many phenotypes for a diseased state 
including cardiac muscle hypertrophy and death.  When the desmin null phenotype is 
rescued by specific targeting of desmin to cardiac tissue only, there is removal of the 
pathological features, such as calcium deposits, fibrotic lesions, mitochondrial 
malfunction and misalignment of myofibrils (Weisleder et al., 2004).  Desmin has 
also been found localised in the nuclear matrix alongside lamin B and vimentin is 
also known to bind to lamin B in mesenchymal nuclear matrices.  IF assembly is 
believed to be initiated (nucleated) from the nuclear membrane (Georgatos et al., 
1987).   
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Figure 1.2 Schematic image of skeletal striated muscle and associated proteins.   
A single sarcomere (Z-disc to Z-disc) is shown in a myofibril, composed of thin actin 
filaments attached to Z-discs, which overlap with thick myosin filaments.  Magnified 
views are represented by dashed lines and show cytoskeletal proteins that have been 
found in these structures, however are unlikely to show all the proteins present 
especially in the case of the Z-disc which is composed of a large group of different 
proteins (Zou et al., 2006).  Desmin can be seen to be associated with both the Z-disc 
and costameres. 
 
Vimentin, as mentioned earlier, can be expressed within astrocytes but is found 
predominantly in cells of embryological mesenchymal origin, such as fibroblasts 
found in connective tissues, which are the support tissues in the body including blood 
vessels.  There is also a high level of a soluble pool of vimentin in the lens in the 
differentiated fiber cells and undifferentiated lens epithelium and also vimentin 
filaments in smooth muscle cells as independent or co-dependent populations of 
filaments with desmin (Nicholl and Quinlan, 1994, Wang et al., 2006).  Within 
smooth muscle cells, vimentin is attached to the desmosomes and downregulation 
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impairs plakoglobin (a major desmosomal protein) membrane localisation (Wang et 
al., 2006).  Vimentin is associated with cell motility and expression is correlated with 
invasiveness (Pana et al., 2012).  This has been shown by an increase in motility and 
invasiveness of cancer cells induced by the presence of vimentin (Hendrix et al., 
1997).  Vimentin is also found in cells responsible for regulation of mechanical stress 
(Kuna, 2012).  The tail region of vimentin is able to bind to actin microfilaments 
(MFs) but also vimentin is able to bind to the actin-binding protein fimbrin and thus 
is able to indirectly interact with MFs (Correia et al., 1999, Cary et al., 1994).  MTs 
can also bind to vimentin and this interaction results in collapse (centripetal 
movement of filaments into a dense coil near the nucleus) of vimentin networks 
when MTs have depolymerised (Cary et al., 1994).  As well as other cytoskeletal 
proteins, vimentin is able to interact with other cellular structures such as organelles 
and in particular the Golgi complex (Gao and Sztul, 2001).  One recent study showed 
that vimentin may be responsible for stabilising collagen mRNA levels, by binding 
to LARP6 at the 5’ stem-loop sequence of collagen mRNA and may help to maintain 
collagen levels (Challa and Stefanovic, 2011).  Vimentin can therefore interact 
specifically with RNA but also DNA (Traub et al., 1983).  It is likely that vimentin 
and GFAP also play roles as nuclear matrix proteins as they have both been shown to 
be able to bind to DNA Holliday junctions, with a lesser extent with GFAP and they 
can induce secondary cruciform branch points in DNA, however they can’t enter the 
nucleus and likely therefore interact with DNA during mitosis (Li et al., 2003).  After 
non-ionic detergents have been used on eukaryotic cells, the cytoplasmic IFs remain 
associated with the outside of the nucleus showing that there is binding occurring.  
Vimentin is carried into the nucleus via a binding partner, examples of which are 
oligo (dG)25 and double-stranded DNA, such as superhelical extrachromasomal 
circular DNA (eccDNA) and once in the nucleus it will likely act to help the cell 
respond to different environmental pressures (Hartig et al., 1998).  No diseases have 
been reported in humans due to mutations in vimentin, however a few studies 
generating mutated vimentin in regions similar with other IFs associated with disease 
have shown that vimentin disruption can lead to disease in mice.  This was 
demonstrated with posterior cataracts in the eye lens fibers (Bornheim et al., 2008).  
Citrullinated vimentin, as mentioned in section 1.4, however has been found 
associated with rheumatoid arthritis and results in collapse of IF networks (Kuna, 
2012). 
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IF Function Disease Cause/ 
correlation 
Reference 
Keratins Support 
epithelial 
cells against 
stress 
 
Epidermolysis 
bullosa 
simplex (EBS) 
Epidermolytic 
ichthyosis 
Palmo-plantar 
keratoderma 
Mutation in: 
K5 and 15 
 
 
 
K1 or 10 
 
K9 
(Bchetnia et 
al., 2012, 
Ishida-
Yamamoto et 
al., 1995, 
Chamcheu et 
al., 2011, 
Sybert et al., 
1999) 
Peripherin Regeneration 
of axons and 
neurite 
elongation 
Amyotrophic 
lateral 
sclerosis 
(ALS) 
Mutation (Eriksson et 
al., 2008, 
McNulty and 
Saunders, 
1992) 
Syncoilin Lateral force 
transmission 
Congenital 
muscular 
dystrophy 
Increased 
levels 
(Brown et al., 
2005) 
NFs Axon radial 
growth 
Alzheimer’s 
disease (AD) 
Parkinson’s 
disease (PD) 
ALS 
Lower NF-L 
 
Lower NF-L 
 
Phosphorylat
ed NFs 
(McLachlan 
et al., 1988, 
Hill et al., 
1993, 
Manetto et 
al., 1988) 
α-
internexin 
Axonal 
outgrowth 
Oligodendrogl-
iomas 
1p19q 
codeletion 
(Ducray et 
al., 2009) 
Lamins Nuclear 
shape and 
stability 
Hutchinson-
Gilford 
progeria 
syndrome 
(HGPS) 
Mutation in 
LMNA 
(Yang et al., 
2011) 
Table 1.2 Summary of IFs and associated diseases. 
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Here is a summary of IFs, apart from the three studied in this thesis, showing 
function and correlated disease. 
 
 
IF Function Disease Cause/ 
correlation 
Reference 
Nestin Promotes 
muscle 
differentiation; 
inhibits pro-
apoptotic cdk-
5 activity 
Pancreatic 
and breast 
cancer 
Increased 
levels of 
nestin 
(Su et al., 2011, 
Sahlgren et al., 
2006, Ishiwata 
et al., 2011) 
Synemin Muscle 
integrity 
Walker-
Warburg 
syndrome 
(WWS) 
Decreased 
levels of 
synemin 
(Tawk et al., 
2003) 
BFSP1 Transparency 
of eye lens 
Cataract BFSP1 
mutation 
(Ramachandran 
et al., 2007) 
BFSP2 Transparency 
of eye lens 
Cataract BFSP2 
mutation 
(Cui et al., 
2007) 
Table 1.3 Summary of IFs and associated diseases. 
Here is a continuation of the summary of IFs, apart from the three studied in this 
thesis, showing function and correlated disease. 
 
 
Keratin, peripherin, syncoilin, NFs, lamins, nestin, synemin, BFSP1 and BFSP2 
disease associations are reviewed in Table 1.2 and 1.3 since the main focus of the 
thesis is on the type III IFs desmin, GFAP and vimentin. 
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1.3 IF assembly and influence of divalent ions. 
IF assembly occurs in a sequential process and the main theory of assembly involves 
the initiating building block being the result of hydrophobic interactions and is the 
dimer, of which two become associated in a tetramer in the A11, A22, A12 or ACN 
conformation (protofilament), experimentally derived c.f. Figure 1.3.   
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Figure 1.3 Type III and NF IF tetramer assembly. 
A) A single α-helical dimer associates B) in either the A11, A22, A12 or ACN 
conformation (protofilament) with another dimer.  The grey region represents the 
overlap of regions 1A and 2B in the ACN conformation. 
 
The monomeric central rod domain has a heptad repeat (a-b-c-d-e-f-g)n where amino 
acids in positions a and d are apolar and mediate the hydrophobic interactions that 
are parallel with the axes of the dimers and ionic interactions occur between amino 
acids of opposite charges in positions e and g (Parry and Steinert, 1995).  Two 
tetramers then associate together to form an octamer and four octamers then form a 
thirty two-mer.  Thirty two-mers, known as unit-length filaments (ULFs), then 
anneal longitudinally with other thirty two-mers and finally compact to form the 
mature filament.  It has been proposed however that the A12 alignment is unlikely to 
mediate interactions between the dimers but it is rather just an arrangement of the 
molecules for adjacent protofilaments (Meng et al., 1996).  NFs and vimentin are 
believed to assemble according to the proposed method outlined above with the 
initial lateral alignment of tetramers which then lengthen, however heteropolymers 
of type I (acidic) and type II (basic) keratins initially form octamers which anneal 
longitudinally, thus lengthening the filament before the usual thirty two-mer 
formation step, as seen with vimentin filaments (Herrmann et al., 1999).  The RP-
box is essential for GFAP assembly and is conserved also in desmin and vimentin.  
Its sequence of RLSL-RM-PPLP is just before the rod domain and removal of the 
first half of the RP-box results in shortened, less stable filaments (Ralton et al., 
1994).  As mentioned earlier there are also the LNDR and TYRKLLEGE conserved 
sequences essential for IF assembly.  Mutations in the LNDR sequence are 
associated with different diseases such as EBS and corneal dystrophy with a high 
proportion occurring at the arginine residue, most likely due to conversion of 
cytosine to thymine due to deamination.  Mutations in the latter TYRKLLEGE 
sequence are associated with impaired filament elongation as seen with the 
substitution of tyrosine for alanine in keratins 8 and 18 in vitro (Hess et al., 2005, 
Hatzfeld and Weber, 1991).  The N-terminal head domain is essential for filament 
formation and is not only required for cytoplasmic IF assembly but also nuclear 
lamin assembly and the C-terminus likely modulates the assembly (Heitlinger et al., 
1992).  The assembly of apolar IFs is different to MTs and actin, which both have 
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been modeled as having subunits associated in a treadmilling process mediated by 
polarity.  Actin exists, for F-actin, in a plus and minus ended state with ATP being 
hydrolysed and ADP-actin dissociation occurring from these regions, respectively 
(Fujiwara et al., 2002).  MTs are similar to actin filaments except GTP and GDP are 
used for the growth and shortening ends.  Contrary to this, IFs do not metabolise 
nucleotides and it has been shown that addition of nucleoside triphosphates to bovine 
GFAP filament networks hinders filament formation likely due to introduction of a 
negative charge to the assembly buffer (Yang and Babitch, 1988).  There is another 
model in addition to the treadmilling model, also known as the Wegner model or 
differential dynamic instability model that proposes phases of sustained growth and 
rapid shortening of tubules and filaments, however both models are predicted to 
occur for MFs and MTs (Grego et al., 2001). 
Nuclear lamins are different to other IFs in that their assembly involves head-to-tail 
association of dimers prior to their longitudinal assembly.  The C-terminal domain is 
more crucial for lamin formation than other IFs as its deletion results in aggregate 
formation (Moir et al., 1991).  Nuclear lamins do not form tetramers but instead have 
an NC-overlap of dimers which is distinct only to non-cytoplasmic IFs (Geisler et al., 
1998).  P-INV IFs are similar to lamins in that they initially form octamers, which 
then laterally associate and finally form the mature filament, however whilst nuclear 
lamins form head-to-tail polymers which lengthen and laterally align, the 
protostomic IFs form tetramers which lengthen and laterally align (Geisler et al., 
1998). 
Recombinant BFSP1 and 2 assembly in vitro results in beaded filaments (filaments 
with a 6-8 nm backbone that appear to be regularly decorated with 12-15 nm beads 
or nodules) although they appear different to native beaded filaments assembled in 
vitro and are thought to consist of BFSP1/BFSP2 tetramers that are released from the 
inner core of the filaments with BFSP1 tails facing the exterior.  When α-crystallin is 
added to the two proteins, the beads appear more similar to the native structures 
(Goulielmos et al., 1996, Carter et al., 1995).  The beaded filament proteins BFSP1 
and 2 can form 10 nm diameter filaments although the optimal conditions for 
assembly are different to the cytokeratins, which they are predicted to be most 
similar to due to sequence similarities.  The reason why BFSP1 and 2 assemble 
together in a non equimolar ratio, whereas the cytokeratins do not, is likely due to a 
number of factors such as the inherent shorter rod 2 domain of BFSP1 compared to 
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BFSP2, the LNDC sequence replacing LNDR in BFSP2 that is unique amongst IFs 
and LNER replacing LNDR in human BFSP1 alongside RYHRIIE(I/N)EG replacing 
YRKLLEGE.  BFSP1 can form 10 nm short filaments whereas BFSP2 forms 
predominantly aggregate structures with a few short filaments and it is only until the 
two proteins are co-assembled (2:1 molar ratio of BFSP2: BFSP1) that 10 nm 
filaments result (Carter et al., 1995, Perng et al., 2007).  
Some IFs are able to form filaments as homopolymers such as type III IFs, α-
internexin and NF-Ls.  However many others need another IF to form filaments.  
This includes synemin, keratins, nestin and NF-M and NF-H chains, which both need 
NF-L (Steinert et al., 1999, Lee et al., 1993).  Desmin can form heteropolymers with 
vimentin and also synemin and most of the type III IFs can co-polymerise with other 
type III proteins, such as GFAP with vimentin (Quinlan and Franke, 1982, Sharp et 
al., 1982).  Nestin and synemin both need other IFs to assemble and the details of 
assembly are not fully known at this moment, in addition to how BFSP1 and BFSP2 
form filaments, therefore Figure 1.4, which details comparisons between the 
different types of IF assemblies, excludes type VI and VII. 
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Figure 1.4 Comparison of different IF assembly mechanisms. 
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Only type I and II and type III and IV IFs share a common mechanism of assembly 
thus highlighting how variable assembly is between the different classes.  This likely 
reflects their sites of expression and specific functions required.  The assembly 
process will influence the surface structure of the filaments and how sHSPs are able 
to interact.  Type VI and VII IF assembly processes are omitted, as it is not clear at 
this moment in time as to the full details of how filament assembly occurs. 
 
 
Cells such as Bergmann and Schwann cells co-express GFAP with vimentin and this 
association of the two filament networks is required to maintain the stability of the 
GFAP filaments, as it was shown in Vim-/- mouse cerebellar extracts that there was 
an increase in the soluble pool of GFAP compared to Vim+ control mice (Galou et 
al., 1996). 
The N-terminal head domain appears to be essential for most IF assembly and the C 
terminal tail regulates filament formation.  This has been demonstrated from the 
splice variant GFAP ε, which has the usual exons 1-7 plus an additional exon 7a 
alongside missing exons 8 and 9, which forms aggregates.  However it is most likely 
that the absence of the tail domain has no significant effect on filament formation on 
its own, demonstrated from when the tail region of GFAP ε was transfected into cells 
with GFAP α and there was no effect on filament formation.  Therefore the 
combined interactions between the tail, head and rod domains must mediate the 
disruptive effects (Nielsen and Jorgensen, 2004).  The head domain is crucial for 
GFAP assembly, particularly the MERRRITS-ARRSY sequence which when 
removed by thrombin results in an inability to form filaments (Ralton et al., 1994). 
Different IFs require different assembly conditions, for instance vimentin does not 
form usual IFs when assembled in low pH, as used for NF-L filaments.  Also the 
assembly rodlets of vimentin in tris(hydroxy-methyl)aminomethane (Tris)-HCl (pH 
8.4) are different to those soluble structures formed with simple epithelial keratins 
that require a higher pH to begin filament formation, although epidermal keratin 5 
and 14 are able to form filaments at pH 8.4 (Herrmann et al., 1996).  When vimentin 
filaments are assembled in a 25 mM Tris-HCl (pH 7.5) and 50 mM NaCl buffer, 
after two seconds ULFs are observed whereas the simple epithelial keratins 8 and 18 
have already formed long IFs.  In addition, different IFs form filaments with 
differing numbers of molecules per cross-section despite being assembled in the 
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same buffer conditions, thus highlighting differences in assembly which are likely 
due to differences in interactions between the N-terminal head and rod domains, the 
result of sequence differences (Herrmann et al., 1999). 
Divalent cations are essential for the formation of IFs and have an influence on how 
many monomers undergo annealing.  Amphibian vimentin assembled with 5 mM 
Ca2+ ions forms twice as thick filaments compared to usual 10 nm widths, although 
retaining the usual 20 nm cross-striation pattern (Hofmann et al., 1991).  There is a 
high-affinity Ca2+- Mg2+ binding site in coil 2B of GFAP that is highly important for 
mediating assembly, showing that these divalent cations are crucial for normal IF 
assembly (Yang Z W., 1988).  In addition there is a Ca2+- Mg2+ binding site in the C-
terminal tail that mediates cross-linking (Lin et al., 2010a).  Monovalent cations do 
not promote filament formation as well as divalent cations and regarding Cu2+ and 
bovine GFAP assembly, there is an induction of aggregates instead of filaments 
(Yang and Babitch, 1988).  When bovine GFAP is assembled at physiological pH 7.4 
without divalent cations, only rod structures are formed.  However, when divalent 
cations are added, filament formation results (Tanaka et al., 1989).  Also thicker 
GFAP filaments are observed at lower pH and upon addition of higher 
concentrations of Ca2+ divalent cations, which likely reflects a reduction in the 
negative charges of the acidic amino acids thus restricting repulsive forces between 
the residues (Tanaka et al., 1989).  IFs consist predominantly of negatively charged 
amino acids and similar to the effects seen with actin filaments and viruses, addition 
of divalent magnesium cations acts to attract parallel fibres and virus particles (Wen 
and Tang, 2006).  They act as effective molecular cross-links in IFs by interacting 
with the negative sidearms of the IFs which comprise the tail regions (Lin et al., 
2010b).  Desmin is also influenced by different divalent cations and has been 
assembled in Cu2+ and Ni2+ ions which were shown to promote increased filament 
widths compared to Ca2+ and Mg2+ ions (Stromer et al., 1987).  Divalent cations 
mediate cross-links between the final 11 amino acid residues in the tail region of 
vimentin (tails of separate vimentin IFs bind to each other) showing their importance 
in modulating filament interactions.  Therefore, it appears that the C-terminal tail is 
highly important for binding to divalent cations and this will be the reason why with 
desmin filaments if the C-terminal tail is truncated there is an absence of strain 
stiffening (measure of toughness and stiffening of IFs due to their stress state) (Lin et 
al., 2010a, Bar et al., 2010).  The C-terminal domain has been shown to mediate 
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forces upon the vimentin network toward the cell periphery, which opposes the head 
domain forces towards the nucleus, which can result in nuclear import and supports 
the idea that vimentin binds to DNA and thus the tail region has very specific 
mechanisms (Lowrie et al., 2000).  As well as the ionic environment, temperature 
has been shown to be an important factor in regulating species variability in 
assembly, with the example of frog vimentin, which has partially unraveled sections 
of filaments at 4 0C in contrast to normal filaments with trout vimentin (Herrmann 
and Aebi, 1999).  GFAP filaments are also dependent upon assembly temperature, 
demonstrated with 23 0C resulting in shortened filaments compared to 37 0C in the 
absence of cations (Tanaka et al., 1989). 
 
1.4 IFs; modifications. 
There are many potential modifications of IFs such as phosphorylation, acetylation, 
ribosylation, O-glycosylation, myristoylation and cleavage.  Unlike MTs and MFs 
that are mainly modified by other proteins, IFs are predominantly phosphorylated 
when modified (Westermann and Weber, 2003, Kawauchi et al., 2006).  An example 
of modulation of microfilaments is where Cdk5 and p27 act to suppress 
phosphorylation of cofilin and increase its activity thus resulting in actin 
reorganisation via direct interactions between cofilin and the actin filaments 
(Kawauchi et al., 2006).  Phosphorylation of vimentin has been linked to axonal 
growth and in vivo, results in depolymerisation of the filaments (Eriksson et al., 
2004, Chang et al., 2012).  GFAP has key phosphorylation sites in its N-terminal 
head domain (serine and threonine residues) for cAMP-dependent protein kinase and 
protein kinase C, which when phosphorylated result in disassembly of the filaments 
and this is also common to vimentin and desmin which also have their 
phosphorylation sites located in the head domain (Inagaki et al., 1990).  This is 
relevant to mediate cytoskeletal framework remodeling within mitotic cells 
(Takemura et al., 2002).  The RP box, at the end of the head domain, in GFAP is also 
phosphorylated at anaphase (Matsuoka et al., 1992).  Therefore in summary, it is the 
phosphorylation leading to global disassembly of IFs that enables the filaments to 
become solubilised and free for future IF polymerisation, which is the result of 
changes in the charge of the head domain with the introduction of a negative 
phosphate group (disrupting the charges of amino acids crucial for ionic 
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interactions).  Regarding myopathy-linked desmin mutations, most involve 
replacement of serines with hydrophobic residues, which will ablate key 
phosphorylation sites thus implicating a deregulation in phosphorylation of desmin 
as a potential factor in the disease state (Sharma et al., 2009).  NFs are known to be 
phosphorylated within their C-terminal tail domain, which will affect their transport 
(through axons) and function (Parry and Steinert, 1995).  Also they are 
phosphorylated in the N-terminal head domain alongside O-glycosylation, however 
NF-M head domain phosphorylation inhibits the phosphorylation of the C-terminal 
tail showing that different domains can modulate each other in an IF (Zheng et al., 
2003, Dong et al., 1993).  O-glycosylation is likely to influence how axons grow and 
interactions of NFs with other filaments (Ludemann et al., 2005).  Phosphorylation 
also affects the assembly status of other IFs in the type III group and also type VI, 
keratins and lamins, however there are no phosphorylation sites in the central domain 
of any IFs as the coiled coils restrict kinase access.  With EBS it is thought that the 
mutations in the keratin proteins will increase or restrict how kinases are able to 
phosphorylate the proteins due to conformational changes in the tertiary structures 
(Jerábková et al., 2010).  During a normal cell cycle, keratins 8 and 18 are 
phosphorylated to enable disassembly and then interactions with the regulatory 
protein 14-3-3.  Keratin 18 is phosphorylated at Ser33 and interacts with 
dephosphorylated 14-3-3 proteins (Ku et al., 1998).  14-3-3 proteins also influence 
GFAP and vimentin filaments and have specific binding to each, independent of each 
other.  The binding occurs mostly at the S and G2/M stages of the cell cycle when 
hyperphosphorylation of the filaments occurs via cell cycle-dependent kinases (Li et 
al., 2006).  Nestin is phosphorylated by cdk5 in myogenic differentiation resulting in 
reorganisation and it is thought that this may be linked to migration of cancer cells 
(Sahlgren et al., 2003, Kleeberger et al., 2007).  Synemin is also known to be 
phosphorylated (Sandoval et al., 1983).  BFSP1 and 2 are both phosphorylated with 
the main sites located in the tail domain of BFSP1 and in the head domain of BFSP2.  
This will mediate the localisation of the proteins as it has been shown with BFSP2 
that phosphorylation increases its lens fiber membrane localisation (Ireland et al., 
1993).  Vimentin is ADP ribosylated in the N-terminal head by the mono-ADP-
ribosyltransferase (ADPRT)	   SpyA, which mediates disassembly of filament 
networks (Icenogle et al., 2012).  This ribosylation of vimentin can be induced by 
brefeldin A (BFA) however is not involved with mediating the downstream bundling 
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effects of vimentin filaments after administration (Styers et al., 2006).  Citrullination, 
the result of deimination of arginines, appears to occur with GFAP and levels may be 
correlated with multiple sclerosis (MS) (Nicholas et al., 2003).  Citrullination has 
also been found with vimentin and correlated with rheumatoid arthritis (Kuna, 2012).  
Deimination of arginine residues also occurs with desmin and vimentin resulting in 
filament disassembly (Inagaki et al., 1989).  Truncation (due to proteolytic 
processing) is another process, which is the result of aging lenses and results in two 
main fragments of BFSP1.  The first one includes the N-terminal head domain, the 
rod domain and part of the C-terminal domain (53 kDa).  The second contains the 
rest of the C-terminus (29 kDa) (Sandilands et al., 1995b).  Another C-terminal 
fragment of 51 kDa has also been found within the nucleus of the lens and other 
varying molecular weight fragments of the C-terminal tail have been identified up to 
62 kDa (Brunkener and Georgatos, 1992).  Truncation seems to be important for 
mediating the posttranslational N-myristoylation in BFSP1, which implicates 
apoptotic events occurring within the lens and helps mediate binding of the proteins 
within membranes.  The apoptotic caspases are responsible for normal lens organelle 
degradation (Zandy et al., 2005).  The truncation process is thought to stabilise the 
beaded filament proteins (they localise from the cytoplasm to the membranes) and 
for BFSP1 the truncated 53 kDa form is still able to co-assemble with BFSP2 and 
forms distinct secondary structures to full-length BFSP1 (Sandilands et al., 1995b).  
In young lens fibre cells where differentiation is a relatively recent process, BFSP1 
and 2 are predominantly in the plasma membrane (Sandilands et al., 1995a).  
Acetylation also occurs after truncation, which results in a charge change and 
potential structural changes (Wang et al., 2010).  Therefore aging results in various 
modifications of the BFSP1 protein, which likely help maintain the transparency of 
the lens.   
Caspases are involved in cleaving different proteins and have been found to target 
GFAP, vimentin and desmin.  They are classified within two main groups of initiator 
(caspases-2, 8, 9 and 10) and executioner (caspases-3, 6 and 7) caspases, which are 
involved in either the intrinsic pathway for apoptosis where intracellular signals 
initiate the pathway, or the extrinsic pathway which is started from death receptors 
binding to ligands (Amarante-Mendes and Green, 1999).  Desmin is cleaved by 
caspase-6 in response to apoptosis and the N-desmin that results acts to dominantly 
inhibit desmin and vimentin assembly (Chen et al., 2003).  Most caspase cleavage 
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sites are found within the linker 1-2 domain of IFs (Caulin et al., 1997).  GFAP can 
be cleaved by caspase-3 in AD brain and this can also be induced in acute postnatal 
injured rat brain alongside cleavage of vimentin in the reactive astrocytes (Mouser et 
al., 2006).  AxD mutant GFAP also induces the cleavage and thus activation of 
caspase-3, which in turn results in its cleavage (Chen et al., 2011).  Vimentin has 
been found to be cleaved by caspase-4 in situations leading to apoptosis, releasing 
p53 usually bound in a complex and activation of pro-apoptotic bax after its 
translocation into the nucleus (Yang et al., 2005).  Therefore it can be seen that 
caspases act on many different IFs. 
 
Response IF Modification Reference 
Disassembly of IFs and 
binding to 14-3-3 
GFAP Phosphorylation (Inagaki et al., 
1990, Li et al., 
2006) 
Reactive gliosis  Caspase-3 
cleavage 
(Chen et al., 2011) 
Lymphocyte migration 
and axonal growth. 
Vimentin 
 
Phosphorylation 
 
(Chang et al., 2012, 
Nieminen et al., 
2006, Icenogle et 
al., 2012) 
Disassembly of IFs  Ribosylation (Icenogle et al., 
2012) 
Release of cytosolic 
p53 and apoptosis  
 Caspase-4, 
caspase-6 and 
caspase-3/7-like 
protease 
cleavage 
(Yang et al., 2005, 
Byun et al., 2001) 
Disassembly of IFs Desmin Phosphorylation (Inagaki et al., 
1988) 
N-desmin (dominant 
inhibitor of assembly) 
 Caspase-6 
cleavage 
(Chen et al., 2003) 
Table 1.4 Summary of IF modifications.  
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Here is a summary of the most common modifications noted of IFs and all IFs have 
been documented as having the potential to be phosphorylated (Chou et al., 1989). 
 
Response IF Modification Reference 
Binding to 
mitochondria and 
axonal transport 
NFs Phosphorylation (Wagner et al., 2003) 
(Parry and Steinert, 
1995) 
Surface modulation  O-glycosylation (Dong et al., 1993) 
Disassembly of IFs Lamins Phosphorylation (Hennekes et al., 
1993) 
Surface modulation  O-glycosylation (Ferraro et al., 1989) 
Membrane affinity  Isoprenylation (Hofemeister et al., 
2000) 
Protein interactions and 
localisation 
Keratin
-18 
O-glycosylation (Ku et al., 2010) 
Localisation BFSP1 Phosphorylation (Wang et al., 2010) 
Membrane binding and 
regulation of the 
cytoskeleton in 
apoptosis 
 N-
myristoylation 
(Wang et al., 2010) 
Structural changes  N-acetylation (Wang et al., 2010) 
Membrane affinity BFSP2 Phosphorylation (Ireland et al., 1993) 
Structural changes  N-acetylation (Wang et al., 2010) 
Table 1.5 Summary of IF modifications.  
Here is a continuation of some common modifications. 
 
 
As can be seen from the above potential IF modifications, whether it be 
physiological or pathological, many different processes require IFs to be altered and 
this highlights how varied their roles are within cells. 
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1.5 AxD and GFAP mutants. 
AxD is a fatal disease, the result of a heterozygous mutation within the GFAP gene.  
W.Stewart Alexander first identified the disease in 1949, 51 years after Rosenthal 
fibers were noted by the German pathologist Werner Rosenthal (Alexander, 1949).  
The most common mutations occur at positions R79 and R239 in the GFAP protein, 
accounting for more than half of all documented mutations and it is believed that 
they act in a gain-of-function manner (Hagemann et al., 2005).  These are commonly 
mutated due to the presence of a cytosine next to a guanine in the DNA sequence, 
separated by a phosphate group (Cooper and Youssoufian, 1988).  Patients present 
with seizures, macrocephaly, dysphagia and Rosenthal fibers, which contain GFAP 
predominantly alongside CRYAB and p62, which is a ubiquitin-binding protein 
(Shiroma et al., 2001).  In addition, GFAP is over-expressed in AxD, likely resulting 
in inhibition of chaperone mediated autophagy and upregulation of macroautophagy 
(increases in p38 signaling down regulates mTOR).  Chaperone mediated autophagy 
is a form of the autophagic and lysosomal degradation system which involves the 
binding of the foldase hsc70 to mis-folded proteins which are brought to lysosomes 
and are then translocated via the lysosome-membrane protein type 2A (LAMP-2A) 
receptor complex, through lysosomal membranes, destined for degradation in the 
lysosomal compartment (Chiang et al., 1989).  Macroautophagy is different to this 
process since autophagosome vesicles are involved which transport cargo to 
lysosomes where fusion of membranes occurs and contents are released into the 
lysosomes for degradation (Itakura and Mizushima, 2010).  
There are many mutations associated with AxD with three main types of infantile, 
juvenile and adult onset and all three have been associated with mutations occurring 
throughout the whole of the GFAP molecule.  Over-expression of WT GFAP leads to 
protein aggregates, however mutant GFAP is more prone.  Despite the three different 
ages of onset, the same mutation can lead to different ages of onset and thus it is 
difficult to pinpoint the exact determining factors leading to the development and 
presentation of the disease.  It is therefore likely that environmental and additional 
genetic factors contribute to disease development.  Mutant GFAP leads to an 
upregulation in the MLK2-JNK pathway and accumulation of CRYAB; it is likely 
that there is upregulation of JNK downstream pathways (causing direct increases in 
GFAP levels) and inhibition of proteasome function also leading to accumulation of 
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GFAP protein which is supported by the finding of activated JNK (phosphorylated 
JNK) being shown to interact direct with over expressed WT and mutant GFAP in 
cells (Tang et al., 2006).  R239C mutant GFAP can inhibit the proteasome system 
and it has been proposed that the larger oligomer complexes may bind to the 
proteasomes and thus not be effectively degraded.  The mutant GFAP reduces the 
cytosolic stores of the ubiquitin-proteasome system and is inefficiently degraded 
within proteasomes (Tang et al., 2010).  Cdc42 and rac small GTPases are known to 
activate the stress-induced JNK pathway alongside the p38 MAPK pathway, which is 
regulated by rho (Lim et al., 1996).  In AxD, both of these pathways are upregulated 
and since the cause of AxD is mutated GFAP, some intermediary stages will be 
required for activation of these signaling pathways and it is thus possible that the 
upstream signaling initiators of the GTPases are involved with interacting with the 
altered filament surface, the result of mutations.  As well as certain signaling 
molecules being affected in AxD, transporter proteins can also be altered such as 
glt1, which is a glutamate transporter found in astrocytes and has reduced levels in 
mice heterozygous for the R236H mutated GFAP, likely due in part to upregulation 
of the MAPK pathway, however expression of CRYAB is able to increase Glt1 
expression (Hagemann et al., 2009). 
Many other neurodegenerative diseases have also been correlated with inefficient 
autophagy mechanisms, such as Huntington’s, AD and Parkinson’s disease (Cheung 
and Ip, 2011).  These diseases are also associated with insoluble protein aggregates, 
similar to AxD.  In the AD brain there is also induction of the caspase cleavage of 
GFAP, which results in the GFAP caspase-cleavage product (CCP) antibody (Ab), 
directed towards the C-terminal cleavage product after DLTD266, colocalising with 
activated caspase-3 in astrocytes.  In response to reactive gliosis, astrocytes cluster 
around senile plaques, which consist of β-amyloid peptide (Aβ) and release 
inflammatory mediators.  The upregulation of activated caspase-3 in AD brain 
reflects most likely the increase in turnover of the GFAP as opposed to an increase in 
apoptotic cell death (Mouser et al., 2006).  Figure 1.5 highlights the structure of a 
monomer of GFAP, including AxD documented missense mutations discovered to 
date, including the two mutations looked at in this study of R79C and R239H. 
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Figure 1.5 Schematic diagram of a human GFAP monomer alongside known 
mutations. 
A diagram of human GFAP is shown above.  The yellow line represents the head 
domain, the gray line represents the pre-coil domain, the red boxes represent the rod 
coiled-coil domains, the orange lines represent the linker regions and the blue line 
represents the tail domain.  The R79C and R239H mutation points are highlighted 
with vertical arrows, with R79C located within the LNDR motif in the 1A region of 
the rod domain and the R239H mutation located within the 2A region.  Other 
mutations are listed in the boxes and it is shown that most mutations occur in the rod 
domain with very few in the tail region and the only mutation documented so far 
before coil 1A is K63Q, which is positioned in the pre-coil domain.  No mutations 
have been documented in the head domain (Brenner et al., 2009, Messing, 2012, Li 
et al., 2005). 
 
1.6 Rheological properties of filament networks. 
Filament networks are viscoelastic showing both solid (elastic) and viscous (liquid) 
components.  Microrheology is a method assessing the properties of colloidal 
substances, which are generally microspheres in the range of 0.001 µm to several 
µm, within a soft material; it specifically looks at the thermal fluctuations of particles 
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to derive linear response functions of the material, utilising the generalised Stokes-
Einstein relation (GSER).  Passive microrheology involves deriving the response 
functions of a material using tweezers to hold the particles in place.  There are a few 
other rheological methods, not using probe particles, such as the utilisation of a 
rotating plate that applies force to a material held against another parallel stationary 
plate and measures the strain (Dhori et al., 1997).  Diffusing-wave-spectroscopy 
(DWS) is similar to single-particle video tracking microrheology except light is 
measured after being scattered from many microspheres to derive an autocorrelation 
function which is then used in the GSER; it measures the properties of isotropic 
solutions (Palmer et al., 1999).  Dynamic light scattering (DLS) involves a laser 
beam illuminating a sample, which is then deflected and the scattered light intensity 
is then converted into an auto-correlation function (Chastek et al., 2008).  The atomic 
force microscope (AFM) applies relatively high forces to a material using a tip 
attached to a cantilever and deformations in the material are used to derive the shear 
modulus (Radmacher et al., 1993).  From all methods, the dynamic shear modulus G 
can be derived which is composed of both the real storage (G’) and imaginary loss 
(G’’) moduli in the equation G = G’ + iG’’.  Optical tweezers were first 
demonstrated in 1986 allowing manipulation of objects, which could be trapped by a 
Gaussian laser beam (Ashkin et al., 1986).  Microrheology has many advantages 
over standard rheology such as minimal invasive disruption in the samples and the 
ability to measure a wide range of frequencies, since rotational rheometers generally 
are limited to frequencies below 100 Hz (Willenbacher and Oelschlaeger, 2007). 
Various rheological methods have been used to assess the properties of filament 
networks, such as displacement and stretching of filaments to discover that they 
likely act as shock absorbers in cells (Kreplak et al., 2005).   
From strain stiffening experiments in vitro it has been shown that different filaments 
have different strain-stiffening properties, which are conducive to the different 
responses required of the filaments dependent upon where they are situated, such as 
vimentin within fibroblasts and desmin found in muscle cells (Schopferer et al., 
2009).  The importance of different regions of desmin on filament function has also 
been derived from strain-stiffening experiments giving important biophysical 
information on filament properties (Bar et al., 2010).  Comparing desmin and 
vimentin networks it has been shown that desmin has greater attractive forces and 
strain stiffening at low salt concentrations that is absent with vimentin filaments 
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(Schopferer et al., 2009).  A more in-depth insight into filament assembly for 
vimentin has also been gathered using strain-stiffening experiments with divalent 
cations showing that these act as cross-linkers within the tail region of the IF (Lin et 
al., 2010a).   
IFs are semi-flexible polymers; however there also exist flexible and rigid polymers.  
Semi-flexible polymers have a persistence length (a length scale for the decay of 
tangent-tangent correlations) which is equivalent to their contour length (total 
filament length) and completely elastic and rigid polymers are either made up of a 
greater contour length with an entirely entropic elastic response or a greater 
persistence length with no entropic elasticity, respectively (Storm et al., 2005).  
Rheology gives a general overview of the properties of filament networks that need 
to be supplemented with other methods to assess more local changes (individual 
filaments), such as thermal fluctuation measurements (Noding and Koster, 2012). 
 
1.7 Heat shock proteins. 
There are five main classes of heat shock protein, c.f. Table 1.6, with classes 1-4 
utilising ATP and known as foldases and class 5 corresponding to the small heat 
shock protein (sHSP) family, which are ATP-independent and known as holdases 
(Karplus et al., 2005). 
Class I, also known as chaperonins, consists of groups II and I.  Group I includes the 
bacterial HSP60 and GroEL, which is found in E.coli and consists of two rings each 
composed of seven subunits, both of which are referred to as having a double donut 
quaternary shape.  GroES binds to GroEL at the apex in the presence of ATP binding 
to the central parts (equatorial regions) of the GroEL rings.  A mixed population of 
singly and doubly capped GroEL chaperones result.  Mis-folded substrates enter the 
central cis ring cavity after ATP initiation, GroES binds resulting in a bigger cavity 
and ATP is then hydrolysed and there is a release of the denatured and GroES 
protein and ADP after binding of the denatured protein and ATP to the trans ring 
(Karplus et al., 2005).  Group II chaperonins are found in archaea and eukaryotes and 
consist of two rings, each containing eight to nine subunits.  They are similar to 
group I as they have an equatorial ATP binding domain and in addition bind to 
substrates at the apex and have a connecting domain (intermediate domain) between 
the apical and equatorial regions.  They have a similar donut shape with double rings, 
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each of which constitute eight subunits (Kalisman et al., 2012).  The apical domain is 
quite different in group II chaperonins compared to group I as it moves (rotates), 
when ATP is bound to the central region and results in a decrease in size of the 
central folding chamber.  The intermediate domain then has a hydrolytic aspartic 
acid residue that moves towards the ATP binding site and upon hydrolysis the apical 
and intermediate regions rock forward using the equatorial hinge and close the 
chamber (Zhang et al., 2011).  Therefore there are lids that open and close the central 
domain.  The t-complex polypeptide 1 (TCP-1) is an example and is made up of 
TriC, CCT and C-cpn and is 1-MDa, with tubulin and actin as its substrates 
(Sternlicht et al., 1993). 
Class II covers the HSP70s, which consist of a nucleotide binding domain (NBD) 
and a substrate binding region (SBD) and like chaperonins from group I, their 
activity is dependent on allostery.  For instance, Hsc70 binds to the cochaperone J 
(Jiang et al., 2005).  Eukaryotic Hsp70 requires Hsp40 and nucleotide exchange 
factor (NEF) and prokaryotic DnaK requires DnaJ and GrpE (Miot et al., 2011).  The 
interactions of HSP70s with their target substrates are transient and the cochaperones 
act to promote the hydrolysis of ATP and thus increase the affinity of the chaperones 
for their client proteins (Raviol et al., 2006).  The re-folding of the substrates is 
believed to occur through release and re-binding cycles within the central cavity 
(Mayer et al., 2000). 
HSP90s are within class III and have three domains: an ATP binding domain, a 
central SBD and a C-terminal domain for dimerisation.  The N- terminal and central 
regions are connected by linker amino acids, which provide flexibility and modulate 
chaperone activity of the protein.  The linker region confers a negative charge to the 
protein and aids in Hsp90 domain organisation.  Cochaperones also interact with 
Hsp90s such as HSP70, isomerases and S100A1 and the linker region aids in placing 
the interaction domains in the correct place (Okada et al., 2004).  Aha1 is a 
cochaperone and interacts with Hsp90-Pf-CL to increase the activity of ATPases 
(Tsutsumi et al., 2012).  HSP90 function is predominantly to mediate correct protein 
folding of signal transduction proteins. 
Hsp100s can un-fold insoluble, aggregated proteins and are found in class IV.  They 
have four main domains consisting of: an N-terminal region, two NBDs and a middle 
domain (M-domain), with a central channel and hexameric ring structure and exist in 
a double ring structure.  In the case of the prokaryote ClpB and its eukaryotic 
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homologue Hsp104, their activities require DnaK, DnaJ and GrpE or Hsp70 and 
Hsp40, respectively (Miot et al., 2011).  For Hsp104, the NBD1 domain is mainly 
responsible for ATPase activity and NBD2 primarily for oligomer formation and 
communication occurs via a coiled coil between the two domains (Wendler et al., 
2007).   
sHSPs are present in all organisms, in all the kingdoms and have diverged early in 
evolution with the most divergence occurring in Arabidopsis thaliana (Waters et al., 
1996).  sHSPs act in concert with HSPs, since once the sHSPs have bound to their 
client proteins; the release of the substrates usually requires the larger chaperones 
which utilise ATP, with the exception of HSP27 for example which has low affinity 
sites that can easily release substrate without any input of energy (McDonald et al., 
2012).  They therefore act as a store for incorrectly and mis-folded proteins but do 
not have the ability to re-fold the proteins, as seen with foldases.  They consist of 
three main domains of an N-terminal region, an α-crystallin central domain and a C-
terminal domain (Haslbeck et al., 2008).  The α-crystallin domain is composed of 
seven to nine β-strands structured as a sandwich and this domain is conserved across 
all the sHSPs.  There are α-helices within the N-terminal head and α-crystallin 
domain. 
 
Figure 1.6 Diagram of CRYAB structure. 	  	  
Variability between the different sHSPs exists in the N-terminal arm and C-terminal 
domain, except there is a I/L-X-I/L conserved motif in the C-terminus that is crucial 
for oligomer formation and this contacts the hydrophobic patch in the α-crystallin 
domain of adjacent subunits to form the oligomers (Poulain et al., 2010, van 
Montfort et al., 2001).  They consist of between 4-40 subunits and rely on the ATP-
dependent functions of HSP60, 70 and 100 for re-folding of the client proteins 
(McDonald et al., 2012).  The variation in the number of subunits per oligomer is a 
key property of sHSPs, which is most likely the result of dissociation of tetramers 
(Bova et al., 2000).  Binding of substrates is initiated via presentation of hydrophobic 
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surfaces on the sHSPs.  Their response to increase affinity for client proteins is not 
only due to mis-folded client proteins but also due to changes in their oligomeric 
structures; often the result of temperature rises as part of a heat stress response.  In 
the case of HSP18.1, increased temperatures result in a preference of higher-order 
oligomer formation over monomers and dimers (Stengel et al., 2010).  
Phosphorylation also influences substrate interactions and phosphorylation of 
CRYAB increases its affinity for unfolded substrates (Koteiche and McHaourab, 
2003).  Wheat (T. aestivum) sHSP16.9 has been crystallised and found to contain 12 
subunits composed of two rings, each containing six α-crystallin domains in a barrel-
shape complex.  The N-termini are important in mediating hydrophobic interactions 
with proteins within the oligomeric structure due to intertwining and knot formations 
(Aquilina et al., 2004, van Montfort et al., 2001).  However, Methanococcus 
jannaschii (Mj) HSP16.5 contains 24 subunits and is a hollow ball-shaped structure 
as shown from its crystal structure and all sHSPs have an α-crystallin domain in 
common, believed to be important for interacting with client proteins (Haslbeck et 
al., 2008).   
 
Class Molecular Weight 
(kDa) 
Proteins 
I (chaperonins) Group I: 60 
Group II: 1000 
GroEL 
TCP-1 
(TRiC/CCT/C-
cpn complex) 
II (Hsp70s) 70 DnaK 
Hsc70 
III (Hsp90s) 90 Hsp90 
IV 100 Hsp104 
ClpB 
ClpC 
V (sHSPs) 12-43 CRYAB 
Hsp16.5 
Hsp20.2 
Table 1.6 Heat shock protein types. 
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1.8 CRYAB; chaperone and cell protector. 
CRYAB is part of the sHSP family, which consists of proteins having the smallest 
molecular weights within the heat shock protein superfamily, as detailed in the 
previous section.  It is a holdase small heat shock protein that has the capability to 
chaperone, preventing aberrant structures and aggregates of proteins, acting as a cell 
protector upon increased associations with interacting target proteins.  It is also 
found as part of the larger α-crystallin complex, which is in the vertebrate eye lens 
and consists of αΑ-crystallin and CRYAB in a 3:1 or 2:1 molar ratio (Srinivas et al., 
2008, Swamy and Abraham, 1991).  This complex constitutes more than 50% of the 
total water-soluble proteins present within the lens and has greater stability towards 
increased temperatures compared to either αΑ-crystallin or CRYAB alone (Srinivas 
et al., 2008, Bova et al., 2000).  Total protein in the lens can be at a concentration of 
up to 450 mgml-1 and thus there are many proteins with the potential for unfolding, 
necessitating the actions of the crystallin complex to bind to the mis-folding 
substrates (Fagerholm et al., 1981).  The α-crystallin complex binds irreversibly to 
other crystallin structures thus aiding in the prevention of light scattering (Hanson et 
al., 2000).  CRYAB has a polydisperse structure and its basic unit consists of a 
dimer, as with HSP20.  When the higher order oligomers dissociate to reveal the 
dimers, these smaller units have more peptide binding sites exposed thus increasing 
affinity for substrates (Bagneris et al., 2009).  The structure of the oligomers has 
been proposed using knowledge gained from the crystal structures of the Mj 
HSP16.5 and T. aestivum HSP16.9 proteins and many different models have been 
suggested (Murugesan et al., 2008).  It is thought that the CRYAB oligomers have a 
central cavity (Haley et al., 1999).  Cryo-EM has been used to generate the 
quaternary structure of CRYAB to reveal 16 subunits, although this varies (Haley et 
al., 1999).  The β-strands 4 and 8 form pockets in which the I-X-I motif within the C-
terminal tail of adjacent monomers is able to dock and aid in building oligomers 
(Laganowsky et al., 2010, Jehle et al., 2010).   
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Figure 1.7 Diagram of CRYAB dimer. 
The C-terminal I-X-I motif interacts with an adjacent monomer’s β-4 and 8 strands. 
 
The interaction of the C-terminal tail with the α-crystallin domain is also crucial for 
determining the architecture and symmetry of the oligomers, such as with Hsp16.9 
and 16.5, dependent upon orientation and rotation of the tail in relation to the α-
crystallin domain (McHaourab et al., 2012).  CRYAB has been shown to increase its 
binding affinity to IFs upon an increase in stress imposed upon the filament 
networks, seen with an increase in temperature imposed upon in vitro formed 
networks.  In addition, with particular reference to the R120G mutation in CRYAB 
located in the α-crystallin domain resulting in cardiomyopathy, desminopathy and 
cataracts, an altered structure of the chaperone also lends itself to increased 
associations with the filament networks (Perng et al., 2004).  In this situation it acts 
in a dominant gain of function manner to promote aggregation instead of preventing 
it and the mutant dimer is more stabile at low pH compared to WT CRYAB 
(Bagneris et al., 2009).  The arginine is replaced with a glycine removing a positive 
charge within the dimer interface already sensitive to pH changes in the 
physiological range, due to a high number of histidines (Clark et al., 2011).  
Therefore it can protect networks in the normal wild-type conformation but if this is 
altered by a mutation, the filament-filament interactions can be increased.  CRYAB 
interactions are important with desmin filaments for muscle homeostasis.  It has the 
ability to prevent damage in muscle by increasing its associations with titin in 
response to ischemic stress as it is usually only found as part of the soluble fraction 
(Bullard et al., 2004).  As well as mutation resulting in decreased chaperone abilities, 
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phosphorylation has also been shown linked to certain diseases with specific 
relevance to aging in the lens with a reduction in chaperone ability (Aquilina et al., 
2004).  WT CRYAB is likely able to transition between dimeric and monomeric 
forms; this has been shown to be pH dependent as acidosis results in a dimer-
monomer conversion of the α-crystallin domain only (Jehle et al., 2009), which 
correlates with an increase in binding to desmin and actin in muscle cells.  Also in 
ischemic conditions there is an increase in phosphorylation of CRYAB and despite 
there being an increase in translocation and increased binding of CRYAB to IFs at 
the low pH, it appears that the chaperone ability has been reduced, alongside a 
decrease in oligomer size (Eaton et al., 2001).  This is unusual as it would be 
expected in ischemia that since the CRYAB is binding more to the unfolding 
substrates, there would be an increase in the prevention of their aggregation (Ito et 
al., 2001).  However the increased phosphorylation seen in hypoxic conditions is 
likely to mediate CRYAB interactions with caspase-3 and other signaling molecules 
to prevent apoptosis and thus even if the ability to sequester the filaments, which 
potentially mis-fold is reduced, the increased binding of CRYAB to the filaments 
likely mediates its interactions with other proteins (Morrison et al., 2003).  However 
studies have shown that CRYAB does protect and stabilise titin and other members 
of the cytoskeleton upon increased binding and thus the ability to chaperone or 
prevent heat-induced aggregation of a protein is different to the effects of stabilising 
the cytoskeleton (Bullard et al., 2004).  
CRYAB acts to protect C6 glioma cells from apoptosis as the result of oxidative 
stress, in response to increased p38β levels (Shin et al., 2011).   CRYAB and αΑ-
crystallin can both bind to the pro-apoptotic Bax and Bcl-Xs proteins thus halting 
their mitochondrial translocation, in response to staurosporine (Mao et al., 2004).  
CRYAB is additionally important in responding to ischemia-reperfusion (I/R) that 
results in stress, with increased levels of CRYAB that protect the myocardium from 
damage.  Serine 59 is a target for phosphorylation, present within the N-terminal 
region (amino acids 1-65) and CRYAB translocates and binds to the outside and also 
enters mitochondria thus potentially binding unfolding mitochondrial proteins (Jin et 
al., 2008).  In relation to AxD, it has been shown that CRYAB can reverse the 
inhibitory effects of toxic mutant GFAP oligomer build-up on proteasome activity 
(Tang et al., 2010). 
  
 
35 
1.9 Aims and objectives. 
In this thesis I have focused on the interactions of CRYAB with type III IFs to gain 
more understanding about how filament structure and CRYAB structure can 
influence the two independent processes of binding of CRYAB to filaments and also 
prevention of filament-filament interactions by CRYAB.  The main objectives 
included looking at desmin and GFAP interacting with CRYAB since oligomer size 
of CRYAB appears to be crucial in mediating binding and any alterations in CRYAB 
oligomers, such as with the R120G mutant, leads to a diseased state that alters its 
interactions with IFs.  The fact that the R120G mutation in CRYAB results in 
desminopathies and cardiomyopathies but not gliopathies highlights how crucial the 
WT CRYAB-desmin interactions are for maintaining homeostasis in muscles.  
Therefore a greater understanding of how CRYAB interacts with the IFs is crucial 
for understanding how pathological states occur and therefore different conditions 
were investigated, hypothesised to alter the oligomer size of CRYAB and also shift 
the equilibrium of IF assembly.  Also rheological and sedimentation experiments 
were carried out to see if the CRYAB-desmin interactions are functional.  Divalent 
cations, temperature and pH changes were studied.  Another aim of this thesis was to 
investigate how the AxD mutants of R239H and R79C human GFAP proteins 
assemble in vitro, alongside the previously studied R416W mutant and how the 
morphology may be explained using hypothesised predictions based upon the 
mutations’ locations within the coiled coils’ heptad repeats and random coils.  As 
mentioned earlier, passive microrheology with optical tweezers was used to probe 
the mechanical properties of WT desmin networks, as a non-invasive technique, to 
assess the frequency-dependent viscosity and elasticity (G’) of the filament networks 
as another method compared to sedimentation assays to see how the 
cardiomyopathy-causing R120G CRYAB mutant results in increased filament-
filament interactions and how WT CRYAB changes the biomechanical properties of 
desmin IF networks.  These rheological experiments add more information in an 
equilibrium situation, as to the nature of the CRYAB-IF interactions, to non-
equilibrium sedimentation assays that have been used thus far as the standard method 
of assessing CRYAB’s effect upon filament networks. 
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Chapter 2; Interactions between WT and mutant GFAP with 
CRYAB 
2.1 Introduction and aims 
The aim of this study was to find out what effects the known heterozygous mutated 
human GFAP proteins, involved in the etiology of AxD, had on filament properties 
compared to WT GFAP filaments and how this influenced their interactions with the 
small heat-shock protein CRYAB.  In addition the interactions of CRYAB with WT 
GFAP was investigated under different assembly methods.  The hypothesis was that 
the R79C and R239H mutated GFAP would have increased associations with 
CRYAB since this has been shown previously for the R416W mutant in astrocytoma 
cells (Der Perng et al., 2006).  Amino acid position 239 in human GFAP is the most 
common hotspot for amino acid substitution non-conservative mutations in AxD.  
Both amino acid positions 239 and 79 were investigated, as they are included in the 
most severe phenotypes.  In addition the R416W mutant was compared as a control, 
having been studied previously in this laboratory (Der Perng et al., 2006).  Also 
using different assembly methods the interactions of CRYAB with WT filaments 
was investigated. 
 
2.1.2 Materials and methods. 
Analytical grade chemicals were used throughout the chapter unless otherwise stated 
and were from Sigma-Aldrich (Poole, UK), Fisher (UK), VWR International Ltd. 
(UK) or Melford Laboratories Ltd. (Suffolk, UK). 
 
2.1.2.1 Construct production.  
Recombinant GFAP DNA was kindly given by Terry Gibbons.  R79C human GFAP 
was originally in pcDNA 3.1 (-) (Invitrogen, UK) between XbaI and HindIII 
restriction sites and transferred into a pET-23b vector (Novagen, UK) using the same 
restriction sites.  R416W human recombinant GFAP originally in pcDNA 3.1 (-) 
between XbaI and BamHI sites was transferred into pET-23b using the same sites.  
WT human GFAP was inserted in a pET-23b vector between NdeI and EcoRI sites 
and R239H human GFAP was between the same sites in a pET-23b vector.  Human 
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WT desmin (pET-23) was kindly received as a glycerol stock from Andrew 
Landsbury alongside human WT CRYAB (pET-23d) and R120G CRYAB (pET-
23d) in BL21 (pLysS) (Novagen, UK).  Human recombinant WT vimentin was 
derived from a pET-7 vector in BL21 (pLysS) within a glycerol stock. 
DNA was transformed into DH5α bacteria using 50 µL of bacteria and 1 µL 
(approximately 100 ng) of purified DNA sample.  They were left to incubate on ice 
for 10 minutes (min) and then heat shocked at 42 0C for 50 seconds (sec).  The 
samples were again cooled to 4 0C for 10 min; 250 µL Luria broth (LB) (1% (w/v) 
bacto-tryptone, 0.5% (w/v) bacto-yeast extract, 1% (w/v) sodium chloride (NaCl)) 
was added and they were put on the shaker at 37 0C for 1 hour (hr) before being 
plated out onto LB agar plates with the antibiotic selection marker of 50 µg/mL 
ampicillin.  
 
2.1.2.2 BL21 E.coli transformation and protein expression. 
BL21 (pLysS) (Novagen, UK) competent cells were transformed with DNA 
plasmids through heat shock; involving 50 µL of BL21 (pLysS) being incubated with 
1 µL of plasmid miniprep (Sigma-Aldrich, UK) purified DNA in an ice bath for 10 
min.  These were then put in a polystyrene float in a water bath set at 42 0C for 50 
sec and transferred back onto the ice bath for 10 min and 250 µL of LB was added.  
The cells were incubated for a further 1 hr at 37 0C on the shaker at 250 rpm, 37 0C 
and plated out onto LB agar plates with 34 µg/mL chloramphenicol (to select for the 
pLysS vector in host cells) and 50 µg/mL carbenicillin (to select for the pET 
vectors).  Single colonies were picked into 5 mL LB broths with the same antibiotics 
and 0.05% (w/v) glucose concentrations and then grown overnight for 16 hr at 37 0C.  
The next day these were diluted 100-fold for scaling up the growth within 2 litre (L) 
capacity Fernbach flasks.  The bacteria were grown at 37 0C, 250 rpm for 
approximately 4 hr until an optical density at 600 nm (OD600) of 0.6 was reached and 
then they were induced with a final concentration of 0.5 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG).  They were grown for a further 4 hr for protein 
expression.  After a 1 mL post-induction sample was removed, spun down and the 
pellet resuspended in 100 µL 2x sample buffer (SB) (100 mM Tris-HCl (pH 6.8), 2% 
(w/v) sodium-dodecyl sulphate (SDS), 10 mM ethylenediaminetetraacetic acid 
(EDTA), 10 mM dithiothreitol (DTT), 20% (v/v) glycerol, 0.2% (w/v) bromophenol 
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blue), the remaining majority was spun down at 6,200xgav in the JLA-8.1000 rotor 
for 30 min, 4 0C (Beckman JA-20-I centrifuge).  Protein expressed in bacteria are 
either mainly present in their native conformation in a soluble state such as for 
human WT and R120G CRYAB where the final bacterial pellet was resuspended in 
20 mL of 50 mM Tris-HCl (pH 8.0), 1 mM EDTA, 300 mM NaCl and 0.2 mM 
phenylmethanesulfonyl fluoride (PMSF), spun and frozen ready for a soluble protein 
extraction, or alternatively the protein has been folded in such a way as to make them 
insoluble and located in the insoluble inclusion body portions and so the final pellet 
was resuspended in 20 mL of a modified Tris, EDTA and NaCl (TEN) buffer of: 10 
mM Tris-HCl (pH 7.4), 150 mM NaCl and 5 mM EDTA, for GFAP, vimentin and 
desmin, then spun again at 5,000xgav, 15 min, 4 0C in the JA-20 rotor (Beckman JA-
20-I centrifuge) and frozen as a cell pellet at -20 0C ready for an insoluble protein 
extraction.  
 
2.1.2.3 GFAP, desmin and vimentin insoluble protein preparation. 
The bacterial pellet was freeze-thawed three times for bacterial cell wall disruption 
and then resuspended in 20 mL of a TEN buffer (10 mM Tris-HCl (pH 8.0), 5 mM 
EDTA, 100 mM NaCl and 1 mM PMSF with one complete protease inhibitor 
cocktail tablet (Roche Diagnostics, UK) and incubated on ice for 15 min.  This was 
homogenised to a bacterial suspension with a 40 mL Dounce homogeniser (Wheaton, 
USA) so the suspension became cloudy and viscous.  The lysates were then 
centrifuged at 30,000xgav, for 30 min at 4 0C in the JA-20 rotor (Beckman JA-20-I).  
The pellet was resuspended in 20 mL high salt buffer (HSB) (1.5 M KCl and 1% 
(w/v) Triton X-100 in TEN buffer with 1 mM PMSF) and homogenised on ice with 
one hundred strokes using the tight pestle.  The homogenates were centrifuged again 
at 30,000xgav, 20 min, 4 0C in the JA-20 rotor (Beckman JA-20-I) and the HSB stage 
was then repeated to aid in complete removal of all DNA contaminants.  As a final 
step the pellet was washed with phosphate buffered saline (PBS) to remove excess 
salts and centrifuged again.  Extraction of the pellet was then carried out due to the 
insoluble nature of the proteins. 
 
  
 
39 
2.1.2.4 Purification of GFAP, desmin and vimentin insoluble protein. 
Can be found detailed in the purification methods for chapter 2 in the appendix. 
 
2.1.2.5 Purification of WT and R120G CRYAB.  
Can be found detailed in the purification methods for chapter 2 in the appendix. 
 
2.1.2.6 GFAP, desmin and vimentin TMAE anion and COO- cation exchange 
chromatography. 
Can be found detailed in the purification methods for chapter 2 in the appendix. 
 
2.1.2.7 WT and R120G CRYAB TMAE anion and size exclusion 
chromatography. 
Can be found detailed in the purification methods for chapter 2 in the appendix. 
 
2.1.2.8 Gel electrophoresis. 
Samples were taken from dissolved samples in 1x final concentration denaturing 
Laemmli SB (50 mM Tris-HCl (pH 6.8), 1% (w/v) SDS, 5 mM EDTA, 5 mM DTT, 
10% (v/v) glycerol and 0.2% (w/v) bromophenol blue), boiled for 5 min at 95 0C and 
in some cases centrifuged if taken from bacterial cells and finally vortexed for a few 
sec ready for running on a 0.75 mm spacer plate thickness 10% (w/v) (0.375 M Tris-
HCl (pH 8.8), 10% (w/v) acrylamide, 0.3% (w/v) bis-acrylamide, 0.1% (v/v) SDS, 
0.05% (w/v) ammonium persulphate and 0.06% (w/v) N,N,N’N’-
tetramethylethylenediamine (TEMED)) or 12% (w/v) acrylamide separating gel, 
with a 4% (w/v) acrylamide (0.123 M Tris-HCl (pH 6.8), 4% (w/v) acrylamide, 
0.12% (w/v) bis-acrylamide, 0.1% (v/v) SDS, 0.05% (w/v) ammonium persulphate 
and 0.06% (w/v) TEMED) stacking gel using a Bio-Rad 15-well comb and Mini-
PROTEAN 3 cell (Bio-Rad, UK).  The separating gel was initially placed between 
short and spacer glass plates held flush together by Mini-PROTEAN 3 gel casting 
frames (Bio-Rad, UK), held in place by pressure cams, on Mini-PROTEAN 3 gel 
casting stands (Bio-Rad, UK).  A layer of water-saturated butanol was placed on top 
of the separating gel to give a flat surface ensuring samples entered the separating gel 
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at the same time.  Once the separating gel was set, the water-saturated butanol was 
removed using de-ionised water and tissue and the stacking gel was placed on top 
with a comb and left to set.  For gel running, combs were removed and the gels were 
placed into a clamping stand, mini tank and 1x running buffer (0.1% (v/v) SDS, 
0.192 M glycine, 0.0275 M Tris) added.  The samples were loaded into the wells 
using gel tips and 2 µL of a pre-stained PagerulerTM protein ladder #SM0671 
(Fermentas, UK) was run in the left most lane of the gels.  Once the samples were 
loaded, the lid was attached to the banana plugs of the electrode assembly.  The lid 
was connected to a direct current (DC) voltage power supply (Bio-Rad, UK) and run 
at a constant 250 volts (V) for 30 min.  The gels were then removed from the tank 
and glass plates, placed into an empty tip box on a shaker and initially fixed for 15 
min in 50% (v/v) methanol and 10% (v/v) acetic acid, then stained for 15 min using 
0.25% (w/v) Coomassie brilliant blue R-250, 50% (v/v) methanol and 10% (v/v) 
acetic acid.  Finally the gels were destained using 10% (v/v) methanol with 5% (v/v) 
acetic acid for a few changes on a shaker and then finally a digitising picture was 
taken with a Fuji digital camera system, using the Luminescent image analyser LAS-
1000 plus (Fuji Film, Japan).  Gel images were imported into Adobe Photoshop CS5 
version 12.0.2 (Adobe Systems Inc., US) and Keynote version 5.1.1 (Apple Inc, US) 
for processing to adjust brightness, contrast and merge samples from separate gels as 
necessary. 
 
2.1.2.9 Semi-dry immunoblotting. 
Gel electrophoresis was carried out.  Gels were removed from the tank after 
electrophoresis and then immediately transferred into buffer B (0.025 M Tris and 
20% (v/v) methanol), alongside an equal dimension 0.45 µm pore size nitrocellulose 
membrane.  18 pieces of Whatman 3MM Chr chromatography papers were cut per 
gel transfer.  6 pieces were soaked in buffer A (0.3 M Tris and 20% (v/v) methanol), 
3 pieces in buffer B (0.025 M Tris and 20% (v/v) methanol) and 9 pieces in buffer C 
(0.025 M Tris, 14 mM glycine and 20% (v/v) methanol).  The Transblot SD Semi-
Dry Transfer Cell machine (Biorad, Herts, UK) was set up as follows from bottom to 
top: papers soaked in buffer A, papers soaked in buffer B, nitrocellulose from buffer 
B, gel from buffer B and finally the papers soaked in buffer C.  Transfer was carried 
out at a constant 0.8 mA per cm2 for 90 min. Membranes were removed, washed 
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extensively in water in a weighing boat on a shaker and then stained in the absence 
of light in Ponceau stain (0.5% (w/v) Ponceau S and 1.0% (v/v) acetic acid) for 5 
min.  The membranes were rinsed again and transfer assessed.  The membranes were 
then blocked at room temperature for 2 hr in blocking solution (3% (w/v) BSA, 5% 
(w/v) non-fat milk powder in TTBS (0.1% (w/v) Tween-20, 25 mM Tris-HCl (pH 
7.4) and 150 mM NaCl)).  The membranes were removed and washed three times in 
TTBS for 5 min intervals.  Then primary antibodies (Abs) were incubated with the 
membranes in polyethylene bags, sealed with a sealer (Mercier Corporation, 
Taiwan), diluted in 5% (w/v) BSA in TTBS overnight at 4 0C, on a rotating wheel 
(Agar Scientific, UK).  The membranes were washed three times in 5% (w/v) non-fat 
milk powder in TTBS for 5 min intervals and then incubated with secondary Abs for 
2 hr at 4 0C using a 1000-fold dilution in 5% (w/v) BSA-TTBS solution with 
polyclonal goat anti-mouse IgG immunoglobulins.HRP (1.3 g/L) (Dakocytomation, 
Denmark).  Five washes with 5% (w/v) non-fat milk powder-TTBS was then carried 
out and the membranes developed in the absence of light for 5 min with ECl I (100 
mM Tris-HCl (pH 8.0), coumaric acid and luminol) and ECl II (100 mM Tris-HCl 
(pH 8.0) and 0.02% (v/v) H2O2) solutions mixed together.  The LAS-1000plus Fuji 
luminescent image analyser (FujiFilm, Japan) was used with the chemiluminescence 
setting and enhanced chemiluminescence for a minimum of 1 min for development.  
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Figure 2.1 GFAP inductions and extractions. 
A) WT, B) R79C, C) R239H and D) R416W human GFAP pre- (lane 1), post- (lane 
2) IPTG inductions and solubilised proteins after inclusion body preparations (lane 
3) were run on gels.  Pre- and post- inductions from 1 mL bacterial culture samples, 
taken from the larger cultures, were spun at 420xgav for 5 min and the pellets were 
resuspended in 100 µL of 2X SB.  5 µL pre- and 2.5 µL post- inductions were loaded 
to the 12% (w/v) acrylamide gel.  The solubilised fraction obtained after an inclusion 
body preparation, extraction, homogenisation and centrifugation is in the final lane 
constituting 1 µL of sample with 1 µL 2X SB and as can be seen, the target protein 
constitutes more than 80% of the total protein.  Protein ladder molecular weights are 
from the pre-stained PagerulerTM protein ladder #SM0671 and are: 170, 130, 95, 72, 
55, 43, 34, 26, 17 and 10 kDa, from the top to the base of the gel. 
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Figure 2.2 Desmin and vimentin inductions and extractions. 
In gel A) WT human desmin and in gel B) WT human vimentin pre- (lane 1), post- 
(lane 2) IPTG inductions and solubilised proteins (lane 3) are shown.  The marker 
lane on the left-hand side of the gel corresponds to the same marker weights 
mentioned in Figure 2.1.  Pre- and post- inductions from 1 mL bacterial culture 
samples were taken from 500mL cultures, spun at 2,000 rpm (420xgav) for 5 min and 
the pellets were resuspended in 100 µL 2X SB.  5 µL pre- and 2.5 µL post- 
inductions were loaded to the 12% (w/v) acrylamide gel.  The solubilised fraction is 
in the final lane constituting 1 µL of sample with 1 µL 2X SB. 
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Figure 2.3 CRYAB inductions and extractions. 
A) WT human CRYAB and B) R120G human CRYAB pre- (lane 1), post- (lane 2) 
IPTG inductions and solubilised proteins (lane 3) are shown.  Pre- and post- 
inductions from 1 mL bacterial culture samples were taken from 500mL cultures, 
spun at 2,000 rpm (420xgav) for 5 min and the pellets were resuspended in 100 µL 
2X SB.  5 µL pre- and 2.5 µL post- inductions were loaded to the 12% (w/v) 
acrylamide gel.  The solubilised fraction is in the final lane constituting 1 µL of 
sample with 1 µL 2X SB. 
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Figure 2.4 WT CRYAB purification. 
The A) human WT CRYAB TMAE purification chromatogram (the y-axis shows the 
absorbance (mV) and the x-axis shows the time (min)) and B) gel of the elution of 
fractions 1-20 are shown.  Fractions 4-20 were pooled together from the TMAE 
column and then applied to a size exclusion column deriving the C) human WT 
CRYAB size exclusion column purification chromatogram and D) gel of the elution 
of fractions 30-42.  Fractions 30-42 were pooled from the size exclusion column.  
Gel fractions were run as 10 µL from 20 µL sample + 20 µL 2x SB. 
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Figure 2.5 R120G CRYAB purification. 
The A) human R120G CRYAB TMAE purification chromatogram alongside B) the 
first gel of the elution of fractions 1-23 (every other fraction), C) the second gel with 
fractions 14-39 (every fifth fraction) and D) the third gel of fractions 59-69 is shown.  
Fractions 1-15 and 24-34 were pooled from the TMAE column and then applied to a 
second column deriving the F) human R120G CRYAB size exclusion column 
purification chromatogram and E) gel of the pooled fractions 37-46.  Note how the 
size exclusion peak for R120G CRYAB is much broader than for WT CRYAB thus 
showing there is more polydispersity. 
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Figure 2.6 R239H GFAP purification. 
The A) human R239H GFAP TMAE purification chromatogram is shown alongside 
the B) gel of the elution of fractions 46-55.  Fractions 45-51 were pooled from the 
TMAE column and run over a second column to derive the respective C) R239H 
GFAP COO- column purification chromatogram and D) gel of the elution of 
fractions 51-71.  Fractions 56-70 pooled from COO- column.  
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Figure 2.7 WT GFAP purification. 
The A) human WT GFAP TMAE purification chromatogram is shown alongside B) 
the first gel of the elution of fractions 1-2, 5 and 6-13 and the C) second gel with 
fractions 35-40.  Fractions 2-12 and 35-40 were pooled from the TMAE column and 
a second column was used to derive the D) WT GFAP COO- column purification 
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chromatogram and E) gel of the elution of fractions 35-44.  Fractions 36-46 were 
pooled from the COO- column.  
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Figure 2.8 R416W GFAP purification. 
The A) human R416W GFAP TMAE purification chromatogram is shown and the 
B) eluted fractions 46-56.  Fractions 46-56 were pooled.  The second column C) 
R416W GFAP COO- purification chromatogram is also shown and D) the gel of the 
eluted fractions 56-79.  Fractions 58-79 were pooled from the COO- column.  
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Figure 2.9 R79C GFAP purification. 
The A) human R79C GFAP TMAE purification chromatogram is shown with the B) 
gel of the eluted fractions 45-56.  Fractions 47-55 were pooled from the TMAE.  The 
C) R79C GFAP COO-column purification chromatogram and D) the gel of the 
elution of fractions 49-75 is shown.  Fractions 58-74 were pooled from the COO- 
column.  
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Figure 2.10 WT desmin purification. 
The A) human WT desmin TMAE purification chromatogram is shown alongside the 
B) gel of eluted fractions 33-53.  Fractions 35-49 were pooled.  The desmin was 
already more than 90% pure and therefore no COO- column was used.  
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Figure 2.11 WT vimentin purification. 
The A) human WT vimentin TMAE purification chromatogram is shown with the B) 
gel of the eluted fractions 40-53.  Fractions 40-51 were pooled from the TMAE.  The 
second purification column C) WT vimentin COO- column purification 
chromatogram is shown with the D) gel of the elution of fractions 40-52.  Fractions 
44-52 were pooled from the COO- column.  
 
 
 
Figure 2.12 WT GFAP dimers. 
An A) immunoblot of two pooled purified fractions from a TMAE column of WT 
GFAP is shown alongside its corresponding B) Ponceau-stained membrane with the 
GFAP monomer bands (in line with the arrow), the E.coli contaminating band (in 
line with the arrowhead and the 72 kDa marker band) and the GFAP dimer (in line 
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with the square) being shown (Quinlan and Franke, 1983).  The GFAP monomer 
from the left lane in A) hasn’t been detected on the blot likely due to irreversible 
luminol substrate exhaustion caused by too much HRP in its vicinity, the result of 
too much sample.  Primary mouse monoclonal SMI-21 anti-human GFAP Ab was 
used at a 5000-fold dilution.   
 
 
For all of the different protein TMAE gel fractions run, it can be seen that there are 
many other bands present in the lanes alongside the target protein bands.  In the case 
of WT and R79C GFAP TMAE column fractions, the band in alignment to the 72 
kDa marker band was analysed as to whether it consisted of a higher oligomer of 
GFAP protein or whether it was a different protein and was sent for MALDI 
analysis.  It was shown that the band corresponded most likely to a Hsp70 chaperone 
in the Shigella flexneri 2a str. 301, using a MASCOT search (Matrix science) 
however the heat shock protein will be from the E.coli BL21 transformation host.  
The band above the 170 kDa marker corresponds to a dimer of GFAP since an 
immunoblot using the SMI-21 GFAP-specific monoclonal Ab gave a signal positive 
for this band.  The COO- column separated this from the GFAP protein on further 
purification.  The second COO- column in all cases appeared to remove most of the 
contaminating bands from the target proteins (Figure 2.4-2.9, 2.11) and these 
fractions were then pooled and used in the assembly experiments. 
 
2.1.2.10 Assemblies. 
Pooled protein fraction concentrations were estimated using a bichinchoninic acid 
(BCA) protein assay kit (Thermo Scientific Pierce®, Rockford, USA) and in some 
instances these were concentrated using an Amicon Ultra Centrifugal filter device 
with a 10 kDa molecular weight cut-off filter (Millipore, Bedford, MA).  Pooled 
protein fractions were defrosted, vortexed and mixed with the initial buffer solution 
relevant to the assembly method being used and with any other proteins if co-
assembly was being carried out.  The protein samples were then put into 9.3 kDa 
molecular weight cut-off rehydrated cellulose membrane dialysis tubing (Sigma-
Aldrich, UK) after rinsing with de-ionised water from storage at 4 0C in 20% (v/v) 
ethanol and clipped with dialysis clips at both ends.  The samples were then 
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transferred into the buffer solutions.  Each buffer solution had a magnetic flee and 
was placed on a magnetic stir bar so that buffer exchange was promoted across the 
dialysis tubing membranes of the samples, using a minimum of a 1:1000 ratio of 
sample: buffer volume. 
GFAP was assembled at 0.4 mg/mL through a series of buffer changes to remove the 
chaotropic denaturant urea and increase the salt ionic strength (I) promoting the 
association of the coiled coils in the protein in much a similar manner used by others 
(Der Perng et al., 2006).  This method was used in the imidazole assembly method 
(Figure 2.14) and in addition a Tris assembly method (Figure 2.13), similar to Hsiao 
et al. (2005), was used and comparisons made between the two (Hsiao et al., 2005).  
For co-assemblies with WT CRYAB, a 1:1 molar ratio of WT CRYAB (20.2 kDa): 
WT GFAP (49.9 kDa) was used with a 0.16 mg/mL concentration of sHSP.  All 
buffer steps were carried out at 23 0C (room temperature) except the final overnight 
assembly buffer dialysis that was carried out at increased temperatures of 37 and 44, 
in some cases and the 10 mM Tris-HCl (pH 8.3) penultimate step in the GFAP 
imidazole assembly method, at 4 0C.  The final temperatures were of the incubator 
ambient temperature not accounting for local heating effects from the magnetic 
stirrer, which resulted in approximately 5 0C increases.  The times taken for each 
buffer change in the assembly protocols were a minimum of 2 hr, but no longer than 
4 hr, apart from the final buffer dialysis which took 16 hr overnight in all cases.  The 
pH values refer to those of the stock Tris-HCl solutions and not the final pHs upon 
addition of salt, which follows the previous standard methodology of assembly 
carried out in this laboratory (Perng et al., 1999a).  MgCl2 was included in the Tris 
final assembly buffer, as it has been shown to be necessary for GFAP filament 
formation (its absence results in defective compaction) however it was not necessary 
for the imidazole method as this chemical already binds magnesium ions that are 
present on the plastic surfaces of the beakers used for assembly.  
 
 
 
 
 
 
 
  
 
59 
 
 
 
 
 
 
 
	  
Figure 2.13 GFAP Tris assembly method. 
Assembly was carried out sequentially clockwise through steps 1-5.  Buffer volumes 
were 0.5 L for the initial buffer (with a 2,500-fold excess of dialysis buffer to sample 
volume) and then 1 L (with a 5,000-fold excess of dialysis buffer to sample volume) 
for all the buffers after with dilutions made for the 6 to 3 M drop in concentration of 
urea.  The final pH was measured after all of the salts were added to buffer 5 and it 
was found to have increased to pH 7.4.  The I of buffer 5 is equal to 0.0607 M (3 sf), 
as detailed in the appendix.  
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Figure 2.14 GFAP imidazole assembly method. 
Assembly was carried out sequentially clockwise through steps 1-4.  Buffer volumes 
were 0.5 L (with a 2,500-fold excess of dialysis buffer to sample volume) for the 
initial buffer and then 1 L (with a 5,000-fold excess of dialysis buffer to sample 
volume) for all the buffers after.  The I for buffer 4 in this method is 0.111 M (3 sf). 
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WT human recombinant GFAP was assembled through either the Tris assembly or 
imidazole assembly protocol forming 10 nm width filaments as shown below (Figure 
2.15).  CRYAB forms oligomers of 1-2 nm in width.  The lengths of the WT GFAP 
filaments seemed to be in the approximate range of 2 to 6 µm.  The filaments are 
morphologically very similar imaged with the transmission electron microscope 
(TEM), assembled through either of the two assembly procedures although the 
sedimentation assay data show that there are differences apparent in the filament 
properties.  
 
2.1.2.11 TEM grid preparation and image collection. 
Cleaved mica (Agar Scientific, UK) was placed onto a microscope slide on double-
sided sticky tape (Scotch, USA), with the clean side facing upwards and carbon 
coated using the Cresington evaporation supply LT750 308 (Cresington Ltd., UK), 
alongside a Cresington MTM10 thickness monitor (Cresington Ltd., UK).  20 µL of 
assembled material was added to 320 µL final overnight assembly buffer in an 
eppendorf lid (20 µg/mL final concentration) and mixed thoroughly, then using 
Valentine’s method a carbon-coated mica sheet was used to trap some sample 
between the mica and carbon film which was lifted off by surface tension, rinsed in 
water and then finally placed into a 1% (w/v) uranyl acetate solution (Harris and 
Horne, 1991).  Between each step the edge of the mica was placed carefully against 
some Whatman 3MM Chr chromatography paper (Whatman, NJ, USA) to remove 
excess liquid by capillary action.  A 400 square copper grid (Agar Scientific, UK) 
was used to lift some of the final negatively stained sample off the surface of the 
uranyl acetate solution for viewing using the Hitachi H7600 TEM, with an 
accelerating voltage of 100kV. 
 
2.1.2.12 Sedimentation assays. 
To assess filament-filament interactions, low speed sedimentation assays were 
carried out utilising 50 µL of assembled protein material.  These were centrifuged for 
10 min at 2,450xgav and 23 0C in an Eppendorf 5417R centrifuge (Eppendorf, US).  
The supernatant was carefully separated from the pellet and 150 µL 1X SB added to 
the pellet and 100 µL 1.5X SB added to the 50 µL supernatant, to make the two 
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fractions equivalent.  Then the sample was loaded as 10 µL of supernatant and pellet 
fraction per gel lane, after resuspension of the pellet and vortexing and boiling of 
both fractions at 95 0C for 5 min. 
For high speed sedimentation assays a similar method was used to before (Djabali et 
al., 1997).  50 µL of assembled sample was layered on top of 50 µL of a 0.85M 
sucrose cushion and centrifuged at 59,875.2xgav, 23 0C for 30 min, in the TLS-55 
rotor, in the TL-100 Bench Top ultracentrifuge (Beckman Coulter, UK).  The 
supernatant was carefully removed from the pellet and 150 µL 1X SB was added to 
the pellet and 50 µL 3X SB added to the 100 µL supernatant.  10 µL of supernatant 
and pellet fractions were loaded per gel lane, after resuspending the pellet and 
vortexing and boiling both fractions at 95 0C for 5 min. 
 
2.1.2.13 Gel protein band quantification. 
Digitising pictures of the gels run of sedimentation assays were taken and analysed 
in the ImageGauge V4.23 program (FujiFilm, Japan).  Boxed areas were made 
around the sample bands and these were duplicated and positioned close to each 
protein band for use as a background reading, using the Quant mode.  The Quant 
Result option then presented a table with each box and their absorbance units so each 
sample band and its respective background could be grouped together.  The 
background absorptions were then subtracted from each of the sample band 
absorptions by assigning the background box as the blank to give a final reading of 
absolute values (AU-BG) used to calculate proportions in the supernatant and pellet 
fractions. 
 
2.1.2.14 Statistical analysis. 
For Student’s T test analysis, data derived from gel quantifications (independent 
repeats of a minimum of n = 3) were transformed using an arcsine-square root 
transformation (using ASIN and SQRT functions in Excel 2008 (Microsoft 
Corporation, US)), taking the arcsine of the square root of numbers, for converting 
the proportional data into normalised data for T-test analysis, as proportions are 
distributed binomially (Zar, 1996).  Data were tested for normality in the SPSS 
Statistics version 21 programme (IBM, US) using a Shapiro-Wilk test and those 
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groups which didn’t have a normal distribution were tested using a Mann-Whitney U 
test as explained in the appendix. 
For data with a normal distribution, a two-tailed F test was then used to verify the 
variances were similar between the two samples of data compared for each test 
(Fowler Jim, 1998), using n-1 degrees of freedom v1 and v2 and p = 0.05.  F values 
were calculated as s21/s22 with s21 being the greater variance.  For those samples that 
had an F value lower than the critical F value, a two-sided, type-2 (equal variance) 
Student’s T-test was used and p values calculated for significance using Excel 
(Microsoft Corporation, US).  Raw data and results are shown in the appendix.  
Averages of the data are represented as bar charts in the text, prepared using Keynote 
version 5.1.1 (Apple Inc., US).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
64 
2.1.3 Results. 
 Observations Page 
#s 
Filament morphology Mutant R79C GFAP forms ULF-like 
filaments. 
Mutant R239H GFAP forms aggregates 
made up of ULF-like filaments. 
65 
CRYAB influence on 
filament-filament 
interactions 
CRYAB reduces R239H interactions after 
assembly in Tris buffer. 
CRYAB increases WT GFAP interactions 
after assembly in imidazole buffer. 
 
69 
 
72 
CRYAB influence on 
filament assembly 
CRYAB hinders WT GFAP formation 
through Tris assembly buffer, which is not 
seen after imidazole buffer assembly. 
76 
 
74 
CRYAB-filament 
interactions (binding) 
CRYAB increases its binding to GFAP 
with increased temperatures.  Most binding 
is seen with the R239H mutant. 
The greatest binding to WT GFAP 
filaments occurs with imidazole buffer. 
 
 
79 
 
82 
Influence of AxD-
causing mutants R79C 
and R239H on WT 
GFAP filament 
assembly 
R239H alters filament morphology at a 
10% level whereas R79C alters filaments 
at a 50% level.  The dominant effect is 
observed only at a 50% mutant level for 
R239H from low speed sedimentation 
assays. 
   85 
84 
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Table 2.1 Summary of chapter’s main findings. 	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2.1.3.1 WT and mutant GFAP morphology. 
	  
Figure 2.15 WT and mutant GFAP morphologies. 
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A) WT GFAP formed usual 10 nm wide filaments of a few µM in length and in B) 
were surrounded by CRYAB particles.  Whereas C) R79C GFAP formed shortened 
filaments of similar lengths to ULFs.  D) R239H formed aggregates when assembled 
alone.  In the presence of CRYAB shown in E) and its inset of G), R79C had shorter 
filaments that could be seen to cluster together and in F) and the inset H) the 
substructure of the R239H aggregates could be seen more clearly with CRYAB, 
consisting also of shorter filaments.  The scale bar is equal to 500 nm. 
 
Two different buffer systems were used to assess WT and mutant GFAP, according 
to Figure 2.13 and 2.14.  
The R239H GFAP forms aggregates that are difficult to see the sub-structure of 
(Figure 2.15 D)), however when CRYAB is added in a 1:1 molar ratio the filaments 
are separated much more and it can be seen that the filaments are much shorter in 
length than WT filaments; ranging approximately between 60-100 nm as measured 
in ImageJ 1.43r (National Institutes of Health, USA) (Colakoglu and Brown, 2009).  
It has been shown already that R239C forms filaments similar to WT GFAP and thus 
the positively charged, basic histidine group in the R239H mutant must influence 
how the unit length filaments anneal and compact (Hsiao et al., 2005).  The R79C 
GFAP is assembly incompetent and forms unassembled protein that appear to be 
similar in length to unit length filaments and R239H; ranging approximately between 
60-100 nm as measured in ImageJ 1.43r (National Institutes of Health, USA) (Figure 
2.15 C)) and it appears to have an increased solubility in comparison to WT GFAP.  
WT CRYAB can be seen to form oligomers of approximately 20 nm in length 
(Figure 2.15 B)).  Upon an increase in temperature to 44 0C, the R79C mutant GFAP 
can be seen to have more associations between the unassembled material (Figure 
2.16 D)).  WT GFAP filaments were also assembled through the imidazole assembly 
procedure (Figure 2.14) and the TEM images show the filaments are similar to those 
formed through Tris assembly (Figure 2.17). 
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Figure 2.16 WT and mutant GFAP morphologies at 44 0C. 
A) and C) WT GFAP forms similar filaments to those formed at room temperature.  
B) WT GFAP with CRYAB is also shown.  D) R79C GFAP with CRYAB appears to 
have increased associations compared to room temperature assembled material and 
in E) the sub-structure of the aggregates can no longer be seen as clearly for R239H 
GFAP with CRYAB.  The scale bar is equal to 500 nm. 
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The WT GFAP filament morphology from imidazole assembly (Figure 2.17) appears 
very similar to that from Tris assembly (Figures 2.15 and 2.16).  Thus no apparent 
differences are obvious from TEM analysis.  However sedimentation assay analysis 
in the following sections shows the different filament properties. 
 
 
 
Figure 2.17 WT GFAP filaments after imidazole assembly. 
A) WT GFAP and B) WT GFAP with CRYAB at 23 0C are shown.  The filaments 
are morphologically similar to those assembled with Tris and there is no obvious 
increase in spacing between the filaments in the presence of CRYAB.  The scale bar 
is equal to 500 nm. 
 
2.1.3.2 CRYAB reduces mutant GFAP filament-filament interactions. 
CRYAB was co-assembled with GFAP in a 1:1 molar ratio with 0.4 mg/mL GFAP 
and 0.16 mg/mL CRYAB through long assembly, according to Figure 2.13, to see 
how the sHSP influences filament interactions.  As seen in Figure 2.18, it acts to 
reduce interactions of the mutant R239H GFAP.  In addition to the Tris assembly 
method, comparisons were made for WT GFAP only, with an imidazole assembly 
method to show that the CRYAB could also increase filament interactions depending 
on the assembly buffer environment. 
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Figure 2.18 WT CRYAB reduces R239H mutant GFAP filament-filament 
interactions through Tris assembly. 
A low speed sedimentation assay gel is shown alongside quantification results.  
Molecular weights of the protein standard are from top to bottom: 170, 130, 100, 70, 
55, 40, 35, 25 and 15 kDa.  In the appendix, Table A.2 and A.3 show the statistical 
tests carried out.  The quantification data in the chart are from at least three 
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independent repeats, shown with error bars representing +/- one standard deviation 
(SD).  Within the chart, the % GFAP SNT refers to the percentage of GFAP (top 
bands) present in the supernatant after low speed sedimentation.  Only for R239H 
through Tris assembly is the ability to reduce filament interactions significant 
statistically (p<0.05) and it appears that with imidazole buffer the CRYAB acts to 
promote increased filament interactions.  The Tris + EDTA section is discussed in 
the next chapter.  SNT and S= supernatant and P= pellet. 
 
Temperature increases appear to reduce the amount of GFAP in the supernatant as 
seen from Figure 2.19, through Tris assembly.  The imidazole assembly leads to 
CRYAB acting to promote more filament-filament interactions since in its presence 
there is an increase in pelleting of filaments compared to when filaments are 
assembled alone (Figure 2.20).  At 44 0C, CRYAB in the presence of WT GFAP 
increases its proportion pelleted under low speed sedimentation conditions compared 
to 23 0C, shown in Figure 2.19.  This is seen to be an effect of interactions with the 
filaments since its assembly alone at this temperature still results in most of the 
CRYAB being present in the supernatant fraction (Figure 2.22).  
 
 
 
Figure 2.19 Increasing the temperature from 23 to 44 0C increases filament-
filament interactions of WT GFAP in the presence of WT CRYAB through Tris 
assembly. 
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Low speed sedimentation assay gels were run of samples, assembled through A) Tris 
and B) imidazole assembly of WT GFAP with CRYAB.  With the Tris assembled 
filaments, most of the protein is in the supernatant portion at room temperature.  
Upon an increase in temperature the opposite is seen and also for imidazole assembly 
most of the filaments are in the pellet portions.  There is a positive correlation 
between an increase in the filament-filament interactions and an increase in the 
interactions of CRYAB with the filaments as seen in Figure 2.25 and 2.26.  S= 
supernatant and P= pellet. 
 
 
Imidazole buffer appears to result in WT filaments that tangle and have more 
increased associations amongst them as shown by a reduction in the amount of 
GFAP in the supernatant fraction at low speed, compared to WT GFAP assembled 
through Tris assembly (Figures 2.18A and 2.20B). 
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Figure 2.20 WT CRYAB increases filament-filament interactions of WT GFAP 
through imidazole assembly. 
Low speed sedimentation assay gels were run of samples from 23 0C.  From gel B) 
there is approximately 50% WT GFAP present in the S portion, which is then 
reduced upon addition of CRYAB, as shown in gel A), significant with a p value of 
0.05 (Table A.4).  The addition of CRYAB to R79C and R239H GFAP has no 
influence on their solubility in imidazole buffer.  The same quantification chart from 
Figure 2.18 is shown.  SNT and S= supernatant and P= pellet. 
 
 
GFAP is not the only IF in which CRYAB can reduce filament interactions as shown 
in Figure 2.21 where CRYAB acts to reduce desmin filament-filament interactions.  
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Figure 2.21 WT CRYAB reduces WT desmin filament-filament interactions 
through Tris assembly. 
A low speed sedimentation assay gel A) was run of samples assembled through the 
method in Figure 2.13, from left to right, of WT desmin and WT desmin + CRYAB, 
at 23 0C.  Comparing lanes 2 and 4, it can be seen that desmin filaments alone have 
more pelletable material than when co-assembled with CRYAB.  S= supernatant and 
P= pellet. 
 
 
Figure 2.22 WT CRYAB is predominantly in the supernatant fraction after low 
speed sedimentations from imidazole and Tris assemblies. 
A low speed sedimentation assay gel A) was run of WT CRYAB after assembly 
according to Figure 2.13 at 23 0C and also a gel was run of B) WT CRYAB, 
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assembled according to Figure 2.14, at 23, 37 and 44 0C.  Most of the CRYAB is 
present in the S portions through both assembly conditions.  S= supernatant and P= 
pellet. 
 	  
2.1.3.3 CRYAB impairs WT human GFAP assembly. 
Next the ability of CRYAB to inhibit WT GFAP assembly was assessed from high 
speed sedimentation assays, which assess assembled (insoluble) and unassembled 
(soluble) material in the pellet and supernatant fractions respectively and this was 
compared between Tris and imidazole assemblies at 23 0C (Ralton et al., 1994).  The 
effect of crystallins on bovine GFAP assembly have shown previously that 
crystallins inhibit assembly of filaments, therefore the effect of CRYAB on human 
GFAP assembly was assessed (Nicholl and Quinlan, 1994). 
 
 
Figure 2.23 WT CRYAB does not inhibit WT GFAP assembly through 
imidazole assembly. 
WT CRYAB does not act to significantly increase the amount of WT GFAP in the 
supernatant at high speed through imidazole assembly, shown from three 
independent experiments as quantified in the chart in Figure 2.24, which is contrary 
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to the findings when GFAP and CRYAB are assembled in a Tris buffer as shown in 
Figure 2.24.  S= supernatant and P= pellet. 
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Figure 2.24 WT CRYAB inhibits WT GFAP formation through Tris assembly. 
High speed sedimentation assay gels (A-C) are shown highlighting how WT 
CRYAB acts to increase the amount of WT GFAP in the SNT portion at 23 0C by 
20%, showing that it can inhibit the assembly of human GFAP.  There is no 
statistically significant difference in the amount of GFAP in the S portions for 
R239H and R79C in the presence of CRYAB, compared to its absence (c.f. appendix 
Table A.6 and A.7).  P = 0.001 for the increased amount of WT GFAP in the S in the 
presence of CRYAB compared to when CRYAB is not present.  WT CRYAB also 
inhibits R416W assembly competency as demonstrated from a Mann-Whitney U test 
in Table A.7.  The quantification data of the average values of protein present in the 
supernatant fractions, after high speed sedimentations, from at least three 
independent repeats is shown with error bars representing +/- one SD.  The Tris + 
EDTA section is discussed in the next chapter.  Only for WT GFAP through Tris 
assembly is the ability to inhibit filament assembly significant statistically where p = 
0.001 (c.f. appendix, Table A.6) and it appears that with imidazole buffer the 
CRYAB does not have this effect.  SNT and S= supernatant and P= pellet. 
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2.1.3.4 CRYAB has increased interactions with GFAP as a result of AxD-
causing mutations, elevated temperatures and a higher I.  
It was found that CRYAB interacts the least with WT GFAP filaments, as shown by 
the lowest proportion of CRYAB co-sedimenting with GFAP compared to the 
R239H mutant, seen in Figure 2.25 for 39 and 44 0C with the Tris assembly buffer.  
Increased temperatures also increase the interactions between CRYAB and the WT 
and mutant GFAP protein.   
Comparing the interactions of CRYAB with WT GFAP from the Tris and imidazole 
assemblies, imidazole buffer with its lower pH and higher I results in more 
interactions than Tris buffer. 
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Figure 2.25 The AxD-causing mutant R239H has increased interactions with 
CRYAB. 
High speed sedimentation assays (A) to E)) are shown from assemblies in Tris 
buffers, with gel E) as the control of CRYAB assembled in the absence of GFAP.  
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Most interactions (binding) of CRYAB with GFAP occur with the R239H GFAP as 
shown in C).  The quantification data of the average values of CRYAB present in the 
pellet fractions, after high speed sedimentations, from at least three independent 
repeats is shown with error bars representing +/- one SD.  CRYAB is predominantly 
in the supernatant after high speed sedimentation at all three temperatures but in the 
presence of GFAP there can be seen a temperature-dependent increase in binding 
which is statistically significant at a 1% probability level for all of the mutants and 
WT protein assembled through both conditions, comparing 23 with 44 0C (c.f. 
appendix, Tables A.8 and A.9).  Also there appears to be more binding of CRYAB to 
WT GFAP assembled through imidazole assembly as opposed to Tris assembly.  The 
Tris + EDTA section is discussed in the next chapter.  S= supernatant and PLT and 
P= pellet. 
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Figure 2.26 Binding of WT CRYAB increases with WT GFAP, at increased 
temperatures with imidazole assembly. 
High speed sedimentation assays of A) WT GFAP assembled with CRYAB and B) 
WT CRYAB alone are shown.  CRYAB is predominantly in the S portion after high 
speed sedimentation but in the presence of GFAP, it increases its quantity in the P 
portion and this increases with increasing temperature.  There is a greater amount of 
binding to filaments from assembly in imidazole buffer compared to Tris buffer.  S= 
supernatant and PLT and P= pellet. 
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2.1.3.5 Dominant effects of mutants on WT GFAP assembly. 
WT GFAP was mixed with the mutant GFAP and then assembled through Tris 
assembly at room temperature.  The R416W mutant GFAP studied previously, the 
result of a point mutation in the tail domain RDGE motif, was also assessed 
alongside the R239H and R79C mutant proteins (Der Perng et al., 2006).  Low speed 
sedimentation assays were carried out on the assembled proteins to assess the 
filament-filament interactions.  For the R239H mutant GFAP which results in 
aggregates consisting of small proteins, there is an increase in pelleting of the GFAP 
material at a 1:1 ratio of WT: mutant GFAP (Figure 2.30).  For the R79C mutant, 
any effect is difficult to observe from sedimentation assays, as the gel pattern is very 
similar to WT GFAP.  However, TEM images of the 1:1 ratio of WT: R79C GFAP 
show that there is a dominant effect of the mutant over WT filament formation due to 
the appearance of much shorter lengths of filaments at this level (Figure 2.27).  At a 
1:1 ratio level for the other two mutants, a clear alteration of filament morphology 
can be seen from TEM images and for R239H this can be seen at a 10% level 
however this is not severe enough to alter the low speed sedimentation profile seen 
for GFAP (Figure 2.30). 
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Figure 2.27 Dominant effect of R79C on WT GFAP filament formation. 
Mutant GFAP was present in the mentioned %s with WT GFAP.  A 50% level of 
R79C GFAP results in shortened filaments, whereas a 10% level does not have any 
dominant effect on WT filament formation.  The scale bar is equal to 500 nm. 
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Figure 2.28 Dominant effect of R239H on WT GFAP filament formation. 
Mutant GFAP was present in the mentioned %s with WT GFAP.  A 50% level of 
R239H GFAP results in shortened filaments and there appears to be an effect on 
filament morphology at a 10% level.  The scale bar is equal to 500 nm. 
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Figure 2.29 Dominant effect of R416W on WT GFAP filament formation. 
Mutant GFAP was present in the mentioned %s with WT GFAP.  A 50% level of 
R416W GFAP results in shortened filaments and even at a 10% level the filament 
structures appear altered.  The scale bar is equal to 500 nm. 
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Figure 2.30 R239H mutant GFAP is dominant over WT GFAP at a 50% level 
for increasing filament-filament interactions. 
Low speed sedimentation assays are shown.  The dominant effect of R239H can be 
seen at a 50% level by an increase in GFAP in the P portion.  D) the quantification 
data represent the average values of GFAP present in the supernatant fractions from 
three independent repeats.  The error bars represent +/- one SD.  Only at a 50% level 
is there an apparent reduction in the amount of soluble protein for the R239H mutant 
GFAP.  Regarding R79C the effects are difficult to see as 100% R79C is similar to 
100% WT GFAP.  SNT and S= supernatant and P= pellet. 
 
High speed sedimentations were carried out to assess assembly efficiency with the 
varying percentages of the mutant GFAP.  It was shown that most of the filaments 
were pelleted, even at a 50% level with R79C GFAP, despite shorter filaments being 
observed from TEM images.  Therefore low speed sedimentation assays appear to be 
more sensitive for assessing filament alterations. 
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Figure 2.31 R239H and R416W mutant GFAP form protein aggregates. 
High speed sedimentation assays are shown.  All of the samples are sedimented 
efficiently apart from 100% R79C GFAP.  D) the quantification data represent the 
average values of GFAP present in the supernatant fractions from at least three 
independent repeats.  The error bars represent +/- one SD.  Any difference in 
pelleting is difficult to assess from high speed sedimentation assay as the mutants 
result in aggregates, which give a similar sedimentation profile to WT GFAP 
filaments.  However differences can be seen between the R79C mutant and the 
R239H and R416W mutant proteins.  SNT and S= supernatant and P= pellet. 
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2.1.4 Discussion 
Two GFAP mutants of R79C and R239H have been studied in regard to their 
sedimentation profiles and morphology after TEM.  The R79C and R239H both 
result in distinct properties.  The R79C protein assembles inefficiently as observed 
from high speed sedimentation data, where more than 35% is present in the 
supernatant fraction.  This is in contrast to R239H GFAP, which is predominantly in 
the pellet due to a promotion of aggregation. 
 
WT and mutant GFAP morphology. 
The R79C GFAP forms structures similar to other mutants of GFAP found within the 
LNDR motif of the protein, such as with the R79H mutant and short fragments, 
however in this case the inability to form filaments does not lead to aggregates of 
proteins, instead it results in a large soluble pool of protein, which under high speed 
sedimentation remains predominantly in the supernatant portion (Figure 2.24) (Long, 
2003).  Mutations in the LNDR motif in other IFs are associated with severe disease 
thus showing that this conserved motif is essential for effective filament formation 
and function, demonstrated with Dowling-Meara EBS due to an identical mutation in 
K10 and 14 (Coulombe et al., 1991, Brenner et al., 2001).  The R239H mutation 
results in aggregates although it is difficult to identify what they are made up of.  
However, when CRYAB is added in a 1:1 molar ratio, the substructures can be seen 
and in fact this mutation also leads to shortened filaments, which are of ULF length 
or longer (Figure 2.15).  Another mutation in human recombinant GFAP at the 239 
amino acid position has been studied before, however this did not disrupt the 
annealing of the protofilaments and instead filament formation was preserved (Hsiao 
et al., 2005).  A reason for this may be because cysteine has a relatively high pK of 
8.5 alongside 12.0 for arginine and both will have a net positive charge, whereas 
histidine has a pI of 6.5 close to physiological pH, under the conditions of assembly 
with pH 7.3 and thus histidine is more negatively charged than cysteine.  R239 is at 
position e in the heptad repeat pattern in coil 2A of human GFAP and since positions 
e and g are involved in the inter-ionic interactions between two oppositely charged 
amino acids, the resulting charge change would be predicted to perturb assembly of 
dimers and potentially tetramers and in this case the replacement with histidine 
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appears to have prevented elongation of the filaments (Parry and Steinert, 1995, 
Stryer, 1996).  
 
CRYAB reduces mutant GFAP filament-filament interactions. 
It can be seen that CRYAB acts to reduce filament-filament interactions between 
R239H GFAP as seen by a statistically significant increase in the amount of GFAP in 
the supernatant in its presence compared to GFAP alone, through Tris assembly 
(Figure 2.18).  There is not a significant difference in the amount of WT GFAP in the 
supernatant portion in the presence of CRYAB compared to its absence although 
there is an effect seen with WT desmin and a reduction in filament-filament 
interactions (Figure 2.21).  However with imidazole assembly the opposite scenario 
is observed and the CRYAB is acting to increase filament associations for GFAP.  
There are a few differences between the imidazole and Tris assemblies that may 
account for the differences in the ability for CRYAB to modify filament-filament 
interactions.  Firstly the pH is much lower for the imidazole buffer having used a pH 
6.8 stock compared to pH 7.3 with Tris.  Also there is a higher concentration of 
buffer at 20 mM imidazole compared to 10 mM Tris and a higher amount of NaCl 
(100 mM) used with the imidazole assembly compared to 50 mM with the Tris 
assembly; the imidazole buffer has a higher I of 0.111 M compared to the Tris buffer 
of 0.0607 M (c.f. appendix, Ionic strength calculations).  No magnesium was 
included in the imidazole buffer, unlike the Tris assembly final buffer, due to the fact 
that imidazole binds magnesium.  The method used for the imidazole assembly is a 
standard method used previously in the laboratory and it is therefore interesting to 
assess how different assembly methods lead to different filament properties.  
However the lower pH for the imidazole buffer may explain the increased filament-
filament interactions as low pH has been shown previously to promote increased 
interactions of CRYAB with desmin filaments isolated from muscle tissue 
(Bennardini et al., 1992).  The ∆pH/∆T for Tris buffers is -0.028 pH units per degree 
centigrade increase, therefore at 23 0C the pH is 7.3, at 39 0C it is 6.9 and at 44 0C the 
pH is 6.7.  However for the imidazole buffer at 23 0C, the pH is 6.8 and this changes 
to 6.5 at 44 0C thus showing a ∆pH/∆T of -0.015 per degree centigrade increase.  The 
pH is thus likely to have an effect upon the ability of CRYAB to bind to filaments, 
therefore not only is temperature influencing the CRYAB-GFAP protein interactions 
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in the following section at three different temperature values.  This information leads 
into the hypothesis at the end of this chapter as to how pH and temperature may 
influence CRYAB interactions with the filaments, which is investigated in chapter 3. 
 
CRYAB impairs WT human GFAP assembly. 
It was shown that through Tris assembly, CRYAB effects were apparent where there 
was an increase in the unassembled material in the supernatant portion of the 
samples after assembly in Tris, with WT GFAP, significant statistically at a 1% 
probability level.  This is represented quantitatively from three independent repeats 
in Figure 2.24.  In vitro assembly inhibition of bovine GFAP has been observed from 
CRYAB using native purified proteins.  In this case however the filament assembly 
was inhibited as there was an absence of long filaments and most of the protein was 
present in the supernatant portion after a high speed sedimentation, whereas from 
these experiments with recombinant human protein there are still filaments, in the 
presence of CRYAB, as shown in Figure 2.15 and there has only been a slight 
increase in the soluble portion of WT GFAP (from 9 to 32%).  However since human 
and bovine GFAP are 96% identical it would be predicted that they have similar 
assembly properties, although the difference between these results and those found 
previously may be due to different post-translational modifications between the in 
vitro and in vivo proteins (Nicholl and Quinlan, 1994). 
 
CRYAB has increased interactions with GFAP as a result of AxD-causing 
mutations, elevated temperatures and a higher I.  
It was in fact seen that as the temperature was raised, CRYAB did associate more 
with the protein and this was at greater levels after imidazole assembly compared to 
Tris assembly (Figure 2.25 and 2.26).   
With imidazole and Tris assembly there is binding of CRYAB to the filaments at 39 
and 44 0C since CRYAB alone is 10% in the pellet at all temperatures for Tris 
assembly (Figure 2.25).  For imidazole assembly it is 10% in the pellet at 23 0C and 
20% at 39 and 44 0C (Figure 2.26).  With Tris assembly, the R239H GFAP has a 
much greater affinity for the CRYAB oligomers compared to even the R416W 
mutant and may be a reflection on the severity of the mutations.  R239H has 
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appeared only in infantile cases whereas R416W has been observed in infantile, 
juvenile and adult cases and therefore the R239H is likely to compromise filaments 
to a greater extent, shown by the younger age of presentation of the disease, than the 
R416W mutant thus leading to increased interactions with CRYAB (Rodriguez et al., 
2001, Kinoshita et al., 2003).  There is not a significant difference in the amount of 
CRYAB binding to WT GFAP and the other mutants at all three temperatures, apart 
from at 39 0C where R239H has a much higher affinity, also the maximum binding 
recorded is greater with the R239H mutant at 44 0C despite an overlap in error bars 
(Figure 2.25).  Not only does binding increase but also much more for the mutants, 
this shows that the increase in binding at higher temperatures is due to a combination 
of both the increased temperature and also altered architecture of the filaments 
(Figure 2.25).  It seems as if the temperature and structural factors are providing the 
means for the increased interactions and that one is exacerbating the other, otherwise 
the increase in binding would be linear as the temperature is increased and within 
each temperature there would be no significant difference in the amount of CRYAB 
binding to the WT or mutant GFAP.   
 
Dominant effects of mutants on WT GFAP assembly. 
As shown from high speed sedimentation quantification, the GFAP filaments have 
assembled at 5 and 10% mutant proportions with WT GFAP, as shown by 
approximately 90% of the total GFAP being pelleted.  At 50% however the mutated 
GFAP has had a dominant effect over the WT filaments formed seen from TEM 
images.  The 50% level of R79C GFAP formed very small protein structures, which 
were very close to the 60 nm length of ULFs.  These clumped and overlapped each 
other (Figure 2.27).  The 50% R239H GFAP also formed much shorter filaments that 
tended to cluster together (Figure 2.28).  At a 50% mutant level for all of the 
mutations, the filaments are shorter and more tangled than wild-type filaments as a 
result of perturbed longitudinal annealing. 
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Figure 2.32 Helical wheel projections of coiled coils. 
There are 3.3 amino acid residues per 360 degree turn of the helix (an amino acid 
every 1090).  Hydrophobic residues are in positions a and d and interchain ionic 
interactions occur between amino acids in the e and g positions. 
 
R239H is in a predicted position e of the heptad repeat in the 2A part of the rod 
domain; the e and g positions are crucial for specifying interactions between 
monomers in a coiled coil and this therefore helps to explain why it is the most 
severe mutant studied here (Parry and Steinert, 1995).  However R79C is located in 
the LNDR portion of the protein in the 1A rod domain but will also affect ionic 
interactions (predicted to be in a g position of the heptad repeat), as cysteine will be 
less positively charged than arginine at the physiological pH used in the experiments.  
Since this was assembled in the presence of 1 mM DTT, any potential disulfide bond 
formation will have been prevented.  These mutations will either introduce or hinder 
the formation of hydrogen-bonds and ionic bonds and will likely affect van der 
Waals forces as well (Parry and Steinert, 1995). 
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Mutation Predicted location in 
coiled coils 
 (a-b-c-d-e-f-g)n 
Hypothesised alteration on 
assembly at pH 7.3 
R79C i) position g 
ii) position g 
Reduction in positive 
charge disturbing ionic 
interactions between coils 
R239H i) position e 
ii) position e 
Reduction in positive 
charge thus reducing ionic 
interactions  
R416W i) random coil 
ii) random coil 
Tryptophan has an 
aromatic side chain which 
is bulky and will interfere 
with how the C-terminal 
RDGE motif interacts with 
neighboring coils 
Table 2.2 Summary of the hypothesised effects of GFAP mutations upon 
filament assembly. 
i) Positions of mutants were derived from the heptad repeat worked out manually 
(positions a and d are hydrophobic amino acids).  ii) The program COILS (SIB, SZ) 
was used to work out the heptad repeat. 
 
Amino acids in position a are predicted to have their side chains projecting out of the 
coiled coils whereas those in position d are predicted to have their side chains buried 
between the coils and therefore any bulky aromatic side groups such as with the 
imidazole ring in histidine will disrupt how the chains interact.  However the R239H 
mutation is not hypothesised to be in an a or d position but it will alter the charge 
responsible for ionic interactions.  For both the R79C and R239H mutants, the 32-
mers have been able to form since ULFs are observed for both but the ionic charge 
disruptions have prohibited their longitudinal annealing and compaction.  The 
R416W mutation is positioned in a random coil and may be why it is less severe than 
the R239H mutant as it won’t affect the alpha helical coil structures but how the tail 
domain interacts with neighbouring coils, which influences compaction (Heimburg et 
al., 1996). 
  
 
97 
The R416W mutant GFAP has been studied previously where a 25% level of R416W 
led to a dominant effect over WT filament formation however a similar effect was 
not seen in this case, only at a 100% level of R416W could the increase in 
interactions be observed from low speed sedimentation assays (Der Perng et al., 
2006).  This is likely due to the fact that the imidazole assembly method was used in 
the paper whereas Tris was used in this case and this supports how the imidazole 
method leads to increased filament interactions.  However the mutant protein 
morphology is similar, to that reported previously for R416W GFAP.  They appear 
as short filaments, which have aggregated together and when it is mixed with WT 
GFAP, a clear reduction in filament length can be seen as shown in Figure 2.29.  At a 
50% level of the mutant, altered structures can be seen from the TEM images.  
R239H appears to be the more severe mutant, supporting the finding of increased 
CRYAB binding in the previous section, compared to R416W since the dominant 
aggregate formation is observed at a 50% level from the low speed sedimentations 
compared to R416W effects which are not seen until a 100% level from 
sedimentation. 
Due to the variability in filaments when mixtures of mutants are present combined 
with WT GFAP and also the occasional presence of positive staining on some of the 
grids, the ability to quantify the lengths and widths of individual filaments accurately 
was hindered and thus a qualitative approach was taken instead of a quantitative 
analysis with statistical tests.  However a few measurements were made using 
ImageJ 1.43r (National Institutes of Health, USA), in section 2.1.3.1. 
In the next chapter a closer look at the interactions between CRYAB and GFAP and 
also the other type III IFs of desmin and vimentin will be carried out, to help gain 
more understanding about how altered filament architecture can lead to increases in 
CRYAB associations and also why temperature appears to influence these 
interactions.  In addition, since differences in CRYAB interactions with filaments 
were observed between the two different assembly methods and the observed 
increased binding of CRYAB to filaments at elevated temperatures and thus lowered 
pH values, a closer look at the effect of pH on CRYAB-filament interactions will be 
carried out.  The hypothesis is that lowered pH and increased temperatures will act to 
promote increased CRYAB-filament interactions. 
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Chapter 3; Conditions influencing WT CRYAB interactions with 
type III IFs GFAP, vimentin and desmin. 
3.1 Introduction and aims 
The purpose of this chapter is to assess how different divalent cation environments, 
temperatures and pH values influence CRYAB interactions with the type III IFs of 
GFAP, desmin and vimentin.  A previous study has assessed the effect of 
temperature and pH on desmin assembly but only with native desmin protein and 
also no comparison has been made to vimentin or GFAP.  Therefore the purpose of 
this study was to see how in vitro desmin protein was affected and how it compared 
to GFAP and vimentin (Bennardini et al., 1992).  Additionally the effects of different 
divalent cations on CRYAB-IF interactions have not been assessed from 
sedimentation assays in great detail before.  Type III IFs have the same molecular 
structure consisting of two non α-helical sections of an N-terminal head and C-
terminal tail domain and a central α-helical rod domain split into four main segments 
of 1A, 1B, 2A and 2B (Strelkov et al., 2002).  GFAP is predominantly expressed in 
glial cells, whereas vimentin is present in mesenchymal tissue and desmin in muscle 
cells, although desmin is also expressed in posterior capsule opacification within lens 
epithelial cells (cataract with fibrotic plaques) (Lovicu et al., 2002).  Vimentin has 
been shown capable of co-assembly with either GFAP or desmin and is co-expressed 
at the same time.  CRYAB is a sHSP, which forms large oligomeric complexes either 
alone or with αA-crystallin to form α-crystallin.  The sHSPs are generally 
upregulated in response to pathological states such as tuberculosis (Yang et al., 
1999).  CRYAB can prevent aggregation of proteins, demonstrated by a reduction in 
thermal aggregation of insulin and interacts with other proteins via hydrophobic 
interactions; at physiological temperatures CRYAB has a greater quantity of 
hydrophobic regions (responsible for binding to hydrophobic pathches on target 
unfolded proteins) than αA-crystallin, which reflects its greater ability for chaperone-
like activity (Datta and Rao, 1999).  IFs interact with sHSPs, as shown by the ability 
of HSP25 to reduce the gel viscosity of GFAP filaments, as assessed by a falling ball 
viscosity assay and also CRYAB’s ability to also prevent IF gel formation (Perng et 
al., 1999a, van Boekel et al., 1999).  Mutations in CRYAB can alter its interactions 
with IFs and induce changes in filament-filament interactions such as with the 
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cataract- and cardiomyopathy-causing R120G mutant, which results in increased 
clumping of desmin and even GFAP filaments, despite the mutation not being linked 
to gliopathy (Perng et al., 1999b, Perng et al., 2004).   
Magnesium ions are known to play a key role in the formation of assembled GFAP 
filaments; with a calcium-magnesium binding site having been reported in the 2B rod 
domain and thus the hypothesis was that removal of magnesium ions would result in 
perturbed assembly (Yang Z W., 1988).  Not much is known about the assembly 
mechanisms of GFAP filament formation, especially regarding the absolute number 
of ULFs that are aligned parallel to each other to form the mature filament after final 
compaction and how the protofilament step is involved.  Changes in the 
concentrations of divalent cations have been linked to pathological states such as 
increased iron levels within the substantia nigra in PD patients, where degenerated 
dopaminergic neurons correlate with iron importers being increased and iron 
exporters decreased in expression levels alongside increased expression of α-
synuclein involved in Lewy body formation (Lv et al., 2011).  Development of AD, 
ALS and Huntington’s disease have also been correlated with high levels of iron 
(Pankhurst et al., 2008, Simmons et al., 2007, Jeong et al., 2009).  However some 
drug-induced skeletal muscle myopathies are due to a reduction in the level of 
muscle metal ions, such as with D-penicillamine administration (Preedy et al., 2001).  
High levels of manganese are implicated in idiopathic Parkinson’s disease (IPD) and 
in the spinal cord of patients with ALS linked to manganism that is coincidental with 
increased levels of CRYAB (Wang et al., 2008).  Mitochondria are known as a store 
of manganese ions; these ions are involved in a few processes including association 
as a chelated ion within the complex of manganese superoxide dismutase, therefore 
skeletal muscle contains a moderate quantity in addition to the high levels in other 
tissues such as the liver and pancreas (Calne et al., 1994, Miyata et al., 1983, 
Murakami et al., 1998).  Therefore although not reported so far, it may be the case 
that accumulated levels of iron or manganese in AxD or desmin-related myopathies, 
linking in with GFAP and desmin studied here, contributes to increased associations 
with CRYAB and therefore it was important to study how manganese and other 
divalent cations may influence these interactions.   
Assembly was carried out investigating the influence of different divalent cations 
(magnesium, manganese and calcium) and their absence on filament structures.  The 
interactions of CRYAB with these filaments were investigated as it has been shown 
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that mutated GFAP, which forms aggregates, has increased associations with 
CRYAB.  Calcium levels are known to be transiently high in cells when released 
from the endoplasmic reticulum (ER), but it is more likely that magnesium ions play 
a role in regulation of GFAP filament networks (Tanaka et al., 1989).  It has been 
shown for Xenopus vimentin that the addition of 5 mM Ca2+ ions results in much 
thicker filaments compared to normal conditions of assembly (Hofmann et al., 1991).  
Therefore in addition to the role that the physiological divalent magnesium ions play 
in GFAP assembly, calcium ions were also investigated in this study alongside 
manganese ions, to assess effects of other physiological divalent cations.  It has 
already been shown that manganese ions result in greater associations of GFAP 
bovine filaments as revealed from turbidity spectrophotometrical measurements 
(Yang and Babitch 1988).  When bovine GFAP has been assembled in 5 mM CaCl2 
it was found to form individual filaments but also filament bundles from side-by-side 
interactions and divalent cation concentrations above 10 mM resulted in aggregate 
formation, thus showing that the divalent cation environment is important for 
influencing the assembly of filaments (Yang and Babitch, 1988).  The ability for WT 
CRYAB to reduce filament-filament interactions was investigated under these 
conditions with GFAP filaments formed in 1 mM Ca2+ and Mn2+ ions, showing that 
manganese ions resulted in the perturbed ability of CRYAB to be able to reduce 
filament-filament interactions since not as much GFAP was present in the 
supernatant portion at room temperature compared to assembly in calcium ions.  
GFAP filaments were found to be most sensitive to their divalent cation 
environment, compared to desmin and vimentin.  Thicker GFAP filaments were 
observed with 1 mM Mn2+ ions, 5 mM Ca2+ ions, in the absence of divalent cations 
and at pH 6.3.  Shortened GFAP filaments were observed with 1 mM Mn2+ ions, at 
pH 6.3 and in the absence of divalent cations giving filaments that were prone to 
aggregation.  There is a clear effect upon WT GFAP filament compaction from 
manganese ions and therefore the effect of this divalent cation on desmin and 
vimentin type III IFs was also investigated.  
To add to the investigation of whether temperature influences the binding of WT 
CRYAB to 10 nm filaments through assembly with magnesium ions, experiments 
keeping a constant pH at different temperatures were devised.  The hypothesis 
inferred from the data in chapter 2 was that at lower pH values and increased 
temperatures the CRYAB would increase its association with the filaments, likely 
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due to alterations in the filament structure.  This follows on from the story in chapter 
2, with the question of how CRYAB increases its interactions with filaments at 
higher temperatures and if it is due to a drop in pH, an increase in temperature or a 
mixture of the two.  Previous studies on CRYAB binding to filaments involved using 
a shortened assembly method (Perng et al., 2008).  Although this has its merits due to 
ease of controlling the final assembly temperatures using a water bath, in this study 
the effects of temperature on binding was assessed using overnight assembly as 
filaments compact a lot better.  
 
3.1.2 Materials and methods. 
 
3.1.2.1 Assembly methods. 
 
3.1.2.1.1 Tris assemblies. 
For assembly of GFAP filaments in the absence of magnesium ions, the method used 
was the same as in Figure 2.13, except 1 mM EDTA (0.0727 mM free Mg2+ ions 
(Ca++ and Mg++ Calculations programme)) was added.  0.4 mg/mL GFAP was 
assembled with or without 0.16 mg/mL WT CRYAB (1:1 molar ratio) unless 
otherwise stated.  In addition MnCl2 and CaCl2 were investigated at concentrations 
of 1 mM and also 5 mM for Ca2+.  High and low speed sedimentation assays were 
carried out as in section 2.1.2.12 and TEM grid preparation was the same.  For 
investigating the influence of different divalent cations on GFAP, desmin and 
vimentin filament assemblies, the same assembly method was used minus the 
penultimate buffer step and without EDTA in the final buffer, at 23-28 and 39-44 0C.  
A 1 mM concentration of divalent cations was used unless otherwise stated. 
 
3.1.2.1.2 Desmin shortened assembly method. 
Filaments were assembled via dialysis using a previous method from the laboratory, 
through 6, 4, 2 and then 0 M urea in 10 mM Tris-HCl (pH 8.0), 1 mM EDTA and 1 
mM DTT and then into 10 mM Tris-HCl (pH 7.0) with 1 mM DTT (Perng et al., 
2004).  The protein was placed on ice at 4 0C in a TLS-55 centrifuge tube before the 
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quick assembly buffer was added with 100 mM imidazole-HCl (pH 6.8) and 1 mM 
DTT final concentrations and left at 37 0C for 1 hr (Perng et al., 2008). 
 
3.1.2.1.3 Manganese ion assemblies. 
Assemblies of GFAP and vimentin were carried out through a 4-(2-
Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) assembly method with 
Mn2+ ions as shown in Figure 3.1.  A 1:1 molar ratio of filaments: WT CRYAB was 
used (0.2 mg/mL vimentin (53.7 kDa) + 0.07 mg/mL WT CRYAB (20.2 kDa) and 
0.2 mg/mL GFAP (49.9 kDa) + 0.08 mg/mL WT CRYAB).  Below is a table 
highlighting the pH values used.  The HEPES buffers (ΔpKa/0C of -0.014) were 
made at three different pH values so that they would be pH 6.9 at their respective 
temperatures. 
 
 
The three stock HEPES buffers’ pH 
values prepared at 23 0C 
 
The three final assembly buffer pH values 
prepared with either buffer 1, 2 or 3 at the 
temperatures shown 
1 2 3 1 
23 0C 
2 
39 0C 
3 
44 0C 
7.1 7.22 7.29 6.9 6.9 6.9 
Table 3.1 pH values of final HEPES assembly buffers measured with salt and 
DTT.   
Final assembly buffer pH values are shown, prepared taking into account a ΔpKa/0C 
of -0.014, for buffer 5 in Figure 3.1 (Beynon and Easterby, 1996). 
 
For the final buffer at 23 0C with manganese ions, initially the pH dropped to 6.8 
when using a pH 7.00 stock solution of HEPES compared to stock pHs of 7.22 and 
7.29 which both dropped to pH 6.9 at 39 and 44 0C in the final assembly buffer 
conditions.  Therefore a pH 7.1 HEPES buffer was prepared and used for the final 
assembly buffer at 23 0C to get a final pH of 6.9.  In this case when higher 
temperatures than 23 0C were used, the manganese ion was behaving as a different 
Lewis acid.  Also, the final assembly buffer pH with 1 mM MnCl2 ions is higher at 
pH 6.9 than pH 6.8 with MgCl2 at 39 and 44 0C using pH 7.22 and 7.29 stock 
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solutions.  It is already known that buffers have metal-binding constants, however 
this is relatively low for HEPES in comparison to phosphates (Sokolowska and Bal, 
2005).  The HEPES buffer is zwitterionic with the weak acid having both a positive 
charge on the NH group and a negative charge on the SO3 group; the conjugate base 
is negatively charged and thus any free cations will compete with H+ ions for binding 
(Good and Izawa, 1972).  Magnesium ions exist only in one oxidation state of +2 and 
manganese can exist in many oxidation states up to +7, however under these 
conditions the +2 oxidation state will be the most stable; only at higher pH values 
such as 14 will the higher oxidation states become more stable (Ghosal et al., 2005, 
Cox, 2004).  Importantly, magnesium ions (ionic radius of 0.65 Å) are approximately 
20% smaller than manganese ions (ionic radius of 0.80 Å) and thus will have a 
greater charge density lending itself to stronger interactions with water and thus more 
capacity for it to accept electrons and act as a Lewis acid (Permyakov and 
Kretsinger, 2011).  Whereas manganese ions will have more covalent interactions, 
with it being a transition metal, leading to a lower hydration and therefore will be a 
less effective Lewis acid, thus explaining why the pH is lower when magnesium ions 
are used instead of manganese, at 39 and 44 0C (Yoder, 2006).  
For anionic phosphate buffers, when cations from salts are added they are attracted to 
the negatively charged phosphate ions leading to more hydronium ions in solution 
and thus a drop in pH and the differences in the ability for different ions to drop the 
pH by different amounts is due to their polarisability.  Also anions, which have 
higher polarisability than cations, will be closer to the phosphates thus reducing 
release of hydronium ions and leading to higher pH values.  However with Tris-HCl 
buffers, these are cationic and the conjugate Tris base is electrostatically neutral and 
cations are thought to lead to increases in pH with a lower quantity of free 
hydroniums, which has been observed in chapter 2 where the addition of NaCl and 
MgCl2 resulted in a whole pH unit increase for the final Tris assembly buffer (Salis 
et al., 2007). 
 
  
 
104 
 
Figure 3.1 GFAP, desmin and vimentin HEPES assembly wheel. 
Protein was assembled clockwise within 1 L buffers (with a 5,000-fold excess of 
dialysis buffer to sample volume) except for buffer 5 (with a 2,500-fold excess of 
dialysis buffer to sample volume) and assembly was for 2 hr for each step, using a 
stirring flee on a magnetic stirrer at 28 0C prior to buffer 5 at 23, 39 and 44 0C 
overnight.  The final buffer was pH 6.9. 
 
Desmin was excluded from the assemblies here as the manganese ions resulted in 
such increased interactions of filaments that inevitable sample loss after pipetting on 
gels occurred. 
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3.1.2.1.4 HEPES and magnesium ion assemblies; CRYAB addition before 
filament formation. 
To assess the pH and temperature dependence of binding of WT CRYAB to GFAP, 
vimentin and desmin with its addition prior to filament maturation, an I of 20 mM 
HEPES alongside 100 mM NaCl was used to ensure proper compaction of the 
filaments.  All filaments were assembled using 28 0C for all the buffers before the 
final assembly step, which was at 23, 39 or 44 0C.  A 1:1 molar ratio of filaments: 
WT CRYAB was used (0.2 mg/mL desmin (53.4 kDa)/vimentin + 0.07 mg/mL WT 
CRYAB and 0.2 mg/mL GFAP + 0.08 mg/mL WT CRYAB).  WT GFAP, vimentin 
and desmin were assembled through the method used in Figure 3.1, except 1 mM 
magnesium ions were used in place of manganese ions in buffer 5.  CRYAB was 
mixed with the filaments in the column purification buffers before assembly was 
begun, for the main experiments.  To remove temperature-heating effects from the 
magnetic stirrers for buffer 5 and to ensure accurate temperatures, a polystyrene base 
was placed between the magnetic stirrers and plastic beakers containing the final 
assembly buffers and samples, to act as an insulator.  All buffers prior to the final 
buffer were at 28 0C and the final buffer was pH 7.3, 6.8 or 6.3.  The final pHs were 
checked with the pH meter upon addition of the salts and DTT, at the appropriate 
temperatures using a thermostatically controlled water bath and are listed in the table 
below.  Calibration of the pH meter was also carried out using two standards either 
side of the pH being measured, at the same temperatures as the final buffers. 
 
The three stock HEPES buffers’ 
pH values, per row, prepared at 
23 0C 
 
The three final assembly 
buffer pH values prepared 
with either buffer 1, 2 or 3, 
per row, at the temperatures 
shown 
Base: acid ratio 
of HEPES 
buffers at final 
temperatures 
used 
1 2 3 1 
23 0C 
2 
39 0C 
3 
44 0C 
 
7.6 7.82 7.89 7.3 7.3 7.3 1:0.8 
7.0 7.22 7.29 6.8 6.8 6.8 0.3:1 
6.5 6.72 6.79 6.3 6.3 6.3 0.09:1 
Table 3.2 pH values of final assembly buffers measured with salt and DTT. 
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As can be seen the pH values were lower in the presence of the salts, similar to the 
previously found trend of a reduction of pH upon addition of NaCl to phosphate 
buffer solutions and the discrepancy was different dependent upon the location 
within the buffering range looked at, dependent upon the different ratios of base/acid 
as shown in Table 3.2 (calculated using the Henderson-Hasselbach equation with a 
pKa of 7.51 at 23 0C) (Robinson, 1929).  The largest ∆pH appears to occur at the 
higher base: acid ratio, which is the opposite of what was found with the effects of 
addition of NaCl or LiCl on the pH of phosphate buffers (Robinson, 1929).  The pHs 
were the same at the different temperatures for each pH looked at and thus 
conclusions could be drawn as to temperature and pH changes influencing the 
binding of CRYAB to filaments.   
 
3.1.2.1.5 HEPES and magnesium ion assemblies; CRYAB addition after 
filament formation. 
As an additional test of the system, experiments at pH 6.3 and 7.3 were carried out 
with CRYAB oligomers added to assembled GFAP filaments, to see if similar results 
were apparent to the binding seen when CRYAB was added before filaments had 
formed.  For this case the WT CRYAB was dialysed alongside the filaments into the 
final assembly buffers of either pH 6.3 or 7.3 overnight at 23 0C using the same 
method as Figure 3.1 with magnesium ions, then CRYAB was added at a 1:1 molar 
ratio to the assembled filaments in the dialysis bags, they were placed into the higher 
pH buffers as necessary in glass beakers and sonicated for 15 sec (enabling the 
CRYAB to get within the filament networks), then they were dialysed for 1.5 hr at 
23 0C and incubated at 23 0C or the increased temperatures for a further 4 hr on 
rotating wheels, within Eppendorfs positioned perpendicular to the axis of rotation so 
that the filament solutions didn’t come into contact with the inner surface of the 
Eppendorf lids.  Since vimentin bound the least to CRYAB in the first section, only 
GFAP was looked at to test the hypothesis that the surface of the filaments have 
changed leading to altered binding and two pH values of 6.3 and 7.3 were studied 
which gave the greatest contrast in binding.  Desmin would have been tested but 
material was lost from most of the samples on the gels run suggesting that despite 
sonication being used, the interactions between the filaments were too great, before 
addition of CRYAB and the filaments were likely sticking to the plastic surfaces and 
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thus only GFAP could be looked at.  Student’s T-tests and Mann-Whitney U tests 
were carried out on the data similar to the analysis carried out in chapter 2 and the 
data are shown in the appendix, comparing the quantity of CRYAB binding to 
filaments from its addition to assembled filaments to the binding seen when CRYAB 
was added before filament formation, at the same pH. 
A further test was set up with the filaments assembled at pH 6.3 at 23 0C and then 
transferred into pH 7.3 for 1.5 hr, before CRYAB assembled at pH 7.3 was added to 
assess any potential for the filaments to revert back to a conformation that has lower 
binding.  The solutions were sonicated and incubated for 4 hr in Eppendorfs.  This 
also aids in understanding if it is predominantly the final filament surface structure 
that has been altered due to a lower pH and increased temperature values, resulting in 
increased associations with CRYAB, as opposed to both alterations in the CRYAB 
structure and the filament surface, which could be presumed from CRYAB addition 
from the same pH.    
 
3.1.2.2 Reduction of GFAP dimer. 
20 µg of WT GFAP assembled through Tris assembly with manganese ions at 23-28 
0C was reduced with 50 mM DTT at 37 0C for 1 hr, similar to a previous method 
used before and an equivalent mass of 4 µg to that loaded as the supernatant portion 
from a low speed sedimentation assay was then run on a sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) gel, alongside the supernatant 
portion (Dornmair and Mcconnell, 1990). 
 
3.1.2.3 Gel electrophoresis. 
Gels were run the same as in 2.1.2.8 except in some instances the PagerulerTM Plus 
Prestained Protein Ladder #SM1811 (Fermentas, UK) was used, which has the 
following recombinant protein molecular weights: 250, 130, 95, 72, 55, 36, 28, 17 
and 10 kDa, instead of the PagerulerTM Prestained Protein Ladder #SM0671 
(Fermentas, UK). 
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3.1.2.4 Sedimentation assays. 
These were carried out the same as in 2.1.2.12. 
 
3.1.2.5 TEM grid preparation and image collection. 
Images were prepared and imaged the same as in 2.1.2.11. 
 
3.1.2.6 Semi-dry immunoblotting. 
Immunoblotting was carried out the same as in 2.1.2.9. 
 
3.1.2.7 Statistical analysis. 
Student T-tests were carried out the same as in 2.1.2.14. 
 
3.1.2.8 Sequence alignments. 
The ClustalW2 (EMBL-EBI, UK) alignment of WT human GFAP (GenBank: 
J04569.1), desmin (GenBank: NM_001927.3) and vimentin (GenBank: 
NM_003380.3) was carried out from pasting the sequences into the input box on the 
EMBL-EBI website (Larkin MA, 2007). 
Sequence similarities were also assessed in BLAST	  (National Library of Medicine, 
US) using the Align option and blastp, after pasting the amino acid sequences.  The 
megablast programme was selected.  The alignment showed the % identities. 
 
3.1.2.9 ImageJ filament measurements. 
TEM images were imported into ImageJ 1.43r (National Institutes of Health, USA) 
and initially the straight line tool was selected and used to draw a line the same 
distance as the scale bar on the image.  Then in the Analyze and Set Scale options, 
the known distance in nm was entered and also the units to drive a scale in 
pixels/nm.  Filament widths and lengths were then measured by using the zoom 
option and also the line tool to span the length of interest and then the Analyze and 
Measure options. 
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3.1.3 Results. 
Questions to 
answer 
Information gathered Page 
#s 
What is the 
effect of the 
divalent 
cations 
Mg2+, Mn2+ 
and Ca2+ on 
the assembly 
properties of 
WT GFAP, 
vimentin 
and desmin? 
i) Mn2+ induces higher oligomeric structures to be formed 
for all three IFs; GFAP dimers are due to oxidative cross-
linking.  It also increases the interactions between 
CRYAB and filaments compared to Mg2+ ions. 
ii) Mn2+ ions increase GFAP and desmin filament-
filament interactions, but not for vimentin. 
iii) GFAP filaments are wider than 10 nm when 
assembled in the presence of 1 mM Mn2+ ions and 5 mM 
Ca2+ ions.  Human vimentin and desmin appear 
unaffected in 5 mM Ca2+ ions. 
iv) Filaments assembled in 1 mM Ca2+ ions appear no 
different to those assembled in 1 mM Mg2+ ions. 
v) The absence of divalent cations leads to disruption in 
GFAP longitudinal annealing, although lengths appear 
longer than ULFs and this leads to increased CRYAB 
binding. 
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133 
131 
 
116 
128 
129 
130 
123- 
125 
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Is pH more 
crucial than 
temperature 
of the final 
assembly 
buffer to 
result in 
increased 
binding of 
CRYAB to 
WT GFAP, 
vimentin 
and desmin? 
i) Low pH is the main determining factor for binding of 
CRYAB and higher temperature acts to exacerbate this 
effect, likely due to changes in the structure of the 
presenting filament and increases in CRYAB 
hydrophobic surfaces.  CRYAB oligomers are wider and 
more variable at pH 6.3 compared to 6.8 and 7.3. 
ii) CRYAB binds predominantly to desmin filaments with 
least preference for vimentin. 
iii) GFAP in pH 6.3 buffer has variable widths, 
implicating a filament structural change is likely 
responsible for increased interactions with CRYAB. 
Vimentin in pH 7.3 at 23 0C is also wider. 
iv) The filament surface is very important for determining 
interactions with CRYAB, demonstrated from the 
assembly stage when CRYAB is added where most 
binding occurs when CRYAB has been present 
throughout GFAP filament formation. 
v) Filaments appear to have some plasticity in their 
surface structures for interaction with CRYAB as those 
assembled at pH 6.3 and put into pH 7.3 bind less 
CRYAB than those just assembled at pH 6.3. 
142 
 
 
 
 
 
140- 
141 
149- 
150 
 
 
153 
 
 
 
 
154 
How does 
temperature 
influence 
binding of 
WT CRYAB 
to filaments 
with Mn2+ 
ions? 
i) With Mn2+ ions, temperature rises induce increased 
binding of CRYAB to the filaments with the preference 
of binding as 
vimentin<GFAP. 
ii) Desmin filaments stuck to the plastic surfaces and 
pipette tips when assembled in HEPES with Mn2+ ions 
thus showing how the interactions between the filaments 
are greatly increased, more so than even the desmin 
assembled in Tris buffer with Mn2+ ions. 
139 
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 Table 3.3 Summary of findings. 	  
3.1.3.1 GFAP assembly is susceptible to its divalent cation environment. 
WT GFAP forms 10 nm filaments when assembled through the standard assembly 
procedure.  However in this case where divalent cations have been chelated, the 
filaments are unable to elongate and compact as usual and have changed filament 
morphologies (Figure 3.4).  However there is some capacity for elongation, referring 
to Figure 1.4 where the assembly mechanism shows type III IFs forming ULFs that 
are approximately 60 nm in length, since the filaments are longer than ULFs.  The 
filaments are also thicker than normal and often reach over 20 nm.  However the 
elongation is not complete and compaction will also be stalled thus giving the 
appearance of sheet-like structures and much wider filaments often over 20 nm thick 
(Figure 3.4).  The lengths vary but some of the shorter filaments are approximately 
300 nm, measured in ImageJ 1.43r (National Institutes of Health, USA).  Despite the 
increased filament-filament associations as shown below in Figure 3.2 B), displaying 
average quantification results of the percentages of GFAP in the supernatants after 
low speed sedimentations, WT CRYAB is able to reduce the filament-filament 
interactions between these filaments. 
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B 
 
Figure 3.2 CRYAB is able to reduce filament-filament interactions of GFAP 
assembled without magnesium ions as demonstrated from low speed 
sedimentation assays. 
A low speed sedimentation assay was carried out on WT GFAP samples after 
assembly according to Figure 2.13 with the addition of 1 mM EDTA to the final 
assembly buffer.  WT GFAP was assembled alone (track 3-4) but when CRYAB is 
present (track 1-2), there is an increase in the soluble portion of GFAP (compare 
track 1 to 3), but notice how the chaperone-like activity of CRYAB can’t prevent the 
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full extent of the increased associations since WT GFAP assembled in the presence 
of magnesium ions has a much lower quantity of material in the pellet fraction, 
shown in B).  S and SNT= supernatant and P= pellet. 
 
In addition to the usual ability of WT CRYAB being able to reduce filament-filament 
interactions, there is also an increase in the co-pelleting alongside these altered 
GFAP filaments at increased temperatures, similar to the trend of increased binding 
to normal GFAP filaments with increasing temperatures, seen in the second chapter.  
This binding is much greater than the binding seen to usual GFAP filaments, as 
displayed in Figure 3.3.  Also unlike section 2.1.3.3 where WT CRYAB was shown 
to hinder formation of WT GFAP filaments, in this case CRYAB has no effect upon 
the pelleting under high speed sedimentation conditions of these altered GFAP 
filaments, as shown in Figure 3.3. 
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          GFAP + CRYAB                      CRYAB                               GFAP 
D 
 
Figure 3.3 CRYAB binds more to GFAP assembled without magnesium ions, 
compared to with magnesium ions, upon increases in temperature as 
demonstrated from high speed sedimentation assays. 
WT GFAP was assembled A) without magnesium ions in the presence of WT 
CRYAB at 23, 39 and 44 0C and quantification results are shown in the Tris + EDTA 
section of chart D).  There is an increase in co-pelleting of CRYAB with GFAP at 
higher temperatures.  The increase in pelleting of CRYAB is due to interactions with 
GFAP as B) most is present in the supernatant at all three temperatures on its own.  
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At increased temperatures C) there is also a reduction in the amount of GFAP in the 
supernatant portions showing an increase in filament interactions.  Comparing the 
amount of GFAP in the supernatant in C) at 23 0C to that with WT CRYAB at 23 0C 
in A) it can be seen that the CRYAB hasn’t increased the soluble portion of the 
assembled GFAP under these conditions and thus has little influence on the assembly 
status of these structures.  S= supernatant and PLT and P= pellet. 
 
 
 
 
 
Figure 3.4 WT GFAP assembled without magnesium ions forms altered 
filaments and CRYAB acts to reduce interactions within these.  
TEM images of A) WT GFAP assembled without magnesium and B) and C) WT 
GFAP with WT CRYAB assembled without magnesium at 28 0C were taken.  The 
CRYAB has reduced the interactions between the GFAP, enabling the lengths to be 
discerned which are much shorter than usual WT filaments, but longer than ULFs.  
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Additionally the filament widths are thicker than 10 nm.  The arrow points to a 
CRYAB particle.  The scale bar is equal to 500 nm. 
 
Despite no alteration in pelleting of assembled GFAP in magnesium-free conditions 
assessed from high speed sedimentation assays, in the presence of CRYAB 
compared to its absence, CRYAB enables the filament structures to be seen more 
clearly from TEM images as shown in Figure 3.4.  
GFAP filaments were then assembled with manganese ions to see what effect this 
divalent cation has on assembly as increased levels have been linked to various 
neurological disorders.  It was found that the filaments are assembly compromised 
and form filamentous sheet structures, even in the presence of CRYAB that is seen in 
Figure 3.5.  However to contrast these findings, when 1 mM Ca2+ ions are used there 
is no apparent alteration in filament formation (Figure 3.6). 
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Figure 3.5 Manganese ions promote the formation of sheet-like filament 
networks of WT GFAP.  
TEM images were taken of WT GFAP assembled alone at A) 28 and B) 44 0C 
(alongside its inset E)).  Images are also shown of WT GFAP with CRYAB at C) 28 
and D) 44 0C.  Assembly was according to Figure 2.13 with 1mM Mn2+ ions.  The 
GFAP filaments are shorter than normal and do not appear as the usual individual 
filaments but instead align next to each other much more and thus appear more like 
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sheets.  The filament widths span up to approximately 30 nm, measured in ImageJ 
1.43r (National Institutes of Health, USA).  The scale bar is equal to 500 nm. 
 
 
 
Figure 3.6 WT GFAP assembled with 1 mM Ca2+ ions form filaments 
morphologically similar to those assembled with 1 mM Mg2+ ions. 
TEM images of WT GFAP assembled in 1 mM Ca2+ ions are shown at A) 39 0C and 
its inset B).  The filaments are 10 nm in width and span up to a few µm thus showing 
that calcium assembled filaments are similar to magnesium assembled filaments that 
are unlike manganese assembled filaments.  The scale bar is equal to 500 nm. 
 
 
The action of manganese ions can also be seen biochemically from low speed 
sedimentation assays with an increase in pelletable GFAP compared to lower 
filament-filament interactions after assembly with magnesium and calcium ions 
(Figure 3.7). 
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Figure 3.7 Manganese ions promote an increase in filament-filament 
interactions of WT GFAP. 
Low speed sedimentation assays carried out on WT GFAP samples are shown.  
GFAP is predominantly in the supernatant portion with magnesium and calcium ions 
whereas with manganese ions most is pelleted showing there has been an increase in 
filament-filament interactions with the manganese ions.  The manganese ions result 
in greater variability of GFAP in the supernatant fraction compared to the other two 
ions looked at, varying approximately 10-40% in the supernatant, but in all cases 
there is a greater amount pelleted compared to the conditions with the other two 
divalent cations.  Manganese ions have also resulted in an upper molecular weight 
band of GFAP showing a larger complex of GFAP has been formed.  S= supernatant 
and P= pellet. 
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Figure 3.8 Addition of CRYAB to WT GFAP assembled with manganese ions 
does not prevent the formation of the higher molecular weight oligomer of 
GFAP.  
Low speed sedimentation assay gels are shown.  A) With 1 mM Mn2+, the upper 
molecular weight band corresponding to larger complexes of GFAP, evidenced in 
Figure 3.17, is shown (arrow) and will be a dimer (Quinlan and Franke, 1983).  The 
increased filament-filament interactions are seen as an increase in the amount of 
GFAP present in the pellet fraction that can’t be reduced at 23 0C, although as with 
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calcium CRYAB can reduce GFAP interactions at 39 0C.  B) Most of the GFAP is 
present in the supernatant at 230C with 1 mM Ca2+ and upon increasing the 
temperature to 39 0C there is an increase in the filament-filament interactions that 
CRYAB is able to reduce in addition to reducing interactions at 23 0C, as more 
GFAP is present in the supernatant fraction.  S= supernatant and P= pellet. 
 
3.1.3.2 Manganese ions promote increased binding of CRYAB to GFAP, desmin 
and vimentin filaments. 
Previously quick assembly (3.1.2.1.2) has been used to investigate binding 
interactions of CRYAB with IFs and it can be seen that these filaments (Figure 3.9), 
in comparison to desmin filaments assembled through Tris assembly (Figure 4.4), 
have many more filament-filament interactions with similarities to the increased 
interactions seen with GFAP filaments formed in the presence of 1 mM Mn2+ ions 
(Figure 3.5 E)) (Perng et al., 2004).  Therefore Tris assembly was used for these 
experiments to utilise conditions as close to the in vivo filament networks as possible 
to assess the role of different divalent cations on filament-filament interactions and 
CRYAB binding. 
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Figure 3.9 WT desmin assembled through the shortened assembly method. 
Note how filaments look similar to the WT GFAP filaments assembled without 
magnesium ions with less spacing between individual filaments, highlighting a lack 
of proper compaction.  The scale bar is equal to 500 nm. 
 
 
Figure 3.10 shows that desmin and vimentin can form usual 10 nm filaments in 1 
mM Ca2+ ions as does GFAP however 5 mM Ca2+ ions result in thicker filaments for 
human GFAP, similar to Xenopus vimentin, but not human vimentin or desmin as 
seen in Figure 3.12.  As well as manganese ions promoting increased filament-
filament interactions for GFAP and desmin (Figure 3.13) it also promotes an increase 
in binding of CRYAB to the filaments, shown from the TEM images in Figure 3.11 
for desmin filaments where there is a greater density of CRYAB particles 
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surrounding the filaments compared to those after assembly in calcium ions.  This 
increased binding due to manganese ions is shown from high speed sedimentation 
assays in Figure 3.15 and is compared to the filaments assembled in the presence of 
magnesium ions, which have lower binding.  From these gel images it can be seen 
that desmin has the greatest binding to CRYAB, GFAP has an intermediary level and 
vimentin binds the least.  Assembled filaments in 1 mM Ca2+ ions also have a 
relatively low binding to CRYAB (Figure 3.16).  The binding with manganese and 
magnesium ions is also increased at the higher temperature range and is highlighted 
in the quantifications shown in Table 3.4. 
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Figure 3.10 Filaments formed with 1mM calcium ions have usual 10 nm 
diameters. 
TEM images are shown of A) and inset B) WT GFAP, C) and inset D) desmin and 
E) and inset F) vimentin assembled through Tris assembly with 1 mM Ca2+ ions at 
39-44 0C.  A 10 nm filament width can be observed for all three filament networks.  
The scale bar equals 500 nm. 
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Figure 3.11 In the presence of manganese ions, CRYAB binding is greater to 
desmin filaments compared to calcium ions.  
TEM pictures of WT desmin assembled with WT CRYAB in the presence of A) 1 
mM Mn2+ or B) Ca2+ ions through Tris assembly at 39-44 0C are shown.  Note how 
the desmin filaments are coated with CRYAB particles (indicated by arrow) in the 
presence of manganese compared to calcium ions.  The scale bar is equal to 500 nm. 
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Figure 3.12 WT GFAP forms thicker filaments in the presence of 5 mM Ca2+ 
ions compared to desmin and vimentin that form 10 nm filaments.  
TEM pictures of A) and inset B) WT GFAP, C) and inset D) desmin and E) and inset 
F) vimentin were taken after Tris assembly with WT CRYAB in the presence of 5 
mM Ca2+ at 23-28 0C.  Human vimentin forms 10 nm filaments in these conditions in 
contrast to Xenopus vimentin, which forms much thicker and shorter filaments 
(Hofmann et al., 1991).  Desmin also forms usual 10 nm width filaments.  However, 
WT human GFAP forms filaments of varying widths along the lengths, mostly 
thicker than 10 nm.  The scale bar equals 500 nm. 
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Figure 3.13 Manganese ions promote increased filament-filament interactions 
for desmin and GFAP but not vimentin. 
Low speed sedimentation assays are shown from assembled filaments from three 
different divalent cation environments at 23-28 0C.  Desmin and GFAP are both 
affected by an increase in filament-filament interactions from manganese ions and 
vimentin the least.  G= GFAP, D= desmin and V= vimentin.  S= supernatant and P= 
pellet. 
 
 
Figure 3.14 CRYAB has no effect upon metal-induced filament-filament 
interactions. 
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CRYAB is not able to reduce the filament-filament interactions any further for all 
three IFs.  G= GFAP, D= desmin and V= vimentin.  S= supernatant and P= pellet. 
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Figure 3.15 Filaments assembled with manganese ions have greater binding to 
WT CRYAB compared to those assembled with magnesium ions.   
High speed sedimentation assays are shown.  CRYAB binds strongest to desmin 
filaments and this interaction is increased upon raising the temperature.  Note how 
when CRYAB is assembled alone C) most of the protein is present in the supernatant 
fraction.  G= GFAP, D= desmin and V= vimentin.  S= supernatant and P= pellet. 
 
 
Figure 3.16 Filaments assembled with manganese ions also have greater binding 
to WT CRYAB compared to those assembled with calcium ions.   
High speed sedimentations of assembled material from 1 mM Ca2+ ions are shown.  
CRYAB does not interact as much with the filaments as with manganese ions 
(Figure 3.15).  G= GFAP, D= desmin and V= vimentin.  S= supernatant and P= 
pellet. 
 
The dimer resulting from GFAP assembly in the presence of manganese ions, seen in 
Figure 3.8 from sedimentation assays, was probed using an anti-GFAP Ab and 
proven to be GFAP (Figure 3.17).  The nature of this band was investigated using 
reduction to see if oxidation was the cause and it was shown that manganese ions 
promote oligomers of GFAP due to oxidative cross-linking (Figure 3.18). 
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Figure 3.17 Manganese ions result in dimer formation of assembled GFAP. 
An immunoblot is shown against 2 µg of each protein.  The membrane was probed 
with the anti-human GFAP SMI-21 10 Ab with a 1:50 dilution.  A strong band 
corresponding to the monomer of GFAP can be seen and the absence of a signal for 
vimentin shows the specificity of the Ab for human GFAP.  G= GFAP and V= 
vimentin.  The arrow indicates the position of the GFAP dimer. 
 
 
Figure 3.18 Dimer of GFAP in presence of manganese ions is due to oxidation.  
WT GFAP after Tris assembly with 1 mM Mn2+ ions was either untreated and run 
from a low speed supernatant as 4 µg of protein (lane 1) or reduced with 50 mM 
DTT at 37 0C for 1 hr and loaded as 4 µg of protein (lane 2).  There is no dimer 
present after reduction with DTT under these conditions. 
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Figure 3.19 Manganese ions promote dimer formation of desmin and vimentin.  
As well as 1 mM Mn2+ ions resulting in WT GFAP dimers, there is also promotion of 
desmin and vimentin to form dimers shown from the high speed sedimentations and 
highlighted by the arrow.  D= desmin and V= vimentin.  S= supernatant and P= 
pellet. 
 
 
Gel quantifications were carried out from three independent repeats of co-assembled 
GFAP, desmin or vimentin with CRYAB to assess the proportion of CRYAB that 
binds.  It can be seen in Table 3.4 that CRYAB binds the most to desmin, at the 
increased temperatures of 39-44 0C; GFAP and vimentin appear to bind the least.  It 
is interesting to see that there is no difference in binding of CRYAB to desmin 
filaments in the presence of magnesium or manganese ions at 39-44 0C, however this 
is not the case at 23-28 0C.  Also binding between CRYAB and GFAP is increased at 
both temperatures when assembled with manganese ions compared to magnesium.  
However with vimentin the increase in interactions is seen only at 39-44 0C and not 
23-28 0C, comparing the two different divalent cations. 
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 % CRYAB 
pellet 
Mg2+ 23-28 0C 
% CRYAB 
pellet 
Mg2+ 39-44 0C 
% CRYAB 
pellet 
Mn2+ 23-28 0C 
% CRYAB 
pellet 
Mn2+ 39-44 0C 
Vimentin 12 +/- 3 19 +/- 2 15 +/- 12 31 +/- 13 
GFAP 8 +/- 4.5 17 +/- 5 28 +/- 2 29 +/- 2 
Desmin 13 +/- 4 53 +/- 7 25 +/- 5 64 +/- 10 
Table 3.4 Percentages of WT CRYAB binding to type III IFs. 
Mean values +/- one SD of percentages of CRYAB binding to filaments after Tris 
assemblies. 
 
An additional test of interactions of CRYAB at increased temperatures with the 
filaments was carried out in HEPES buffer as outlined in Figure 3.1.  In this instance 
a constant pH 6.9 was investigated at the three temperatures of 23, 39 and 44 0C.  
Similar to the changes in morphology of GFAP filaments after Tris assembly with 1 
mM Mn2+ ions, assembly in HEPES with 1 mM Mn2+ also results in altered filament 
architectures (Figure 3.20 D-F)).  However the filaments are longer after the HEPES 
assembly with 1 mM Mn2+ ions compared to Tris assembly, comparing Figure 3.5 A) 
with Figure 3.20 D). 
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Figure 3.20 Manganese ions alter assembly of GFAP filaments.  
TEM pictures are shown of WT GFAP (D-I) and vimentin (A-C) with WT CRYAB 
after assembly in HEPES buffer at pH 6.9 with 1 mM Mn2+ ions at 23 (A and D), 39 
(B and E) and 44 0C (C and F).  WT GFAP filaments vary approximately 10-30 nm 
in width along their lengths, whereas vimentin filaments remain at the usual 10 nm 
width.  The scale bar is equal to 500 nm. 
 
As seen with Tris assembly, CRYAB binds more to GFAP than vimentin filaments 
(Figure 3.21) in the presence of manganese ions and this increases with increasing 
temperature.  A difference is observed for vimentin and GFAP, comparing pH 6.8 
with magnesium ions to pH 6.9 with manganese ions at 39 and 44 0C for vimentin 
and 23 0C for GFAP, c.f. Table A.11 and A.14. 
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Figure 3.21 CRYAB binds to GFAP and vimentin filaments in a temperature-
dependent manner.  
High speed sedimentations were carried out on assembled A) WT GFAP with 
CRYAB, B) WT vimentin with WT CRYAB and C) WT CRYAB alone.  CRYAB 
binds much more to GFAP than vimentin.  S= supernatant and P= pellet. 
 
 
 % CRYAB 
pellet 
Mn2+ 23 0C 
% CRYAB 
pellet 
Mn2+ 39 0C 
% CRYAB 
pellet 
Mn2+ 44 0C 
Vimentin 9 +/- 3 13 +/- 3 18 +/- 2 
GFAP 10 +/- 3 13 +/- 3 30 +/- 10 
Table 3.5 % of CRYAB binding to filaments in HEPES buffer at pH 6.9. 
A statistically significant increase was observed for vimentin comparing binding 
with CRYAB in the presence of manganese to magnesium ions at 39 and 44 0C (p = 
0.05) and also GFAP at 23 0C (p<0.05). 
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3.1.3.3 Lower pH and increased temperatures promote increased binding of 
CRYAB to GFAP, desmin and vimentin filaments. 	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Figure 3.22 Charts of binding of WT CRYAB to type III IFs. 
CRYAB was present throughout assembly, carried out at three different pH and 
temperature values of A) 23, B) 39 and C) 44 0C.  This showed increased binding of 
CRYAB to the filaments at low pH values and increased temperatures and preference 
of binding to desmin in comparison to GFAP and vimentin.  Data are represented as 
the average values of three independent experiments with error bars showing +/- one 
SD.  Averaged raw data are shown in Table A.15-A.17.  G= GFAP, D= desmin and 
V= vimentin. 
 	  	  
The amount of CRYAB co-pelleting alongside the sedimentable filaments (Figure 
3.23) was quantified using ImageGauge (FujiFilm, Japan), from three independent 
experiments and the average values are represented as bar charts in Figure 3.22.  This 
highlights how CRYAB binds the most to desmin filaments at pH 6.3 and at 39 and 
44 0C. 	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Figure 3.23 Binding of CRYAB to IFs is increased upon a drop in pH and an 
increase in temperature.   
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High speed sedimentation assays were carried out on assembled A) WT desmin, B) 
GFAP and C) vimentin with WT CRYAB after assembly with HEPES buffers set to 
pH 6.3, 6.8 and 7.3 at 23, 39 and 44 0C with 1 mM Mg2+ ions.  These gels are an 
example of those used for the quantifications in Figure 3.22.  A temperature- and pH- 
dependent effect can be seen with CRYAB binding, to all of the filaments, with a 
preference for desmin filaments.  D) very little CRYAB pellets when assembled 
alone at all three temperatures.  Note how GFAP at 230C has more protein present in 
the supernatant compared to desmin and vimentin at pH 6.8 and 7.3, however at pH 
6.3 the CRYAB does not appear to have the same inhibitory effect on GFAP 
filament formation.  S= supernatant and P= pellet. 
 
 
To assess how pH and temperature influence the interactions of CRYAB with type 
III IFs, three pH and temperature values were assessed ranging from physiological 
pH 7.3 to ischemic pH 6.3, using pH 6.8 as the mid-point of this range at 23, 39 and 
44 0C.  Previous experiments in this laboratory have shown that increased 
temperature causes increased binding of WT CRYAB to desmin filaments, however 
this was not accounting for pH changes (Perng et al., 2004).  Therefore nine 
individual pH buffers were used to keep the pH constant at the three temperatures 
studied.  The filaments in the experiments from this section were assembled 
according to 3.1.2.1.4. 
High speed sedimentation assays were used to assess the binding of CRYAB to the 
filaments.  In Figure 3.22 the increased co-pelleting of CRYAB can be seen 
alongside the filaments at the lower pHs and increased temperatures.  The 
temperature dependency is more obvious at the lower pH values; at pH 7.3 only by 
comparing the sedimentation of CRYAB with WT GFAP can it be seen that there is 
an increase in binding from 23 to 44 0C.  There does not appear to be an increase in 
binding for vimentin and desmin at pH 7.3 upon increasing the temperature, however 
at pH 6.3 and 6.8 this is not the case. 
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Figure 3.24 A general trend of increased filament interactions occurs upon a 
drop in pH and an increase in temperature with the exception of desmin.   
Low speed sedimentations on assembled A) WT desmin, B) GFAP and C) vimentin 
with WT CRYAB are shown.  A temperature- and pH- dependent effect can be seen 
with filament interactions.  For all three types of filaments, most of the filaments are 
pelleted at pH 6.3 at 39 and 44 0C.  This is in contrast to pH 6.8 and 7.3 where most 
of the protein is present in the supernatant portions, with the exception of desmin, 
which is pelleted under all pH values and temperatures.  S= supernatant and P= 
pellet. 
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To assess filament-filament interactions within the co-assemblies, low speed 
sedimentation assays were carried out.  With the exception of desmin, increased 
filament-filament interactions as observed by an increase in the pelletable filaments 
was seen at the lower pH values and increased temperatures (Figure 3.24).  For 
GFAP the increased interactions were seen at 39 and 44 0C for pH 6.3 and 6.8.  For 
vimentin these were seen only at 44 0C in pH 6.3.  Desmin filaments had increased 
filament-filament interactions at all pH values assessed, even when CRYAB binding 
was relatively low at pH 7.3. 
The morphology of the assembled filaments with WT CRYAB was assessed using 
the TEM.  All filaments were morphologically similar at all three pH and 
temperature values, apart from WT GFAP that had variable widths at pH 6.3 at 23 0C 
(Figure 3.28 A)) and vimentin in pH 7.3 buffer at 23 0C that was also wider.  
Increasing the temperature restored the vimentin filaments to usual 10 nm widths.  
Three measurements of filament widths were taken for the three different pH values 
at 23 0C (Table 3.6).  To further support the sedimentation assay data showing the 
increased binding of CRYAB at pH 6.3, the TEM images also show an increase in 
the density of CRYAB oligomers coating the filaments and the arrows in Figure 3.28 
point to CRYAB oligomers bound to the surface of the filaments.   
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Figure 3.25 Desmin forms usual 10 nm filaments at all three temperatures and 
pH values. 
TEM images of desmin filaments assembled at three temperatures and pH values 
with WT CRYAB show normal 10 nm IFs at all nine conditions.  The scale bar is 
equal to 500 nm. 
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Figure 3.26 GFAP forms 10 nm filaments under all conditions apart from pH 
6.3. 
TEM images of GFAP filaments assembled at three temperatures and pH values with 
WT CRYAB show normal 10 nm IFs at all nine conditions apart from thicker widths 
and shorter lengths at pH 6.3 at 23 0C.  The scale bar is equal to 500 nm. 
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Figure 3.27 Vimentin forms usual 10 nm filaments with most temperature and 
pH values. 
TEM images of vimentin filaments assembled at three temperatures and pH values 
with WT CRYAB show normal 10 nm IFs with most conditions (Table 3.6 
highlights wider filaments at pH 7.3).  The scale bar is equal to 500 nm. 
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Figure 3.28 CRYAB increases binding to desmin, vimentin and GFAP at pH 6.3. 
TEM images were taken of A) GFAP at 23 0C, B) vimentin at 39 0C and C) desmin 
at 23 0C, all at pH 6.3 with CRYAB.  Note the coating of the filaments with CRYAB 
particles and especially the regular spacing of the sHSP sandwiched between two 
vimentin filaments (oligomers are adjacent to each other with a repeat distance of 
approximately 20 nm (width of individual CRYAB particles) when situated between 
two filaments whereas with individual filaments the repeat distance of CRYAB is 
irregular).  The repeat distance of CRYAB coating individual desmin filaments is 
also approximately 20 nm.  Also note how the GFAP filaments have uneven widths, 
which tend to be thicker than the usual 10 nm.  The arrows denote where CRYAB 
oligomers appear bound to the surfaces of the filaments.  The scale bar is equal to 
500 nm. 
 
 
 
 
 
 
  
 
151 
Protein  Protein widths (nm) 
 pH 6.3 6.8 7.3 
GFAP  24 +/- 5 12 +/- 1 13 +/- 2 
Desmin  12 +/- 1 12 +/- 3 10 +/- 1 
Vimentin  11 +/- 2  10 +/- 1 15 +/- 2 
CRYAB  15 +/- 5 10 +/- 1 10 +/- 1 
Table 3.6 Widths of IFs and CRYAB 
Three filament and CRYAB oligomer widths were measured and averaged from 23 
0C.  For the filaments, this was done on either three separate filaments or on the same 
filament from the TEM images in Figure 3.25-3.27 and CRYAB oligomers were 
measured in one image, on three separate oligomers, per pH (widths were similar in 
the presence of any of the IFs). 
 
Filament width measurements were also taken at the higher temperatures and wider 
filaments were also observed for GFAP at pH 6.3 at the higher temperatures but not 
at pH 6.8 or 7.3.  Since the above data show a trend of increased binding under 
certain pH and temperature conditions when CRYAB has been present for the whole 
of the filament assemblies, another experiment was carried out investigating whether 
a similar trend would be observed with the addition of CRYAB oligomers to 
assembled GFAP filaments.  This did show a similar trend demonstrating that 
increased interactions can be seen when CRYAB is presented to filaments at 
different stages of formation (Figure 3.29).  However it was shown that binding was 
less at 39 0C when CRYAB was added after the filaments had been formed at pH 6.3 
and 7.3 (c.f. Table A.20 and A.22). 
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Figure 3.29 Binding of CRYAB to assembled GFAP IFs is increased upon a 
drop in pH and an increase in temperature.   
High speed sedimentations were carried out on assembled WT GFAP with WT 
CRYAB added after filaments were formed.  Similar increased binding of CRYAB 
can be seen at the lower pH and higher temperatures as shown in Figure 3.23 when 
CRYAB was added before the filaments had formed, however there is a significant 
decrease in binding of CRYAB at 39 0C at pH 6.3 (p<0.05) and 7.3 (p= 0.051) when 
CRYAB is added after filament assembly compared to its addition before filament 
assembly.  S= supernatant and P= pellet. 
 
The above sedimentation binding data were averaged and are shown in Figure 3.30.  
It can be seen that at pH 6.3 there is much more binding to WT GFAP compared to 
pH 7.3 and this is temperature dependent. 
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Figure 3.30 Chart of binding of WT CRYAB to assembled WT GFAP IFs.   
CRYAB was added to assembled WT GFAP filaments, at pH 6.3 or 7.3 at three 
different temperatures.  This showed increased binding at low pH and increased 
temperatures similar to when CRYAB is added before filaments have formed.  At pH 
6.3 and 7.3 at 39 0C there is a statistically significant smaller quantity of CRYAB co-
pelleted with WT GFAP when CRYAB has been added to assembled filaments 
compared with CRYAB addition before filaments have formed (c.f. Table A.20 and 
A.22).  Data are represented as the average values of three independent experiments 
with error bars showing +/- one SD.  There is no significant difference observed at 
23 or 44 0C. 
 
 
Another experiment involved assembling WT GFAP filaments at pH 6.3 where most 
binding is observed and then dialysing back into pH 7.3 for 1.5 hr.  The purpose was 
to see if the filaments retain any memory of their previous state or if the time of 
dialysis is sufficient to revert back to a state where lower binding is observed.  From 
Figure 3.31 it can be seen that the binding is not as much at 23 and 39 0C 
(approximately 10% CRYAB is in the pellet fraction at both temperatures) compared 
to when GFAP has been formed at pH 6.3 and CRYAB from pH 6.3 is added in 
Figure 3.30 (17 and 29% of the total CRYAB is present in the pellet at 23 and 39 0C, 
respectively).   
 
  
 
154 
 
Figure 3.31 Plasticity of GFAP filaments in response to pH influences CRYAB 
interactions.   
The filaments were formed at pH 6.3 at 23 0C, dialysed into pH 7.3 buffer for 1.5 hr 
and WT CRYAB formed at pH 7.3 was added and incubated at 23 (lanes 1-2) and 39 
0C (lanes 3-4).  It appears that the time for exchange of the pH 6.3 for the higher pH 
7.3, for the assembled filaments, was sufficient to revert the higher binding, seen in 
Figure 3.29, to a lower binding (c.f. Figure 3.29 lanes 1-4 for pH 6.3 and 7-10 for pH 
7.3).  S= supernatant and P= pellet. 
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3.1.4 Discussion. 
GFAP assembly is susceptible to its divalent cation environment. 
Divalent cations are highly important for GFAP assembly and when they are 
removed this significantly affects the final compaction stage.  EDTA does not 
chelate the sodium ions present and so this remains free to influence the assembly of 
the filaments, which highlights the specificity of magnesium ions for promoting 
normal assembly of GFAP. 
When CRYAB is added to these filaments it can be seen that it has an effect to 
reduce the filament interactions and in fact it can be seen more clearly that these 
altered filaments are made up of shortened filaments that have not elongated fully, 
although they are longer than ULFs.  These filaments also appear longer than those 
obtained with bovine GFAP in the absence of divalent cations (Tanaka et al., 1989).  
The lengths vary but some of the shorter filaments are approximately 300 nm.  The 
filaments are also thicker than normal and often reach over 20 nm.  There is a slight 
ability to reduce filament-filament interactions, visible after a low speed 
sedimentation assay has been carried out (Figure 3.2).  However the chaperone-like 
activity of CRYAB is not great enough to overcome the full extent of the increased 
interactions of the GFAP filaments since there is still a much higher proportion of 
pelleted material compared to filaments assembled in the presence of magnesium 
ions (Figure 3.2 and 2.18) showing that either the chaperone-like activity of CRYAB 
has been exhausted at these concentrations and/or CRYAB would require an ATP-
dependent chaperone to then re-fold the filaments to a more assembly-competent 
state, likely in the presence of magnesium.  For future work it would be interesting to 
dialyse these filaments into a buffer with magnesium ions to see if the process is 
reversible.  In addition, in comparison to normal WT GFAP filaments, which have 
minimal binding to CRYAB at 23 0C in Tris assembly, it appears that when the 
filaments have no magnesium ions CRYAB binds much more to these structures.  
Filament architecture is disrupted upon an increase in temperature through Tris 
assembly where CRYAB also binds much more, which may be due to a change in 
pH as well as temperature.  The GFAP protein has an essential divalent cation 
binding site in the 2B rod domain (determined from flow dialysis experiments with a 
radioisotope of calcium), which is 70% identical with the similar region in desmin 
and 60% identical with the similar region in vimentin, as assessed using ClustalW2 
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(EMBL-EBI, UK) and BLAST (National Library of Medicine, US) (Yang Z W., 
1988) and this region is shown in Figure 3.32.  Since the GFAP filaments have been 
compromised in assembly formation when divalent cations are absent, it is likely that 
the mutations within the critical site of amino acid residues 320-349, for divalent 
metal ion binding, found associated with AxD would result in similar properties of 
altered filaments, although this is not the only region in GFAP that has been 
correlated with binding divalent cations (Yang Z W., 1988).  The mutations found in 
this region include L331P that has a mild phenotype (Shiihara et al., 2004), E332del 
that is also mild (Jefferson et al., 2010) and the R330G and E332K mutations on the 
same allele which have a mild phenotype and lead to less aggregation compared to 
other cases (Bachetti et al., 2008).  The in vitro properties of these assembled mutant 
filaments have not been assessed up to now but it could be the case that the 
mutations do not affect the metal binding and this is why the phenotypes are not as 
severe as would be expected if filaments were formed similar to Figure 3.4 A). 
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Figure 3.32 Sequence alignment of GFAP divalent cation binding site against 
desmin and vimentin.   
The ClustalW2 alignment of WT human GFAP (GenBank: J04569.1), desmin 
(GenBank: NM_001927.3) and vimentin (GenBank: NM_003380.3) has been carried 
out and the boxed area represents the important Mg2+-Ca2+ binding site in GFAP 
(Yang Z W., 1988, Larkin MA, 2007).  Most variability between the three sequences 
occurs in the N-terminal head domain.  Symbols: * indicates a single, fully 
conserved residue, : indicates conservation between groups with strongly similar 
properties, . indicates conservation between groups with weakly similar properties. 
 
The region of residues 320-349 constitutes 24% of rod 2B and alteration of this 
domain in GFAP with mutation of the KLLEGEE sequence at the C-terminal end of 
rod 2B along with removal of the tail domain causes more perturbed assembly than 
when just the tail domain is removed, seen from transfection studies with a higher 
incidence of aggregate formation as the result of alteration to the conserved 
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TYRKLLEGEE sequence (Chen and Liem, 1994).  However the tail region seems 
less important as long as the RDGE motif is maintained that is situated at amino acid 
position 416-419, since complete removal of the tail results in some aggregate 
formation after transfection into vimentin positive cells.  This shows the importance 
of the 2B domain, which may be not only a reflection on the available amino acid 
residues for ionic interactions with other dimers but also the potential to bind 
divalent cations.  This is in contrast to the head domain, which results in altered 
assembly when parts are removed (Chen and Liem, 1994).  The head domain has 
been shown to be important for alignment and lateral interactions of IFs during 
assembly (Yang and Babitch, 1988).  The magnesium-calcium binding site in the C-
terminal tail mediates cross-linking from the divalent cations, which is in the last 11 
amino acids of the tail region in vimentin in addition to the site in the rod 2B region 
shown in Figure 3.32 (Lin et al., 2010a).  Therefore even if filaments have formed 
after truncation of the end of the tail region it is likely that filament properties will 
have been altered leading to weaker networks and lowered resistance to mechanical 
stress since it was shown that vimentin with the last 11 amino acids removed from 
the C-terminus was not effectively cross-linked by magnesium despite the presence 
of the 2B rod domain binding site (Lin et al., 2010a).  The C-terminal tail is crucial 
for determining the diameters of IFs and therefore alterations in their interactions 
from different divalent cations likely influence this, as shown by thicker filaments 
for GFAP (Herrmann et al., 1996). 
Unlike with Tris and magnesium ion assembly, where CRYAB can inhibit filament 
assembly at 23 0C, when no divalent cations are present this is not the case as seen in 
Figure 3.3.  Perhaps in the diseased state there is a reduction in available divalent 
cations to bind to GFAP and this adds to the problem of aggregate formation. 
From low speed sedimentation assays the filaments assembled in Tris assembly with 
1mM Ca2+ give similar sedimentation values to those assembled in magnesium ions 
and they also are morphologically similar (Figure 3.6 and 3.7).  With 5mM Ca2+, 
GFAP filaments appeared to have a range of widths, which were thicker than 10 nm 
seen with 1 mM Ca2+ ions, like Xenopus vimentin (Figure 3.12).  With the 
manganese ions, the filaments appear to associate together more as seen by a greater 
increase in proportion of protein in the pellet fraction in low speed sedimentation 
assays and this increased association is also seen from the TEM images where sheet-
like structures are formed (Figure 3.5 and 3.7).  This is also further supported by the 
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appearance of a higher molecular weight band positioned above the 130 kDa marker 
band corresponding to a potential dimer of GFAP, showing higher oligomeric GFAP 
structures are being formed (Figure 3.7).  This higher molecular weight band is 
investigated further in the next section.  An approximation of the molecular weight 
was derived from a natural log-log plot of arbitrary distance travelled against 
molecular weights of standards, utilising the arbitrary distance travelled of the higher 
molecular weight species and this derived a value of approximately 220 kDa (Figure 
A.3 in the appendix).  In fact from the TEM pictures the filaments appear to align 
alongside each other apparently forming sheet-like structures.  With manganese 
associated ALS, there is an upregulation in GFAP expression as this has been seen in 
mouse models of ALS mice due to the stress response in Schwann cells and therefore 
the manganese ions in vivo will perhaps be influencing altered GFAP filament 
formation which may add to the pathogenesis of the disease (Keller et al., 2009). 
The diameters of filaments assembled in 1 mM Ca2+ ions are a similar width to the 
usual 10 nm for all three filaments.  However the filament widths of the GFAP 
manganese-induced filaments can reach up to 30 nm, thus highlighting potential 
problems with filament compaction.  This is likely to add to the paradigm of filament 
assembly, specifically with ULFs and support for their formation which then under 
go compaction after annealing (Georgakopoulou et al., 2009).  
CRYAB has been shown to reduce filament-filament interactions of GFAP solutions 
assembled in the absence of magnesium and calcium ions and thus this heat shock 
protein was co-assembled with GFAP formed in the presence of manganese ions to 
see if it could also reduce the increased filament interactions here.  CRYAB was 
unable to prevent the formation of the dimer and could not reduce filament-filament 
interactions of GFAP filaments formed with 1 mM Mn2+ ions at 23 0C (51 +/- 17% 
GFAP in the supernatant alone compared to 49 +/- 25% GFAP in the supernatant 
with CRYAB) as averaged from three independent repeats however effects were 
seen at 39 0C (from 4 +/- 1.5 % GFAP in the supernatant alone compared to 28 +/- 
10 % GFAP in the supernatant with CRYAB) resulting in more protein in the 
supernatant fraction after low speed centrifugation (Figure 3.8).  It has been found 
previously that CRYAB has reduced chaperone abilities when assembled with 1 mM 
Ca2+ ions, however from low speed in this instance with 1 mM Ca2+ assembled at 23 
0C (83 +/- 7% GFAP in the supernatant alone changing to 89.0 +/- 1.3% GFAP in the 
supernatant with CRYAB) and 39 0C (2.3 +/- 1.4% GFAP in the supernatant alone 
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changing to 20.8 +/- 7.9% GFAP in the supernatant with CRYAB), the CRYAB 
seems to be able to reduce the filament-filament interactions shown in Figure 3.8 B), 
therefore showing that there is some difference between chaperone ability to reduce 
aggregation in a heat shock assay and to reduce interactions between non-
aggregating filaments (Ganadu et al., 2004).  Also the buffer conditions are different 
in this assay compared to the heat shock assay that will play a major part in the 
activity of the protein.  In all three divalent cation environments looked at, CRYAB 
is able to reduce filament interactions at 39 0C, although the heat shock protein does 
not alter the apparent morphology of filaments which have not assembled properly 
such as with the manganese ions, likely due to higher temperatures increasing 
available hydrophobic binding regions.  For both manganese and calcium assemblies, 
after high-speed sedimentation the WT GFAP was mostly pelleted showing effective 
filament formation albeit altered interactions detected from the low speed assays 
(Figure 3.15 and 3.16).  Regarding binding with WT GFAP at 23 0C, WT CRYAB is 
28 +/- 1.98% in the pellet with manganese ions compared to 8.07 +/- 4.6% with 
magnesium ions and at 39 0C WT CRYAB is 29 +/- 2% in the pellet with manganese 
ions compared to 17 +/- 5% that co-sediments with WT GFAP formed with 
magnesium ions, showing that manganese ions promote increased filament-CRYAB 
interactions. 
 
Manganese ions promote increased binding of CRYAB to GFAP, desmin and 
vimentin filaments.  
The divalent cations appear to influence the binding of CRYAB to the filaments 
studied here, as it was found from Tris assembly that CRYAB binds much more to 
vimentin, desmin and GFAP filaments in the presence of manganese ions as opposed 
to magnesium ions when pH is not controlled for, which was discussed in the 
previous section.   
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 % CRYAB 
pellet 
Mg2+ 23-28 0C 
% CRYAB 
pellet 
Mg2+ 39-44 0C 
% CRYAB 
pellet 
Mn2+ 23-28 0C 
% CRYAB 
pellet 
Mn2+ 39-44 0C 
Vimentin 12 +/- 3 19 +/- 2 15 +/- 12 31 +/- 13 
GFAP 8 +/- 4.5 17 +/- 5 28 +/- 2 29 +/- 2 
Desmin 13 +/- 4 53 +/- 7 25 +/- 5 64 +/- 10 
Table 3.6 Percentage of WT CRYAB binding to filaments. 
Mean values +/- one SD of percentages of WT CRYAB binding to filaments. 
 
Manganese ions only appear to result in increased filament interactions with GFAP 
and desmin (Figure 3.13).  This will be expected since desmin has more pronounced 
filament bundling than vimentin and thus has greater interactions between the 
filaments (Schopferer et al., 2009).  The desmin filaments assembled with 
manganese ions can be seen coated with WT CRYAB oligomers after assembly at 
39-44 0C, more so than after being assembled with calcium ions and this highlights 
that although the filaments look similar when assembled with both ions, there are 
subtle changes that reflect greater binding with manganese ions to CRYAB (Figure 
3.11).  Also this greater binding appearing on TEM images is reflected in the 
sedimentation quantification results (Figure 3.15 and 3.16).  Interestingly, CRYAB 
appears to bind much more to desmin filaments under these conditions compared to 
the other two filaments and this will be discussed in more detail in the next section. 
There is a high quantity of mitochondria in skeletal and cardiac muscle and 
mitochondrial dysregulation has been shown in desmin-related cardiomyopathy such 
as a lack of organisation important for providing ATP and a reduction in maximal 
respiration rate (Schroder et al., 2003, Vendelin et al., 2005).  Mitochondria contain 
manganese in a complex with superoxide dismutase, which protects against oxidative 
damage and therefore superoxide dismutase binds to manganese in the sarcoplasm 
before being transported to the mitochondrial matrix.  Muscle contains a relatively 
low quantity of manganese ions with a higher amount found within cardiac than 
skeletal muscle tissue and also red muscle as opposed to white muscle.  Additionally 
the interfibrillar population of mitochondria, which have greater oxygen 
consumption, also have higher levels of manganese than the subsarcolemmal 
population of mitochondria (Sanchez-Morito et al., 1999, Kondo et al., 1991).  
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Desmin interacts with mitochondria since desmin K/O mice have displaced 
mitochondria although interactions with manganese ions have not been studied 
(Milner et al., 2000).  Perhaps desmin is sensitive to manganese ions because of its 
presence in muscle.  The induction of dimers of the three IFs studied here from the 
divalent manganese cation-catalysed disulfide bond formations, but not from 
magnesium ions, will be partly due to the greater ionic radius of the ion increasing 
interactions between IFs (Lin et al., 2010b).  Copper is noted for being able to 
oxidise cysteinyl residues, although the mechanism is not fully known and in this 
case manganese also appears to have the same property (Niazi, 2007).  Protein 
dimers are associated with AD and increased levels of Aβ dimers that are induced 
from copper ions (Shankar et al., 2008, Barnham et al., 2004, Proctor et al., 2012).  
Perhaps in AxD there is an increase in GFAP dimer formation although mutations 
have been correlated with a decrease in dimerisation with homodimers of the 
mutants, however heterodimers with GFAPα resulted in a similar capacity for 
dimerisation as GFAPα alone and will be the situation in the disease state due to 
populations of both WT and mutant GFAP because of the heterozygosity of the 
disease (Nielsen et al., 2002) 
The higher molecular weight band from the manganese assembled GFAP samples 
corresponds to an oligomer as proved from the immunoblot using the assembled WT 
GFAP and the Ab specific for human GFAP of SMI-21 (Figure 3.17).  Sending a 
sample for mass spectrometric analysis further proved this.  Therefore one 
hypothesis was that as the manganese ions induce the formation of these oligomers, 
these might act to inhibit the normal compaction step in IF assembly and this 
oligomer may explain the increased widths of the GFAP filaments.  It has been 
proposed previously however that filament oligomer bundles likely play a role in 
stabilisation of glia and neurons with strong filament-filament interactions (Shaw and 
Hou, 1990).  The cysteine residue in vimentin is also highly important and has been 
proposed to be involved in binding to other proteins during oxidative stress through 
disulfide bonds (Rogers et al., 1991). 
The next question that was answered was whether or not this species was formed 
from oxidative cross-linking of the GFAP filaments or whether it could be from 
covalent coupling.  Manganese ions usually protect cells from oxidative damage 
however it is possible that the ions increase the associations between the filaments 
resulting in oxidative cross-links.  GFAP has one cysteine residue in the 2B rod 
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domain and the oligomer is thus likely due to the formation of disulfide bonds 
between these groups.  After treatment with 50 mM DTT for 1 hr at 37 0C it was 
found that the higher molecular weight oligomer was removed (Figure 3.18).  This is 
unlike higher molecular weight oligomers of GFAP which have been discovered 
previously that were created from glutamine-lysine cross-links mediated in vivo from 
tissue transglutaminases and thus more stable (Shaw and Hawkins, 1992).  The 
oligomer will most likely be a dimer as GFAP dimers were reported previously to 
run at an unexpected mobility of approximately 170 kDa and in this case it was 
approximately 220 kDa (Quinlan and Franke, 1982, Quinlan and Franke, 1983).  In 
mice over-expressing GFAP, genes encoding for iron homeostasis and 
metallothioneins 1, 2 and 3 that bind toxic metals are elevated (Hagemann et al., 
2005).  Astrocytes are also the main manganese store in the CNS and perhaps GFAP 
is more responsive to altered levels in manganese ions because of this (Agustina 
Alaimo, 2011). 
Assembly of GFAP, desmin and vimentin was carried out in the presence of 5 mM 
Ca2+, showing increased filament widths for GFAP.  Previous studies looking at 
assembly of bovine GFAP in 5 mM Ca2+ also showed increased filament widths at 
this concentration, but also filament bundling which is not seen in this instance 
(Tanaka et al., 1989, Yang and Babitch, 1988).  Vimentin and desmin appear 
unaffected however and form usual 10 nm filaments (Figure 3.12). 
CRYAB binding is dependent upon pH, time for pH change, temperature, structure 
of filament surface (altered either from a mutation, pH or temperature) and also the 
structure of the CRYAB surface (altered either from a mutation, pH or temperature).  
The hypothesis is that under normal filament assembly conditions the CRYAB does 
not bind very much to the filament surfaces but binds very transiently and this allows 
the protein to reduce filament-filament interactions but when this is altered to non-
ideal filament structures (aggregates, disassembly of coils) such as with a rise in 
temperature, drop in pH or a mutation, the CRYAB binds much more but no longer 
can a reduction in filament interactions be seen in some cases because the 
aggregation has exhausted the ability of CRYAB to reduce the aggregation.   
WT GFAP assembled in HEPES at pH 6.9 with manganese ions forms the usual 
dimer seen from Tris assembly and the same is seen for vimentin (Figure 3.21).  
HEPES buffer can however form free radicals (responsible for cross-linking protein) 
and since the oligomer is due to a redox reaction this buffer will give an incorrect 
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representation on the influences of the metal ions alone.  However the morphology of 
the filaments look similar to those from Tris assembly with magnesium ions, except 
for GFAP where an uneven width distribution can be seen, similar to that seen in Tris 
buffer with manganese ions where widths of up to approximately 30 nm are seen 
(Figure 3.20).  The amount of co-pelleting of CRYAB is statistically greater at pH 
6.9 with the manganese ions than 6.8 with magnesium ions for vimentin at 39 and 44 
0C and GFAP at 23 0C thus highlighting that the manganese ions promote increased 
associations of CRYAB to the filaments in these conditions (Figure 3.21).  Divalent 
cations are known to affect the chaperone activity of CRYAB with copper reported 
to increase it and it was shown that copper has a binding site on the protein and 
interactions with three histidines via coordination sites on the imidazole rings 
(Ganadu et al., 2004).  Calcium ions however have been shown to inhibit the 
chaperone-like reduction in aggregation of the insulin B-chain upon reduction, 
however CRYAB seems to be able to still reduce filament-filament interactions 
assessed from low speed sedimentation assays in Figure 3.8 B).  The copper binding 
of CRYAB is implicated in cytoprotection by sequestering copper ions and thus 
preventing the oxidation of other proteins and when copper is applied to lens 
epithelial cells there is an up-regulation in CRYAB and αA-crystallin (Ahmad et al., 
2008).  Therefore, similar with copper ions it may be the case that CRYAB 
chaperone activity is increased since there’s an increase in interactions observed 
from high speed sedimentation assays with manganese ions, although investigations 
without filaments would need to be carried out to assess this.  
GFAP filament assembly appears to be the most sensitive to different divalent 
cations, compared to desmin and vimentin.  This has been shown by the formation of 
different filament structures after assembly in the absence of magnesium ions, in the 
presence of 5 mM Ca2+ ions in Tris buffer and in the presence of 1 mM Mn2+ ions in 
Tris and HEPES buffers.  Increased GFAP filament widths are also noted in the next 
section at pH 6.3.   
 
Lower pH and increased temperature values promote increased binding of 
CRYAB to GFAP, desmin and vimentin filaments.  
HEPES buffers were used for these experiments in preference to phosphate buffers, 
which do not change pH with temperature fluctuations, as they have limited divalent 
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metal chelation unlike phosphate buffers where nearly all divalent metals will 
precipitate out of solution (Zeyer et al., 1986).  Additionally, an overnight assembly 
procedure was used as opposed to a final assembly step for 1 hr in a water bath, 
which has been carried out previously in the laboratory (Perng et al., 1999a).  The 
reason for not using the shortened method in this case was to allow the filament 
structures to resemble those in vivo as close as possible since the shortened assembly 
always leads to filaments that have not compacted as well which would likely 
influence the interactions with CRYAB; compare Figure 3.9 and 3.25. 
At pH 7.3 even upon raising the temperature to 44 0C, the binding does not increase 
significantly of WT CRYAB to all of the filaments looked at, however upon 
lowering the pH to 6.8 and 6.3 there is an increase in binding at 23 0C, which can be 
increased further upon raising the temperature (Figure 3.22).  Therefore pH is the 
crucial determining factor to result in increased binding of the small heat shock 
protein and temperature increases are also dependent upon this variable.  A 0.2 
mg/mL concentration of IFs was used for the sedimentation assays to help reduce the 
propensity for the filaments to stick to the pipette tips and the samples were vortexed 
after assembly.  WT GFAP filament assembly inhibition from WT CRYAB occurs at 
pH 6.8 and 7.3, but not at pH 6.3 and is not the case for desmin and vimentin (Figure 
3.23).  A similar trend of inhibition from native bovine phosphorylated CRYAB on 
native in vitro assembled bovine GFAP filaments at higher pH values has been seen 
before however the extent of inhibition is not as great in this chapter (Nicholl and 
Quinlan, 1994).  All three filaments formed usual 10 nm wide filaments under all 
nine conditions apart from GFAP at pH 6.3 and vimentin at pH 7.3 at 23 0C which 
both had more variable and wider widths (Figure 3.28 A) and 3.27).  This 
demonstrates how GFAP assembly appears more sensitive than desmin and vimentin 
assembly.  Desmin also seemed to have more variable widths at the lower pH values.  
The data also show how increased temperature not only increase filament 
entanglement but also the efficiency of compaction and their surface structure since 
at 39 and 44 0C GFAP filaments at pH 6.3 are still wider than 10 nm but not as wide 
as at 23 0C (Figure 3.26).  The increase in binding to the filaments at the lower pHs is 
likely due to changes in the charge of histidine residues in CRYAB, which are 
sensitive to pH changes near the physiological range, to a more positive charge.  It is 
the only amino acid that is electrically neutral around pH 7.3 and there are many of 
these residues situated in the dimer interface of CRYAB (Clark et al., 2011).  
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Therefore any charge changes in this region will affect the ability of the oligomers to 
form dimers and potentially result in a preference for monomer formation.  Table 3.6 
demonstrates that the CRYAB oligomer widths are wider and more variable at the 
lower pH value of 6.3 thus showing that the pH is affecting oligomer size of the 
sHSP as well as the assembly equilibrium of filaments.  The repeat distance of 
CRYAB binding to vimentin at pH 6.3, between two filaments, is equivalent to the 
width of a CRYAB oligomer (20 nm) and therefore difficult to assess what part of 
the filament structure they are binding to.  Studies have been carried out to assess 
what sequence in CRYAB binds to the filaments but not what filament sequence 
interacts with CRYAB (Ghosh et al., 2007).  Further studies would need to be carried 
out to assess what sequence/s CRYAB is interacting with, such as protein pin arrays.  
There are limitations of using negative staining for quantifying filament and CRYAB 
widths, which include low resolution and artifacts (uneven stain).  Positive staining 
can also occur where the uranyl acetate complexes with the filaments and therefore 
will likely alter the chemistry and thus values of widths.  Cryogenic electron 
microscopy would be a better method to use since the true shape of the proteins can 
be viewed (they don’t get flattened against a carbon film as the sample is kept 
hydrated and frozen) and can aid in deriving the secondary and tertiary structures.  
This would be especially useful for CRYAB to assess how its secondary and 
quaternary structures are altered where an increase in oligomer width is observed at 
the lower pH.    
CRYAB can reduce filament interactions more readily at increased pH values 
(Figure 3.24).  The exception here appears to be desmin, which has high filament-
filament interactions at all pH values; this is unusual as generally there is a 
correlation between lowered binding with CRYAB and lowered filament-filament 
interactions, demonstrated with vimentin and GFAP filaments (Figure 3.23 and 
3.24).  Increased temperatures however result in an increase in filament-filament 
interactions.  Increased temperature increases the binding of CRYAB to the filaments 
(Figure 3.23 and 3.29), acting as an activator for CRYAB.  Subunits exchange 
constantly in the sHSP and temperature increases will increase the on- and off- rates 
of subunit exchange, reported previously, thus triggering increased activity of 
CRYAB (Liu et al., 2006). 
When CRYAB reduces filament interactions, its association (binding) to filaments is 
increased and vice versa regarding GFAP and vimentin filaments.  In one study at 
  
 
167 
acidic pH it was shown that stable oligomers of CRYAB, with a reduction in 
dissociation, are preferred alongside a drop in chaperone activity demonstrated from 
SPR experiments, which is in contrast to higher pH values with smaller oligomers 
and increased chaperone activity.  Increased temperatures were also associated with 
increased chaperone activity (Liu et al., 2006).  Other studies suggest that lower pH 
increases the chaperone activity of the sHSP and it is likely that the drop in pH results 
in a preference for monomers.  From the data in this chapter it can be hypothesised 
that both scenarios are likely whereby at acidic pH there will potentially be an initial 
increase in active monomer states, which have been observed previously from NMR 
studies, which then bind to filaments and then formation of stable oligomers which 
will lead larger complexes alongside a drop in chaperone activity (Liu et al., 2006, 
Jehle et al., 2009).  At this moment in time it is not known how CRYAB dissociates 
and associates and what the functional unit is which interacts with IFs.  CRYAB 
monomers have been shown to bind to microtubules and act to inhibit their assembly 
at high molar ratios and it is the monomers, which bind and the larger oligomers, 
which associate with unassembled tubulin, therefore this also supports the idea that 
when binding is promoted of CRYAB to filaments there would be a preference for 
CRYAB monomers (Houck and Clark, 2010).  At physiological pH the autoinhibitory 
IXI motif (amino acids 159-161) in the C-terminal tail of CRYAB binds within the 
β4-β8 groove and competes with hydrophobic substrate proteins for interaction 
whereas at acidic pH 6.5 the IXI motif is released from this binding site thus 
increasing the available substrate binding regions (Jehle et al., 2010).  At increased 
temperatures the ability of CRYAB to bind to substrates is increased due likely to a 
preference for monomer formation and an increase in chaperone-like activity 
(Spinozzi et al., 2006).  It is also likely that at low pH and higher temperatures the 
extent of aggregation of the filaments is too great for the CRYAB to overcome and 
thus there is no longer a reduction in filament-filament interactions but instead 
increased binding, seen for GFAP and vimentin (Figure 3.24).  This is the opposite 
scenario that is seen with tail truncated Q151X mutated CRYAB where an increase in 
binding is observed with a reduction in filament interactions; the increased binding 
may be due to the fact that the autoinhibitory motif in the C-terminal tail, as 
mentioned earlier, is no longer able to mask the β4-β8 groove for binding in addition 
to a change in tertiary structure (Hayes et al., 2008). 
From these experiments, which kept constant pH and temperature values and also 
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from those in the previous section assessing binding in the presence of different 
divalent cations, which did not control for pH, it can be seen that CRYAB binds the 
most to desmin IFs.  The reason for this will lie with the desmin amino acid sequence, 
which likely contains many more hydrophobic binding sites for CRYAB compared to 
the other two IFs.  This was observed from a sequence analysis of the grand average 
of hydropathy (GRAVY) for the three IFs and desmin has the highest hydrophobic 
profile (-0.723) compared to GFAP (-0.773) and vimentin (-0.823) (Stothard, 2000).  
Also the fact that mutations in CRYAB have only so far been discovered associated 
with desminopathies and not gliopathies highlights how the interactions between 
CRYAB and desmin are perhaps stronger.  However the preference for desmin will 
likely not only lie with desmin’s amino acid sequence since it has been shown that 
CRYAB has different specific sites for interacting with desmin and GFAP and thus 
the CRYAB sequences will also influence the extent of interactions (Ghosh et al., 
2007).  Vimentin is able to co-assemble with both desmin and GFAP and since it has 
the least binding to CRYAB it is likely that it aids in modulating GFAP and desmin 
networks rather than playing an important functional role in interacting with the sHSP 
(Wickert et al., 2005, Menet et al., 2001).  The dimer-monomer transition of CRYAB 
mediates increased chaperone activity and any deletion of amino acids which reduces 
the oligomer size acts to increase its chaperone ability, such as with the removal of 
54FLRAPSWF61 residues near the end of the head domain (residues 1-67) which 
increased the oligomer hydrophobicity (Santhoshkumar et al., 2009).  Figure 3.28 B) 
shows how at pH 6.3 CRYAB appears to line up along the vimentin filament surface 
in a regular periodicity showing that the interaction between the sHSP and the 
filaments is specific, despite observing the lowest interactions out of the three IFs 
studied and this demonstrates how there are hydrophobic areas on CRYAB which 
become adsorbed to the target protein to prevent aggregation (Spinozzi et al., 2006).  
Similar periodic coating of GFAP filaments has been observed with α-crystallin and 
therefore since vimentin is expressed in the lens fibre cells with α-crystallin, specific 
interactions must occur (Nicholl and Quinlan, 1994). 
In addition, the interactions between CRYAB and the filaments were investigated 
with CRYAB added to assembled filaments to compare to the interactions seen with 
its addition before their formation.  There was a significantly lower amount of 
CRYAB binding to the GFAP filaments at 39 0C at pH 6.3 and 7.3, when CRYAB 
was added to formed filaments compared to its addition before the filaments had 
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formed showing that the filament surface is crucial for mediating CRYAB-filament 
interactions (Figure 3.29).  However the same general trend was observed of 
increased binding at the low pH and raised temperatures thus supporting the notion 
that in vivo where there will be both soluble and insoluble filaments which are 
assembling and disassembling, when the pH is dropped and the temperature is 
increased there is a promotion of increased CRYAB interactions with the filaments.  
Another facet to this was investigated with the GFAP filaments being formed at pH 
6.3 and then the buffer exchanged for the higher pH 7.3 over 1.5 hr before CRYAB 
was added, from pH 7.3.  This showed a lower binding of CRYAB compared to the 
binding seen from the GFAP filaments formed at pH 6.3 and CRYAB from the same 
pH having been added (Figure 3.31).  Therefore under the conditions of the 
experiment, the 1.5 hr was sufficient time to reduce the binding seen showing that 
the filaments are in a seesaw state which can be tipped in favour of higher or lower 
binding and it is likely that once formed they are still capable of altering their 
surfaces depending on the pH environment they are placed in.  However the lower 
binding seen is also likely due to the fact that CRYAB was formed at the higher pH 
compared to the previous experiments where the filaments formed at pH 6.3 had 
CRYAB added which was formed at the same pH. 
In the next chapter more information about how CRYAB interacts with IFs will be 
gained by looking at the interactions between desmin and CRYAB in their 
equilibrium state.  These experiments look at the elasticity of the filaments and also 
the viscosity of the solutions and how CRYAB acts to alter these factors. 
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Chapter 4; Rheometrical properties of desmin filament networks 
and the influence of CRYAB.  
4.1 Introduction and aims. 
This work is a progression from the influences of human WT CRYAB upon GFAP 
and desmin filament-filament interactions seen from chapters 2 and 3 and is another 
method to quantify this utilising an equilibrium method.  Sedimentation and bulk 
viscometry have been used before to assess how CRYAB reduces filament-filament 
interactions, however microrheology is a more sensitive technique as it allows local 
elastic and viscous components to be derived (Perng et al., 1999a, Mizuno et al., 
2008).  It is a non-invasive technique to study the interactions between desmin and 
CRYAB and is an important complementary technique to the methods used in 
chapter 2 and 3.  Optical tweezers have the greatest frequency range compared to 
other methods such as passive video particle tracking and diffusing-wave-
spectroscopy (DWS).  The alpha-crystallin domain has been crystallised.  This 
encompasses the R120G point mutation position responsible for cataract, 
desminopathy and myopathy (Clark A.R. et al. 2011).  It is hypothesised that this 
mutant results in larger oligomeric complexes that perturb the normal chaperone and 
functional activities present in vivo between WT CRYAB and desmin filaments.  In 
vitro work has also already shown that this mutant results in aggregation and 
increased binding to filaments.  Here the viscosity changes associated with these 
interactions were investigated.  One question is: does WT CRYAB act to increase 
pore width in the meshwork or does it act to promote assembly-disassembly at the 
level of individual filaments?  A series of experiments were set up to help elucidate 
this and also delve deeper into filament network properties.  Elasticity has been 
studied for various filament solutions, which are all seen as being elastic solids 
capable of deformation in phase with the imposed strains.  There are a few constants 
that can be derived from rheological measurements of filament networks, such as G’ 
(elastic modulus) and G’’ (loss modulus) from single trap passive microrheology. 
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4.2 Materials and methods. 
4.2.1 Filament and chaperone sample preparation. 
4.2.1.1 Single Trap Rheology. 
4.2.1.1.1 Assembly. 
Desmin filaments were assembled either alone or in a mixture with CRYAB, 
according to Figure 4.1 up to the penultimate step, as shown below.  For the 1:1 
molar ratio, concentrations of 0.2 mg/mL desmin and 0.07 mg/mL CRYAB were 
used and for the 1:0.2 ratio of desmin: R120G CRYAB, 0.2 and 0.015 mg/mL were 
used respectively.  PLL(20)-g[3.5]-PEG(2) (PEG-PLL) (SuSos, Zurich) -coated 
carboxylate-modified polystyrene 2.0 µm yellow-green fluospheres (Invitrogen, UK) 
were added at a mass of 0.0125 mg to each sample before the final overnight 
assembly step. 
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Figure 4.1 Desmin assembly. 	  
4.2.1.1.2 Microsphere coating. 
For coating of the fluospheres, the stock bead solution was initially diluted to 0.5% 
(w/v) upon dilution with Milli-Q® (Millipore, UK) water and then an equal volume 
of 1 mg/mL stock of PEG-PLL polymer was added and incubated for 15 min, 16 rpm 
at room temperature on a spinning wheel (Agar Scientific, UK).  PEG-PLL is made 
up of L-lysine that is charged, thus binding to the beads and ethylene glycol that 
prevents the beads from clumping to each other and attaching to filament and glass 
surfaces, as it is inert.  This was centrifuged down (5,200 xgav, 15 min, room 
temperature) and resuspended in 200 µL of 20 mM Tris-HCl (pH 8.3) buffer and 5 
µL of this was added to each sample of 195 µL.  Protein samples were then 
transferred into the final overnight assembly buffer.  
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4.2.1.2 AMOLF two particle single trap rheology. 
4.2.1.2.1 Desmin and vimentin with/without CRYAB assembly. 
Assembly was carried out, for desmin and vimentin samples, the same as for the 
single trap rheology except 1 mM MgCl2 was added to the final overnight assembly 
buffer.  Concentrations of proteins used were 1 mg/mL IFs with or without 3.7 
mg/mL WT CRYAB.  A 200 or 100 µL volume was used for assembly using a slide-
A-Lyzer MINI dialysis unit with a 20 kDa molecular weight cut-off (MWCO) 
(Thermo Scientific, UK).  Microspheres were added to the final assembled material 
either before or after the final assembly step and it was shown that there was no 
difference in the G’ and G’’ moduli between the two conditions (Figure 4.7).  The 
beads were added after the final dialysis step in the samples analysed.  
 
4.2.1.2.2 Microsphere coating. 
Protein lobind tubes (Eppendorf, DE) were used and 15 µL of a stock preparation of 
microspheres were added (1 µm diameter polystyrene) and sonicated for 5 min in a 
floater in a sonic water bath and centrifuged (16,300 xgav, 5 min, room temperature).  
The supernatant was removed and 300 µL of PEG-PLL solution was added and 
incubated on a rotating wheel (22 rpm, 30 min, room temperature).  This was 
centrifuged again (7,400 xgav, 5 min, room temperature) and the supernatant was 
again removed.  65 µL of Tris-HCl (pH 8.0) buffer solution was added to resuspend 
the beads and they were left at 4 0C until use.  1.75 µL was added to the assembled 
samples. 
 
4.2.2 Data acquisition for passive viscosity measurements using a 1064 nm 
single-trap for microrheology. 
100 µL of the assembled protein and microsphere samples were placed into circular 
well slides (Agar Scientific, UK) and coverslips (Scientific Laboratory Supplies Ltd., 
UK) of depth 0 sealed on top with nail varnish.  They were then inverted and placed 
onto a metal stage with a circular cut-out for the trapping objective to make contact 
with the coverslip.  Citifluor (Agar Scientific, UK) was used as oil for the objective 
imaging.  An optical tweezer trapping instrument was utilised, built by Scott Silburn, 
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to record the motion of a trapped bead in the protein solutions to gather passive 
viscosity measurements.  An Nd:YAG laser at 1064 nm was used to trap beads 
through a 100x, 1.25 numerical aperture (NA) oil-immersion objective lens (Nikon, 
UK), with 10mW of laser power.  White light was provided from a tungsten-halogen 
KL1500 light source (Schott, USA) from above and the slides were placed onto a 
translation stage movable in the x-, y- and z- axes, using micrometers.  The laser 
beam was expanded initially using a Galilean beam expander and split through a 
50/50 splitter so that a recording of the power could be taken with a power meter and 
the rest sent via an infrared (IR) optimised mirror to the trapping objective (Figure 
4.2).  An image of the trapped microsphere travelled back down the optical path of 
the trapping laser.  This then passed through a beam splitter and was sent to the 
camera after passing through two filters (650 nm short-pass).  A lens of 200 mm was 
used to focus the image onto the camera sensor.  A high-speed DSi camera (Durham 
Smart Imaging, UK) built by Dr Christopher Saunter recorded the position of single 
trapped microspheres using centroids on the DSi smart GUI camera software with a 
centre-of-mass (CoM) algorithm on-camera.  Microspheres were trapped and 
analysed using a 4.6 kHz camera frame rate for 1.5 min.  A K-type thermocouple 
was used to record the ambient temperature of the samples, since it was impossible 
to directly measure the temperature of the protein samples as they were enclosed on 
the microscope slides, despite there being slight heating effects from the infrared 
laser which were minimal.  On the DSI camera software, a tracking region was 
created for each trapped bead to give a threshold for the algorithm to record data.  
Pixels below a certain luminosity weren’t included and those above were included.  
The 2 µm microspheres used were relatively uniform in size with the coefficient of 
variation being relatively low; 5% for sizes of 0.1 µm decreasing to 1% for 10-15 µm 
diameters, for Invitrogen Molecular Probes fluospheres.  MATLAB R2007b 
(MathWorks, UK) was used to process the data retrieved from the position utilising 
scripts written by Scott Silburn (calculations in appendix).  The output files were in 
the form of .csv, opened in Excel 2008 (Microsoft Corporation, US) and contained 
the X and Y frequency dependent viscosity values (Pa.s), which were then averaged 
and plotted against frequency (Hz).  Initially calibration was required of the 
recording system to enable conversion of the data recorded in pixels to physical 
lengths.  A microscope graticule (Agar Scientific, UK), with 100 x 0.01 mm 
divisions, was used and a still image captured with the 10 µm divisions.  This was 
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put into ImageJ 1.43r (National Institutes of Health, USA) from which three separate 
rectangular selections were made, to give an average of the whole image, covering 
the whole length of the image to then derive a luminosity profile, from the Analyze > 
Plot Profile options.  The luminosity profile was copied directly into Excel.  A 
central difference was used upon the luminosity values, giving a chart plotted with 
pixels (x-axis) against central luminosity differences (y-axis), as the derivative of the 
profile plot.  For the central luminosity differences, for each pixel the average 
luminosity was taken for the pixel values from the previous two to the two after.  As 
an example, for pixel 2, the difference was calculated by subtracting the value for 
pixel 0 from the value for pixel 4 and divided by 4.  The peaks on the chart were 
separated by 10 microns and thus the distance between the peaks gave the number of 
pixels per 10 microns. The distances were finally divided by 10 to get the conversion 
to pixels per µm, which were then used in MATLAB for data analysis.  The bead 
diameter was calculated to be 9.5 +/- 0.02 pixels per µm, with the standard error 
representing the error for the top, middle and bottom of the graticule picture, from 
three independent luminosity charts.  The trap stiffness (spring constant) from the 
laser was derived from three buffer only samples and this was then subtracted from 
subsequent analysed sample data in MATLAB. 
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Figure 4.2 Optical tweezer set-up for single trap data. 
Image kindly provided by Scott Silburn.
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4.2.3 Data acquisition for passive viscosity measurements using 1064 and 808 
nm single trap microrheology.  
Experiments were carried out at the FOM Institute for Atomic and Molecular Physics 
(AMOLF), Amsterdam (NL). 
Samples were placed in sample chambers prepared using a small glass microscope 
slide attached to a larger slide after melting parafilm strips between the two to hold 
them together to leave a gap for the sample, on a hot plate set to 50 0C with the use 
of tweezers to gently press the smaller glass slide against the larger slide to melt the 
parafilm.  The samples were pipetted in the side after the chambers had cooled, 
drawn in by capillary action.  Evaporation was prevented by sealing with a thin layer 
of vacuum grease from a syringe.	  	  Sample microscope slide chambers were analysed 
on an inverted Nikon Eclipse Ti microscope (Nikon, NL), which used two lasers of 
808 and 1064 nm wavelengths, controlled by a custom-written programme in C++ of 
microRheology (version 1.0.4350.20571 copyright ©FOM AMOLF 2010, 
Amsterdam) and was used to optically trap microspheres in the filament samples.  
The samples were focused with a 100x oil-immersion objective lens (NA 1.4) 
(Nikon, NL).  Objective oil was also used for the condenser, which was lowered on 
top of the chamber after the sample had been focused with the aid of a CoolSNAP 
HQ2 camera (Photometrics, AZ).  A magnetic dichroic mirror was then placed above 
the condenser so as to divert the laser beams from the path of imaging.  A laser 
detection card was used to check whether or not bubbles were present in the oil, 
which would distort the lasers and the bubbles were removed if necessary.   
Back-focal-plane laser interferometry was used to detect the displacement intensity 
fluctuations of the microspheres from the focus of the sample plane and the data was 
recorded with a 100 kHz bandwidth with quadrant photodiodes (QPDs) used to 
record the thermal motion of the trapped microspheres; the oscillation of the drive 
laser was switched off for these passive measurements (Gittes F., 1998).  The 1064 
nm laser was set to 1 W (approximate power of 24 mW) and the 808 nm laser was 
set to 45 mW (approximate power of 20 mW).  The acoustic optical deflector 
(AOD)-X was set to 30% and the AOD-Y was set to 100%.  The cross-hair was 
assessed to see if the QPD detectors were saturated or not; if they were the lenses 
were adjusted to allow the laser spots to be centered if they deviated from the centre 
of the traps.  The position of the 1064 nm laser spot in relation to the 808 nm laser 
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spot could be moved using the cursor in the microRheology programme.  Once beads 
were trapped, the camera and light box were switched off to reduce noise in the 
power spectrum at lower frequencies before measurements were recorded.  
Calibration was carried out for just buffer at a 10 µm distance from the coverslip 
surface, to avoid surface effects.  Separate power spectral densities were recorded 
and fit with a Lorentzian in the microRheology programme.  The corner frequency 
was used to derive the trap stiffness (N/m) and displacement (µm/V) values from 10 
independent measurements of 7MS of data for individually trapped microspheres in 
both the 808 and 1064 nm lasers for buffer, which were averaged and used to derive 
the real shear (G’) and imaginary loss (G’’) moduli from the samples in the 
microRheology programme.  For the buffer calibration values, a Lorentzian graph for 
each separate file and laser trap was fit using the two graph-cursors available in the 
programme to derive the trap stiffness and displacement.  The output data were 
plotted in Excel, averaging the parallel (para-) direction values that contained less 
noise for G’ and G’’, against frequency (Hz).  The	  calculations were the same as 
those used for the analysis of the single 1064 nm trap data in Durham based on the 
fluctuation-dissipation theorem (FDT), except the true values were used for Figure 
4.7 and only the apparent in the generalised Stokes relation, to derive the G’ values 
in Figure 4.8 (Atakhorrami et al., 2006).  The elastic modulus was calculated from 
G_app by subtracting the apparent modulus in buffer thus compensating for the 
presence of the optical trap (Addas et al., 2004).  The apparent G’ values were used 
instead of the true values since the buffer initially appeared to have an unexpected 
high elastic response using just the true values in the generalised Stokes relation 
equation.  The programme calculates the real (α’(f)) and imaginary (α’’(f)) parts of 
the transfer function (apparent response) using the power spectral density, the 
fluctuations-dissipation theorem (FDT) and the Kramers-Kronig relation.  The 
apparent responses (α’(f) and α’’(f)) are then used in the GSER to derive G(f) for the 
shear and loss moduli.  G’’ sample was calculated as: G’’ apparent sample- solvent 
viscosity (2*Pi*frequency*viscosity of water at 21 0C). 
The following conditions were present of: 1 W (24 mW) laser power for the 1064 nm 
laser, 45 mW (20mW) laser power for the 808 nm laser, QPD for the 1064 nm laser 
of Gain 1x and filter 100kHz, QPD for the 808 nm laser of Gain 1x and filter 100 
kHz, 293.15 kelvin.  
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4.2.4 High speed sedimentation assays. 
Sedimentation assays were carried out the same as in 2.1.2.12. 
 
4.3 Results. 	  
4.3.1 Single-trap microrheology. 
R120G CRYAB gave such dramatic aggregation of desmin filaments that initially 
the viscosity appeared no different to buffer alone at a 1:1 molar ratio (Figure 4.5); 
the hypothesis is that the desmin filaments clumped together leaving large spaces in 
which the beads were trapped giving the same viscosity as buffer.  Thus lower ratios 
of desmin: heat shock protein were used and it was found that a 1:0.2 molar ratio of 
desmin: R120G CRYAB gave an increase, likely due to the ability to position the 
beads next to the filament networks.  However at the same ratio, WT CRYAB had 
lost its ability to chaperone the desmin filaments and only until a ratio of 1:1 was 
used was there a decrease in viscosity observed from desmin alone, due likely to an 
increase in mesh pore size (Figure 4.6).  As biochemical evidence for R120G 
CRYAB having increased interactions with desmin filaments, assembly in HEPES 
buffers as in 3.1.3.3 at pH 7.3 was carried out showing greater binding for R120G 
CRYAB to desmin filaments compared to WT CRYAB; compare Figure 4.3 to 3.23.  
WT CRYAB acts as a stealth protein in reducing filament-filament interactions as 
seen by a reduction in viscosity of desmin solutions (Figure 4.6). 
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Figure 4.3 Binding of R120G CRYAB to desmin IFs at pH 7.3 is temperature 
dependent and greater compared to WT CRYAB. 
High speed sedimentation assays were carried out on WT desmin and R120G 
CRYAB samples assembled through HEPES buffers at pH 7.3.  A clear increase in 
co-pelleting of R120G CRYAB can be seen with desmin compared to WT CRYAB 
at the same pH, c.f. Figure 3.23 A). 
 
 
 
Figure 4.4 Desmin filament morphology in the absence and presence of WT 
CRYAB. 
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Desmin filaments were assembled according to Figure 4.1 of A) WT desmin alone 
and B) WT desmin with WT CRYAB in a 1:1 molar ratio.  The scale bar is equal to 
500 nm. 
 
 
 
 
 
 
 
 
 
Figure 4.5 A 1:1 molar ratio of WT desmin: R120G mutant CRYAB gives a 
similar passive frequency-dependent viscosity as buffer from single-trap 
microrheology. 
Averages from three independently trapped beads were taken and error bars are 
shown as +/- one SD.  Desmin has a higher frequency-dependent viscosity than 
buffer as expected.  However using the 1:1 molar ratio of desmin: R120G CRYAB 
used here, the frequency-dependent viscosity is the same as buffer.  Honey, buffer 
and water are purely viscous solutions whereas desmin is a complex solution that has 
varying viscosity dependent upon the stress applied.  Honey has a higher viscosity 
than water and also desmin filaments. 
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Figure 4.6 WT CRYAB has the ability to reduce the frequency-dependent 
passive viscosity of desmin filament networks, whereas the R120G mutant 
increases filament bundling and viscosity.  
Microspheres were trapped and their natural thermal motion recorded for 1.5 min at 
4.6 kHz in a 1064 nm laser.  All data are the average of 3 (buffer), 3 (desmin) and 5 
(desmin + WT CRYAB) independently trapped microspheres apart from the sample 
of desmin and R120G CRYAB (1:0.2 molar ratio), which is the average of 2 
microspheres.  Error bars are +/- 1 SD.
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4.3.2 Two particle- single-trap microrheology (AMOLF). 
The elastic, shear moduli data were averaged from at least 5 independent beads per 
sample.  The parallel (para-) directions were taken in most cases, excluding the 
perpendicular (perp-) values, as these generally have less noise.  
 
 
1064 nm 808 nm 
Displacement 
(µm/v) 
Trap stiffness 
(N/m) 
Displacement 
(µm/v) 
Trap stiffness 
(N/m) 
X 0.771228 2.60364E-05 X 0.398946  7.52E-05 
Y 0.769733  Y 0.5078  
Table 4.1 Calibration results for two-particle single tracking used in the analysis 
of samples for which the microRheology programme calculated the real and 
imaginary modulus values from the true responses.  
An average of 10 beads were taken to derive the calibration values for sample 
analysis. 
 
 
1064 nm 808 nm 
Displacement 
(µm/v) 
Trap stiffness 
(N/m) 
Displacement 
(µm/v) 
Trap stiffness 
(N/m) 
X 0.741816667 
 
2.23967E-05 X 0.43502 6.80E-05 
Y 0.873783  Y 0.42802  
Table 4.2 Calibration results for two-particle single tracking used in the analysis 
of samples where the modulus real and imaginary values were calculated from 
the apparent response functions.  
An average of 5 beads were taken to derive the calibration values for the 1064 nm 
laser and 10 for the 808 nm laser. 
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A small elastic response difference was detected for 1 mg/mL desmin when WT 
CRYAB had been added at a 1:10 molar ratio, shown in Figure 4.8, from the 808 nm 
laser trap.  However the G’’ values were no different, shown in the frequency range 
of 0.1 - 100 Hz in Figure A.4, since negative values were obtained for desmin.  The 
data from the 1064 nm laser were negative for both desmin and desmin + WT 
CRYAB for G’ values. 
 
 
 
 
 
 
Figure 4.7 No great difference is observed in the G’ and G’’ moduli of desmin 
filaments assembled with microsphere addition before and after the final 
assembly step.  
G’ and G’’ derived from the true responses, of 1 mg/mL desmin measured from 5 
independently trapped beads in the 1064 nm laser are plotted as averages with beads 
added before and after the final assembly step.  More of a viscous component 
(imaginary) can be seen compared to an elastic response (real).  Line colours; beads 
added after the final assembly buffer: blue = G’’ and red = G’; beads added before 
the final assembly buffer; green = G’’ and purple = G’. 
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Figure 4.8 WT CRYAB in a 10-fold molar excess to desmin reduces the elastic 
response of desmin networks. 
Microspheres were trapped in an 808 nm laser trap and their motion was recorded; 5 
beads were analysed for 1 mg/mL desmin and 10 for 1 mg/mL desmin + 3.7 mg/mL 
WT CRYAB.  Sample files were analysed in the microRheology programme and the 
apparent real and imaginary responses used to calculate G’, which is plotted against 
frequency.  Error bars represent +/- 1 SD.  WT CRYAB can be seen to reduce the 
apparent G’ of the desmin networks. 
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4.4 Discussion. 
The advantage of passive microrheology is that it is a valid tool for observing the 
mechanical properties of an equilibrium system in a non-invasive way since there is 
no need to strain the system to measure local viscoelastic properties.  Sedimentation 
assays will potentially shift the equilibrium of protein assembly, balanced between 
disassembled and assembled filaments, to more disassembled filaments than would 
be seen with filaments in vivo.  Therefore microrheology is a preferred method for 
assessing filament interactions, as the trapping of microspheres will not affect the 
equilibrium.  Microrheology also is advantageous as it measures local responses 
instead of taking an average of the viscoelastic properties, which is the case for DWS 
and this is especially essential for the desmin and R120G CRYAB samples in this 
chapter where filaments are entangled and thus the passive viscosity measurements 
that give higher values are found close to the filament networks and if an average 
was taken as with DWS, such a difference in the frequency-dependent passive 
viscosity might not be seen.  Microrheology is useful for studying the interactions of 
CRYAB with filament networks since the usual method for assessing interactions 
has been high and low speed sedimentation assays, which have a disadvantage in that 
they are assessing protein interactions in a non-equilibrium system.  The fact that 
CRYAB can reduce the elasticity of desmin networks shows that it may be 
influencing the structures of the filaments and not just the network mesh pore size as 
shown by a reduction in passive viscosity.  However it can’t be seen just from 
microrheology whether the reduction in elasticity is due to effects at the filament or 
network level.  When low speed sedimentation assays have been showing reductions 
in filament-filament interactions such as for desmin in Figure 2.21 and R239H GFAP 
in Figure 2.18, this has been due to a reduction in the elastic response and viscosity 
of the networks from CRYAB.  The elasticity is a reflection on the bending, sliding 
and potential breaking of the filaments in response to deformation and when it has 
been lowered due to WT CRYAB this may mean the filaments are more dynamic 
and flexible.  Divalent cations are highly important for IF assembly, as demonstrated 
in chapter 3 with impaired GFAP filament elongation and compaction in their 
absence.  It has been demonstrated that divalent cation cross-linking influences the 
elastic behaviour of vimentin filaments and thus desmin and they act as effective 
molecular cross-links similar in action to the F-actin network molecular cross-links 
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(Lin et al., 2010a).  Therefore divalent cations are crucial for the G’ values observed 
here.  Divalent cations act to mediate attractive interactions between negatively 
charged side arms of IFs and this cross-linking will contribute to the observed G’ 
values (Lin et al., 2010b). 
To answer the question of how CRYAB reduces elasticity of desmin networks, 
rheology will need to be complemented with other information such as thermal 
fluctuation of individual filaments which could provide information on the mesh 
pore size in the presence and absence of CRYAB (Koster et al., 2010, Noding and 
Koster, 2012).  Additionally, beads that are smaller than the network pore size could 
be used, as these should not get trapped in the meshwork and the use of mean square 
displacements (MSDs) could derive the mesh size (Koster et al., 2010). 
Despite a clear reduction in the G’ of the desmin filament networks from the 
presence of WT CRYAB, no difference was observed in the G’’ values and in fact 
the values were negative from the data analysis and so could not be used.   
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Chapter 5; Final discussion and future directions. 
5.1 Main results. 
With AxD and cardiomyopathy, CRYAB-IF interactions are increased and thus their 
interactions have been studied in this thesis to assess any potential functional 
interactions.  The main conclusions from this thesis are outlined within Table 5.1.  
They demonstrate that desmin-CRYAB interactions are functional since CRYAB 
binds to desmin the most out of all three type III IFs studied here and CRYAB is able 
to alter the biomechanical properties of desmin filaments, shown by a reduction in 
the plastic modulus.  R120G mutant CRYAB causes cardiomyopathy and has 
increased interactions with desmin filaments and since it was shown that it increases 
the viscosity of the filaments compared to WT CRYAB, this shows that the mutant 
CRYAB is affecting the way the filament networks are interacting.  CRYAB also 
interacts with GFAP, relevant for AxD and was shown to have increased binding to 
AxD mutants compared to WT CRYAB.  Two main mutations were studied of 
R239H and R79C and CRYAB was shown to reduce R239H filament-filament 
interactions despite the formation of aggregates and also have a slight inhibitory 
effect upon WT GFAP filament formation.  The dominant nature of the R79C and 
R239H mutants was investigated by assembling varying percentages of the mutants 
with WT GFAP.  R239H had a dominant effect at a 50% level from low speed 
sedimentation assays in comparison to R416W with effects only seen at a 100% level 
under the conditions of assembly used.  Both the R239H and R79C mutants are 
predicted to disrupt the ionic interactions within the dimers thus disrupting assembly 
that will lead to an increase in exposed surfaces for interaction with CRYAB and 
also explain the disruption of WT GFAP filaments when co-assembled with the 
mutants.  R239H also appeared to bind much more CRYAB than R416W thus 
highlighting the greater severity of the R239H mutant compared to R416W.  
Temperature was shown to influence the CRYAB-filament interactions as higher 
temperatures promoted increased binding of CRYAB to the filaments, also likely due 
to potential unfolding of the IFs.  As well as mutation of IFs, the influence of 
divalent cations on IF assembly was studied.  Manganese ions were shown to 
increase the filament-filament interactions of GFAP and desmin and result in dimer 
formation.  GFAP is compromised the most by alterations in its assembly 
environment as it was shown to form thicker filaments in the presence of manganese, 
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absence of divalent cations, low pH and 5 mM calcium.  CRYAB interactions were 
investigated in all conditions apart from 5 mM calcium and these conditions led to 
much greater binding of CRYAB compared to assembly conditions with 1 mM 
magnesium ions and pH 7.4.  Desmin however was found to bind the most to 
CRYAB and it was shown for all three IFs that low pH results in increased 
interactions and higher temperatures also promote greater interactions.  High 
temperature and low pH usually shift protein assembly to more disassembled states 
and thus it’s likely that the IFs become more destabilised leading to increased 
interactions with CRYAB.  These experiments are important as they show that the 
interaction between desmin and CRYAB is functional and thus predisposes to 
disease with the R120G mutation in myocytes.  The widths of the CRYAB oligomers 
were measured and found to be wider at pH 6.3 compared to 6.8 and 7.3 that may be 
a reflection on a shift to CRYAB monomers that are known to have higher affinity 
for client proteins.  Wider GFAP and desmin filaments were also observed at pH 6.3 
compared to the higher pH values thus demonstrating how pH can disrupt filament 
interactions.  Importantly a difference was observed in the amount of binding of 
CRYAB to GFAP filaments dependent upon the assembly stage it was added, 
showing that with CRYAB present throughout the whole of filament assembly there 
is much greater binding compared to when CRYAB is added to formed filaments.  
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Chapter 2     
Structure  Mutant AxD 
phenotype 
Location in 
coiled-coils 
Morphology 
 R79C I and J Position g ULF lengths 
 R239H I Position e Aggregates of ULF 
lengths 
 R416W I, J and A Random coil 
(RDGE motif) 
Aggregates of 
short filaments 
CRYAB-IF 
interactions 
TEM and 
sedimentation 
data 
   
 Interactions 
greatest with 
the R239H 
mutant GFAP 
   
Chapter 3      
 Morphology of 
IFs 
Widths of 
CRYAB 
Interactions of 
CRYAB-IFs 
Effects of 
increased 
temperature 
pH 6.3 GFAP widths 
are greater and 
more variable 
More 
variable 
and wider 
than pH 
6.8 and 7.3 
Greater binding 
to all IFs; 
especially 
desmin.  Repeat 
distance on 
vimentin is 
regular (20 nm) 
between 2 
filaments 
Increased 
temperature 
increases the 
binding of 
CRYAB to IFs 
(also for pH 6.8 
and 7.3) 
Chapter 4 WT CRYAB reduces the plastic modulus and viscosity of desmin 
filaments and R120G mutant CRYAB increases the viscosity 
Table 5.1 Summary table of main results. 
I = infantile, J = juvenile and A = adult. 
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5.2 Mutants of GFAP and interactions with CRYAB. 
GFAP mutation is linked to AxD and it was shown in chapter 2 that the R239H 
mutant has a much greater association with CRYAB compared to WT, R79C and 
R416W GFAP, as observed from high speed sedimentation assays.  This links in 
with the discovery that Rosenthal fibres contain aggregates of mutated GFAP 
alongside p62, HSP27 and CRYAB and thus CRYAB is sequestered to the 
aggregated filaments (Der Perng et al., 2006).  In addition the amino acid sequence 
of an IF is crucial for normal assembly and when mutated in the case of AxD the 
filaments are no longer normal, as demonstrated in chapter 2 by shortened ULF-like 
filaments of 60-100 nm in length for both the R79C and R239H mutants with the 
latter leading to aggregates, as with R416W.  Type III IFs assemble with the 
formation of ULFs initially and then the longitudinal annealing and compaction of 
these and therefore the two mutants studied here appear to have a halted assembly 
before the annealing step (Parry and Steinert, 1995).  Removal of crucial residues 
can also disrupt assembly such as removal of the head domain in GFAP, which 
always leads to disrupted filaments showing that the entire head domain is needed 
for efficient assembly, also removal of the entire tail domain results in aggregate 
formation when no other filament network is present, which is recovered to normal 
filaments if in the presence of vimentin (Chen and Liem, 1994).  Removal of the 
initial half of the RP-box in the head domain of GFAP also leads to shortened 
filaments (Ralton et al., 1994).  Shown in chapter 2, the R239H mutant which is 
correlated only with infantile cases of AxD was more severe in terms of its dominant 
effect over WT filament formation and increased binding with CRYAB compared to 
R416W which is associated with infantile, juvenile and adult onset cases of AxD 
(Kinoshita et al., 2003).  R416 is located at the beginning of the RDGE motif, 
conserved in all type III IFs, in the tail domain and the R239 site is situated in the 2A 
rod domain (Chen and Liem, 1994).  It will be a combination of the location and also 
the type of amino acid (either basic histidine or neutral tryptophan), which leads to 
differences in the aggregates and severity of the disease.   Since the entire tail 
domain can be removed and filaments can still form if in the presence of vimentin 
whereas the head domain is necessary for filament formation, this demonstrates that 
the head domain is more crucial for assembly than the tail region.  Histidine is more 
prone to charge change at the pH of assembly since one of the side chains has a pK 
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close to pH 7 and therefore a negative charge will result at pH 7.3 for this group, 
which is unlike arginine that will be more positively charged since it is a basic amino 
acid with a side group that has a much higher pK.  The amino acid position of 239 is 
also in position e of the heptad repeat in the coiled coil responsible for inter-ionic 
interactions and therefore mutation will disrupt how neighbouring monomers interact 
and the formation of dimers and this may be why the R239H is more severe than 
R416W since the RDGE motif of GFAP has been proposed to not be sufficient alone 
for GFAP assembly, demonstrated when amino acids were deleted between the end 
of the rod 2B domain and the start of the RDGE sequence, whereas with desmin the 
RDGE motif is sufficient (Chen and Liem, 1994).  R79 mutations (in the LNDR 
motif of rod 1A also in a crucial position for inter-ionic interactions at position g in 
the heptad repeat) have been correlated with less severe phenotypes than the R239 
mutations and the R239H has a more severe clinical course than the R239C mutation 
phenotypes (Rodriguez et al., 2001, Smith et al., 2002).  The heptad assignment of 
coiled coils is derived from the research of David Parry and is demonstrated in 
Figure 2.32 (Parry, 1982).  The LNDR motif is crucial for normal functioning of 
many IFs since mutations have been linked to diseases other than AxD, such as skin 
blistering with type I keratins (Yamanishi et al., 1994).  The arginine to cysteine 
mutation in the LNDR motif also appears to occur at a relatively high frequency in 
diseases (Pittenger et al., 2007).  As well as the GFAP R79C mutant, BFSP2 also has 
a cysteine replacing an arginine residue within the LNDR motif (LGGC), unique to 
IFs, however this is present normally in the sequence and it has been shown with 
K18 that if two glycines are present alongside the cysteine, filament assembly is 
restored whereas if only LNDC is present the filaments are perturbed, as seen in this 
instance with R79C GFAP (Pittenger et al., 2007).   
It was demonstrated in chapter 2 that the R79C mutant binds less to CRYAB than the 
R239H and R416W mutants and has a dominant effect upon filament morphology at 
a 50% level, as opposed to R239H that is dominant at a 10% level, thus 
demonstrating its less severe phenotype. 
CRYAB was shown to influence filament-filament interactions and could reduce the 
propensity for the R239H mutant GFAP shortened filaments to associate, observed 
with p<0.05.  CRYAB didn’t have any affect on WT or the R79C mutant quantities 
in the pellet fractions at low speed, perhaps a reflection on WT GFAP filaments that 
do not need any alteration of filament-filament interactions and also R79C that is 
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predominantly soluble and has low interactions already.  CRYAB interactions 
influencing filament behaviour are dependent upon the buffer environment, 
demonstrated from the apparent increase in WT GFAP filament-filament interactions 
from imidazole assembly when CRYAB was present compared to its absence with a 
p value of 0.05, which is in contrast to assembly through Tris where levels of GFAP 
are unchanged with the addition of CRYAB after low speed centrfiguation.  
Therefore pH and ionic strength are factors that influence these interactions.  The 
buffer conditions also influence filament-filament interactions in the absence of 
CRYAB as discussed in the next section and demonstrated with R416W and WT 
GFAP mixtures.  Ionic strength is crucial for IF assembly and it requires monovalent 
cations for type III IFs, alongside divalent cations for GFAP.  When ions are 
removed the IFs do not form long filaments but instead assembly is halted at the 
elongation step and most of the species are dimers, tetramers and a few higher order 
oligomers (Kooijman et al., 1995).   
CRYAB was also shown to have a slight inhibition on WT GFAP filament formation 
in section 2.1.3.3, observed by an increase in non-pelleted GFAP in its presence.  
This has been shown before with phosphorylated CRYAB and bovine GFAP, 
however with these the inhibition was much greater as no filaments were observed 
whereas in this thesis filaments are still present but there has been an increase in the 
soluble portion of GFAP, likely due to modifications of the proteins that are absent 
in this thesis (Nicholl and Quinlan, 1994).  
Three different temperatures of assembly were used in chapter 2 assessing the 
interactions between CRYAB and the different mutants of GFAP.  R239H bound the 
most to CRYAB and for all of the mutants including WT GFAP there was an 
increase in interactions with increased temperature.  However this could not be 
attributed solely to a temperature-dependent effect since the pH of the Tris buffers 
changed with temperature, therefore the next section discusses the findings from 
experiments that investigated the temperature and pH-dependent effects of CRYAB-
GFAP interactions. 
The morphology of the R239H mutant GFAP and the fact that it has the greatest 
interactions with CRYAB demonstrate how it is associated with the most severe 
phenotype of AxD.  AxD is the direct result of GFAP mutations and it is likely that 
CRYAB is acting to reduce the increased interactions between the altered filaments.  
Importantly one of the main functional roles of CRYAB in the disease is to reverse 
  
194 
the inhibition of proteasome activity from the GFAP mutants (Tang et al., 2010).  By 
interacting directly with the filaments, CRYAB also reduces the sizes of aggregate 
oligomers (Figure 2.15) and can result in smaller GFAP oligomers alongside 
monomers, which are believed to occur alongside proteasome re-activation (Tang et 
al., 2010).  
 
5.3 Divalent metal ions, pH and temperature influences on IFs and interactions 
with CRYAB. 
The removal of divalent metal ions from GFAP assembly was assessed in chapter 3 
since divalent cations are crucial for GFAP assembly and it was demonstrated 
previously that bovine GFAP forms rod structures without divalent cations (Tanaka 
et al., 1989).  Divalent metal ions also impart IFs with elasticity, acting as effective 
molecular cross-linkers and thus the G’ of desmin networks could be assessed in 
chapter 4 (Lin et al., 2010b).  However the elasticity will not only be due to bending 
of the filaments in response to deformation but also rearrangement since the cross-
links won’t be as strong as for instance avidin with actin filaments which have 
almost covalent bonds with the filaments (Wachsstock et al., 1994).   
Human GFAP was shown to form shortened (approx. 300 nm), wider (approx. over 
20 nm) filaments that were longer than ULFs in the absence of divalent metal ions 
and had an altered appearance with greater filament-filament interactions and thus 
unlike the mutants of R79C and R239H assembled with divalent cations which had 
ULF lengths, these structures annealed longitudinally past the ULF stage but not as 
much as WT filaments.  When higher concentrations of ions were used such as with 
5 mM Ca2+, much thicker filaments were observed and this will be because the 
positive ions attract the negative amino acids of the IFs and lead to bundling of 
parallel fibres, which has been correlated with increased stability of networks (Wen 
and Tang, 2006, Shaw and Hou, 1990).  The increased widths in filament 
morphology in manganese ions were absent for vimentin and desmin filaments and 
will likely be due to the fact that astrocytes, the predominant site of GFAP 
expression, are the main stores of manganese ions and thus GFAP is more receptive 
to alterations in its concentrations (Agustina Alaimo, 2011).  Divalent cations are 
also stronger at promoting assembly of GFAP than monovalent ions, which is a 
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reflection on their different sites of binding to the filaments (Yang and Babitch, 
1988). 
The absence of divalent cations results in increased associations with CRYAB and is 
likely due to a similar mechanism as seen with R239H whereby the aggregates likely 
have increased hydrophobic sites leading to increased CRYAB-filament interactions.  
Also, manganese ions result in increased interactions of desmin, GFAP and vimentin 
with CRYAB.  The increased filament associations are also supported by the 
oxidative dimer formed for GFAP.  Divalent metal ions are important since 
alterations in the concentrations of different metal ions have been associated with 
various disease states, such as AD and PD and since alterations in morphology of 
filaments and interactions with CRYAB have been observed in vitro, the divalent 
cations likely contribute to what is seen in vivo, such as co-localisation to amyloid 
fibrils alongside increased expression of CRYAB in AD (Shammas et al., 2011).  
Copper levels have been found reduced and iron levels increased in the amygdala of 
AD brains, but manganese ions remain unaltered (Akatsu et al., 2012).  Perhaps in 
desminopathies and AxD there is a sequestering of manganese ions to the muscle 
fibres and astrocytes resulting in greater associations between CRYAB and the IFs, 
although increased levels of manganese have not been reported.   
GFAP filaments were much more susceptible to assembly changes than vimentin and 
desmin, as shown from assembly in manganese ions and also 5 mM Ca2+ ions, which 
both resulted in thicker filament widths.  This highlights how the three IFs have very 
distinct properties and in addition, adding to the discussion below, at the lower pH of 
6.3 where increased interactions of CRYAB with IFs is observed there is also an 
observed alteration in the filament morphology of GFAP which also appears much 
thicker (Figure 3.28).  Only in 5 mM Ca2+ ions was the full-length GFAP filaments 
seen despite wider filaments in contrast to the other conditions mentioned, also 
resulting in thicker filaments, where the filaments were shorter in length.  This shows 
that elongation is halted from manganese, a lack of divalent cations and a drop in pH 
whereas the 5 mM calcium ions do not appear to impede elongation despite 
hindering filament compaction.  In addition, CRYAB binding to vimentin and GFAP 
was assessed in the presence of 1 mM manganese ions at pH 6.9 and was shown to 
be significantly greater, for vimentin and GFAP, than the binding seen in the 
presence of magnesium ions at pH 6.8 (Table 3.5 and A.11 and A.14).  The fact that 
binding was greater at the higher pH also supports the fact that the manganese ions 
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promote increased CRYAB-filament associations, since usually greater interactions 
are seen at lower pH values (section 3.1.3.3) and if experiments had been carried out 
at pH 6.8 with manganese ions then there would have likely been a greater difference 
observed. 
Filament bundling has been observed previously with 5 mM calcium ions and 
appears to occur with manganese ions observed by an increase in side-by-side 
interactions (Figure 3.5 B)) however CRYAB was able to reduce some of the 
increased interactions, observed from low speed sedimentation assays (Figure 3.8 
A)), which is supported by the finding that CRYAB has been shown to debundle IFs 
and inhibit aggregate formation whilst not altering filament lengths (Head et al., 
2000, Perng et al., 1999a, Yang and Babitch, 1988).  The ability to debundle IFs 
appears to be affected by the local pH since the IFs had fewer interactions, assessed 
from low speed sedimentation assays, at the higher pH values (Figure 3.24).  
Additionally the ability for CRYAB to inhibit GFAP IF formation is favoured at the 
higher pH values (Figure 3.23 B)).  CRYAB has been shown to be able to inhibit IF 
formation but appears to act to stabilise microtubules especially promoting mitosis 
and nucleation and plays a crucial role in preventing disorganisation of actin 
filaments upon heat stress by increasing its associations, which are believed to aid in 
prevention of heart failure, where actin filaments are found to have degenerated that 
precede changes in polymerisation of actin fibres (Nishida et al., 1987, Xi et al., 
2006).  Thus it is likely that the increased affinity of CRYAB for IFs upon heat stress 
and lowered pH plays a functional role in keeping the cells in a normal physiological 
state and aids in prevention of disease (Singh et al., 2007). 
Outlining the importance of the ionic environment for filament formation, it was 
shown in chapter 2 that imidazole buffer resulted in GFAP filaments with much 
greater interactions than those assembled in Tris buffer.  This was demonstrated from 
low speed sedimentation assays where most of the GFAP was pelleted and also from 
high speed sedimentation assays whereby CRYAB didn’t have the same inhibitory 
effect upon WT GFAP formation as it did in Tris buffer.  This will also likely 
account for the increased effect of the R416W mutant over WT protein observed 
previously in the laboratory after an imidazole assembly at a 25% level whereas 
when Tris assembly was used the dominant effect was not seen even at a 50% level 
by low speed sedimentation, however the dominant effect was seen using the TEM 
(Der Perng et al., 2006).  Additionally there appears to be a theme throughout with 
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CRYAB binding, as the imidazole buffer demonstrated with increased interactions of 
CRYAB with GFAP compared to Tris buffer and therefore it seems that increased 
ionic strength or changes in the divalent cation environment, leading to increased 
interactions between filaments, can lead to increased interactions between CRYAB 
and the filaments. 
Type III IFs were studied, of vimentin, desmin and GFAP as they belong to the same 
group and evolved at a similar time, looking at interactions with CRYAB.  Therefore 
any difference observed in interactions with the CRYAB is likely not going to be due 
to the general assembly mechanism of the filaments as they have the same method of 
assembly, but the variation in amino acid sequences.  CRYAB mutation has only 
been linked to the disease of desminopathy and this highlights the importance of 
CRYAB-desmin interactions and also why desmin-CRYAB interactions are the most 
compared to GFAP and vimentin (Djabali et al., 1997). 
Studies have previously investigated the binding of CRYAB to purified native 
desmin and actin filaments showing an increase in interactions between the filaments 
and the sHSP at lower pH and increased temperatures, however this is the first time 
that recombinant human desmin has been studied and compared to vimentin and 
GFAP (Bennardini et al., 1992).  However similar binding patterns have been 
observed with increased interactions between the sHSP and IFs at the lower pH 
values and increased temperatures.  At 39 and 44 0C at pH 6.3, more than 35% of the 
total CRYAB co-pelleted with GFAP and desmin filaments after high speed 
sedimentation and much less CRYAB was associated with vimentin (less than 30%).  
Desmin bound the most to CRYAB, likely a reflection on the fact that it has the 
highest hydrophobic profile out of the three IFs and reflects how desmin-CRYAB 
interactions are crucial for physiological states in muscles since myopathy is the 
result of either desmin or CRYAB mutations which result in desmin aggregates that 
associate with CRYAB (Maloyan et al., 2009).  The pH will also influence how the 
magnesium divalent cations can bind to the IFs and thus will also contribute to 
altered structures of the filaments and partly explain why CRYAB binds with 
preference at the lower pH value of 6.3 (Ghalebani et al., 2012).  When pH is 
lowered in muscle, sHSPs translocate to the Z-discs and this highlights therefore 
their crucial role in being targeted to desmin filaments (Golenhofen et al., 1998).  
Regarding structural changes in the CRYAB oligomers influenced by pH, at the 
lower pH values there is perhaps a preference for monomer formation as 
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demonstrated from experiments where the α-crystallin domain was isolated and 
assessed (Jehle et al., 2009).  However it has also been reported that low pH acts to 
stabilise oligomers and they will likely cluster together to form large complexes, as 
demonstrated in Figure 5.1 (Liu et al., 2006).  It is not currently known what the 
mechanism is of CRYAB dissociation and association in favoured environments for 
interacting with IFs.  However it is likely that monomers are able to dissociate from 
the complexes as phosphorylated CRYAB has been found to consist of odd 
numbered units, which is in contrast to other HSPs such as HSP16.5, which consist 
of much greater units such as 24 in this case to retain the symmetry (Aquilina et al., 
2004, Haslbeck et al., 2008).  The Q151X, missing the C-terminal tail region, mutant 
CRYAB also supports the dissociation of dimers/monomers since TEM images 
revealed an absence of CRYAB particles highlighting how the oligomers are much 
smaller than WT CRYAB (Hayes et al., 2008).  Additionally these smaller oligomers 
were more effective chaperones.  Although the TEM images in chapter 3 show that 
the lower pH and increased temperatures result in increased clustering of WT 
CRYAB oligomers around the filaments, these have not been quantified and 
therefore future work would need to measure this to see if the number of CRYAB 
oligomers bound to filaments is increased at low pH.  The C-terminal tail region in 
one monomer of CRYAB is able to dissociate from another monomer upon a drop in 
pH as shown in Figure 5.1, thus increasing potential hydrophobic substrate binding 
domains and explaining how CRYAB is able to increase its association with target 
proteins (Jehle et al., 2010).  The C-terminal tail has been reported previously to be 
more flexible in αA-crystallin than CRYAB and is likely due to the fact that in the 
lens the chaperone complex needs to be soluble for longer due to lower rates of 
protein turnover, however this demonstrates the importance of the flexibility of the 
tail region in the chaperone’s interactions (Lindner et al., 1998). 
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Figure 5.1 CRYAB-IF interactions influenced by pH. 
The C-terminal tail from one monomer is released from the β4/β8 site within the 
other monomer, thus increasing target protein affinity (Jehle et al., 2010). 
 
As well as pH influencing the interactions, increased temperature also promotes 
increased associations between the filaments and CRYAB.  High temperatures 
increase the dynamics of CRYAB oligomers due to increased association and 
dissociation rates (Liu et al., 2006).  It was also observed from alpha-crystallin 
complexes with ovotransferrin that increased temperatures increase the 
hydrophobicity of the protein complexes, likely explaining the increased associations 
between CRYAB and target substrates at higher temperatures (Lindner et al., 1998).  
Additionally higher temperatures reduce the critical concentration of divalent cations 
required for filament assembly (Chou et al., 1990). 
Regarding the increased CRYAB interactions with IFs in different divalent cation 
environments, it is likely that structural changes are occurring for CRYAB as well as 
the filament surfaces. 
CRYAB-IF interactions are important as CRYAB is able to influence the size of IF 
oligomers which can impact on proteasome function in AxD for instance and during 
stress there is a translocation of CRYAB to the insoluble formed IFs, from the 
soluble IF subunit pool, showing that the interactions are functional (Tang et al., 
2010, Nicholl and Quinlan, 1994).  The altered filament structures therefore from 
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higher temperatures and different divalent cations act as a cue for CRYAB to 
increase its interactions and alter the organisation of IF networks as seen in vivo 
whereby more diffuse networks are observed without an alteration in polymerisation 
state (Muchowski et al., 1999, Head et al., 2000).  Increased temperatures and 
decreased pH act to shift the assembly equilibrium of proteins to disassembled states.  
Therefore the increased binding of CRYAB to the filaments under these conditions, 
as observed from sedimentation assays, may be due to increased interactions between 
the partially unfolded and soluble IFs rather than just the fully formed filaments.  
Mutations also result in disassembly of proteins in most cases and a similar reason 
for increased interactions with CRYAB will likely be occurring. 
Mutations in CRYAB are associated with muscle myopathies and also cataracts, such 
as the R120G mutant, which hinders dimer formation since this residue is directly 
involved in monomer-monomer interactions (Sacconi et al., 2012).  However no 
gliopathies associated with CRYAB have been found; the cataracts are likely the 
cause of aberrant interactions with BFSP1/2 and vimentin in addition to a loss of its 
ability to prevent apoptosis by protecting cytochrome c against oxidation within 
mitochondria (McGreal et al., 2012).  The R120G mutation results in desmin 
aggregates within muscles of affected patients and also vimentin aggregation 
alongside increased binding of vimentin to CRYAB within the lenses of mouse 
knock-in models thus showing that vimentin-CRYAB interactions are also important 
(Andley et al., 2011).  It has been noted that the R120G mutation likely favours 
monomer formation and this correlates with increased binding to desmin and 
vimentin filaments and the potential pattern of monomer preference for increased 
interactions of CRYAB with filaments has also been demonstrated in chapter 3 at the 
lower pH values, which also will perhaps promote monomer formation (Clark et al., 
2011, Andley et al., 2011).  The R120G mutant also forms larger complexes than 
WT CRYAB demonstrating a bigger quaternary structure (Perng et al., 1999b).  It 
has also been shown that the R120G mutant CRYAB is partially unfolded which 
leads to decreased subunit exchange and stability (Liang and Liu, 2006).  Therefore 
the increased interactions of the mutant will be due to altered oligomer sizes and also 
partial unfolding.  The altered oligomer size will be due to a change in the 
equilibrium of dissociation, likely contributed to by a time-dependent truncation of 
the C-terminus, which has been implicated in the process of subunit exchange in 
CRYAB (Aquilina et al., 2005).  However it was reported that the decrease in 
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subunit exchange as measured from FRET was not very much and is due to most of 
the C-terminus still being present (Liang and Liu, 2006).  Terminally truncated αA-
crystallin has been found associated with cataracts and the αA-crysallin1-168 has been 
found only in the water-insoluble lens fraction, thus showing how the hydrophilic C-
terminal tail is essential for normal functioning of this protein, which will also be the 
case for CRYAB (Aquilina et al., 2005).  It was found that when CRYAB was 
present throughout GFAP assembly the interactions were increased compared to its 
addition after filament formation for pH 6.3 and 7.3 at 39 0C.  This highlights how 
important the presenting filament surface is for mediating interactions with CRYAB 
and the difference will either be the result of a different filament surface mediated by 
the presence/absence of CRYAB and/or different interactions with the oligomer 
dependent on the stage of filament formation when the sHSP oligomer is present. 
Developing on chapter 3 data, future work should investigate whether the altered 
GFAP filaments induced from a lack of magnesium ions can be promoted to form 
normal filaments if they are dialysed into a buffer with magnesium ions.  It would 
also be important to see if chaperone proteins can actively re-fold these structures 
once CRYAB has bound to them, in the presence of ATP and magnesium ions.  
Experiments without CRYAB would also be carried out to assess how CRYAB aids 
in the re-folding process. 
In chapter 3, the ability for GFAP filaments to revert to a different CRYAB binding 
preferential structure was assessed by assembling filaments at pH 6.3 where the 
greatest binding has been shown, dialysing into pH 7.3 where lower binding was 
observed and adding CRYAB from pH 7.3.  This showed that low binding was 
present, however this could have been because the CRYAB was assembled at pH 7.3 
and not 6.3, instead of the fact that the GFAP filament surface changed.  GFAP 
should be assembled at pH 7.3 where low binding is observed, then dialysed into pH 
6.3 and CRYAB from pH 6.3 added to see if the reverse can be observed with an 
increase in binding, although again the same issue of CRYAB having been 
assembled at the final pH will complicate the interpretation.  A true test to eliminate 
whether the change in binding is due to the filament or CRYAB structure would 
involve adding CRYAB assembled at the first pH to the filaments, however this is 
limited by the experimental set-up since adding CRYAB to the latest pH buffer that 
GFAP is in could potentially change the CRYAB structure again.  Therefore other 
methods are needed that analyse the surfaces of the CRYAB and GFAP filaments.  
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There are a few techniques that could be used such as measuring hydrophobicity 
with bis-ANS although as outlined before it is difficult to correlate hydrophobicity 
with chaperone activity, as other factors will also play a role (Kumar et al., 2005).  
Ideally NMR and crystallographic analyses would need to be carried out.  
Sedimentation velocity experiments on CRYAB assembled at pH 6.3 and 7.3 at 23, 
39 and 44 0C would help understand how the oligomeric species might be changing 
responsible for the differences in interactions (Prabhu et al., 2012).  Circular 
dichroism would aid in determining the secondary structure of the CRYAB and IFs 
under the different conditions and small angle X-ray scattering (SAXS) would give 
an idea of any un-folding or aggregation.  Size exclusion chromatography would be 
another method to assess what basic unit is preferred in the lower pH conditions for 
CRYAB where increased interactions are seen with the IFs.  In addition fluorescence 
resonance energy transfer microscopy (FRET) could be used, labelling individual 
monomers of CRYAB with different fluorophores and then assessing how these 
associate at the low and high pH values.  Two different populations of CRYAB 
would have to be fused with separate donar/acceptor fluorophores and then mixed to 
assess interactions (Sreelakshmi and Sharma, 2005).  This would be useful to gauge 
how subunits may be exchanging and their rate of exchange but would not give much 
insight into what units are associating/dissociating.  Ideally there needs to be a 
sequence in CRYAB which is only exposed as a monomer and can be attached to a 
fluorescent label via a conjugated antibody and then quantified to assess the actual 
number of monomers in the CRYAB solutions.  This may be problematic since 
CRYAB is polydisperse and thus buried residues are likely to change between the 
different oligomer sizes. 
 
5.4 Desmin and CRYAB interactions assessed from microrheology. 
WT CRYAB acts to reduce the G’ of desmin networks and the frequency-dependent 
viscosity, unlike the cardiomyopathy- and cataract- causing R120G mutant. 
Regarding rheological measurements of desmin filament networks and the influence 
of CRYAB, it would be useful to use polarised light to assess where the networks are 
in relation to the microspheres being trapped.  Other studies would need to be carried 
out to complement the elastic responses of desmin in the absence and presence of 
CRYAB to ascertain if its effects are at the individual filament or overall network 
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level in reducing desmin elasticity.  Thermal fluctuation would be a useful method to 
assess persistence lengths of the filaments, which would give some idea on the 
filament widths and also bundling (Noding and Koster, 2012).  The plateau modulus 
would also be a useful constant to derive the mesh size of the networks.  This would 
require measurements of the G’ where it is independent of frequency at different 
concentrations of protein and then a direct impact on mesh size from CRYAB could 
be derived (Schopferer et al., 2009). 
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Appendix  
Purification methods for chapter 2. 
2.1.2.4 Purification of GFAP, desmin and vimentin insoluble protein. 
The final pellet from the insoluble protein preparation was dissolved in 5 mL of 
extraction buffer (8 M urea, 10 mM Tris-HCl (pH 8.0), 5 mM EDTA and 0.2 mM 
PMSF) at room temperature for 2 hr.  The urea buffer had charged particles removed 
using amberlite (Merck, DE), with stirring at room temperature for 30 min and was 
vacuum filtered through a cellulose nitrate 0.2 µm pore-sized filter (Whatman, NJ, 
USA), to prevent carbamylation of protein.  Then the extracted protein was 
homogenised to extract more from the inclusion bodies, using a 15 mL Dounce 
homogeniser (Wheaton, USA).  The sample was centrifuged in a TLS-55 rotor, at 
201,247xgav, for 20 min at 4 0C in the TL-100 Bench Top ultracentrifuge (Beckman 
Coulter, UK).  1 µL of supernatant was removed and dissolved with 2x Laemmli SB 
in an equal volume and run on a SDS-PAGE gel to check the quality of the inclusion 
body preparation (an adequate preparation had at least 80% of the total protein as the 
target protein).  Then the supernatant was dialysed overnight at 4 0C, regarding 
GFAP, into: 6 M urea, 10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 20 mM NaCl, 0.2 
mM PMSF and 1 mM DTT for anion exchange chromatography on a Fractogel-
EMD trimethylaminoethyl (TMAE)-650(S) column (Merck, UK).  For desmin and 
vimentin these were dialysed into: 7M urea, 10 mM Tris-HCl (pH 8.0), 1 mM 
EDTA, 20 mM NaCl, 0.2 mM PMSF and 1 mM DTT.  Rehydrated cellulose dialysis 
tubing was used (Scientific Laboratory Supplies Ltd., UK) and rinsed with de-
ionised water before use.  Before loading the sample onto the column, the dialysate 
was filtered through a 0.45 µm and then a 0.2 µm polyethersulfone (PES) filter 
(Whatman, NJ, USA) using a 5 mL syringe. 
 
2.1.2.5 Purification of WT and R120G CRYAB.  
The bacterial pellet was resuspended in 20 mL TEN buffer (50 mM Tris-HCl (pH 
8.0), 1 mM EDTA, 300 mM NaCl and 0.2 mM PMSF) and underwent three freeze 
thaw cycles.  The cells were then defrosted to room temperature and lysozyme added 
at a final concentration of 1.0 mg/mL and mixed using the 40 mL Dounce 
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homogeniser and tight pestle (Wheaton, USA).  This was shaken for 15 min, at 70 
rpm and 37 0C.  Then the solution was homogenised and centrifuged at room 
temperature for 15 min in the JA-20 rotor, 30,000xgav (Beckman JA-20-I).  
Benzonase nuclease (Novagen, UK) at a final concentration of 100 units/mL was 
added to the homogenate, mixed well and incubated at room temperature for 30 min 
with gentle shaking.  Polyethyleneimine (PEI) at a final concentration of 0.005% 
(w/v) was added to remove contaminating DNA and incubated on ice for 10 min.  
This was then centrifuged in the JA-20 rotor, using 31,360xgav, at 4 0C for 30 min to 
pellet any DNA and RNA (Beckman JA-20-I).  The supernatant was then dialysed 
overnight into buffer A (20 mM Tris (pH 7.4), 1 mM MgCl2, 1 mM EDTA, 1 mM 
DTT and 0.2 mM PMSF), used as the anion exchange buffer. 
 
2.1.2.6 GFAP, desmin and vimentin TMAE anion and COO- cation exchange 
chromatography. 
The dialysate was injected into the 5 mL capacity loop on the Merck-Hitachi 
Chromatography System (Merck-Hitachi, UK) and the column (either TMAE-650(S) 
Fractogel-EMD or COO--650(S) Fractogel-EMD) was equilibrated overnight with at 
least 10 column volumes of buffer A (TMAE: 6/7 M urea, 10 mM Tris-HCl (pH 8.0), 
1 mM EDTA, 20 mM NaCl, 0.2 mM PMSF and 1 mM DTT).  6 M urea was used for 
GFAP purification and 7 M urea was used for desmin and vimentin purifications 
according to previous laboratory protocols.  After the sample was loaded onto the 
column, one column volume of buffer A was run through before a 0.02 (to elute 
some contaminants in the wash step) - 1 M linear NaCl gradient was initiated.  The 
flow rate was 1 mL/min.  Fractions were collected using the BioFracTM fraction 
collector (Bio-Rad, UK).  The protein content of the eluate fractions was monitored 
using the ultraviolet (UV) spectrometer and data processed using a Chromelean 
Client (Dionex, UK) to give a chromatogram plot.  Peak fractions on the 
chromatogram were run on SDS-PAGE gels to assess if proteins were present, 
loading 10 µL sample from 10 µL mixed with 10 µL SB.  Target fractions were 
pooled together.  These were then dialysed overnight into COO- buffer (6 M urea, 20 
mM sodium formate (pH 4.0), 5 mM EDTA and 1 mM DTT) whilst the COO- 
column was also equilibrated in the same buffer.  The column was also run using a 
linear gradient, this time of 0 - 1 M NaCl with a 1 mL/min flow rate.  For WT 
  
206 
desmin and vimentin, 7 M urea was used in all the buffers, as has been used 
previously in the laboratory, as opposed to 6 M urea.  WT and mutant GFAP eluted 
in the range of 0.2 - 0.4 M NaCl for TMAE and COO-.  WT desmin eluted in the 
range of 0.2 - 0.3 M NaCl with TMAE purification and 0.3 - 0.4M NaCl for COO- 
purification.  WT vimentin eluted at 0.3 - 0.4 M NaCl for TMAE and COO- 
purifications. 
 
2.1.2.7 WT and R120G CRYAB TMAE anion and size exclusion 
chromatography. 
The dialysate was injected into the 5 mL capacity loop on the Merck-Hitachi 
Chromatography System and the TMAE column was equilibrated overnight with at 
least 10 column volumes of buffer A (20 mM Tris-HCl (pH 7.4), 1 mM MgCl2, 1 
mM EDTA, 1 mM DTT and 0.2 mM PMSF).  After the sample was loaded onto the 
column, one column volume of buffer A was run through the column before a linear 
NaCl gradient was run from 0 - 1 M; the flow rate was 1 mL/min.  Fractions were 
collected using the fraction collector (Bio-Rad, UK).  WT CRYAB eluted in the 
range of 0 - 0.1 M NaCl, as it does not stick to the column; the contaminants stick 
however.  Most of the R120G CRYAB also eluted at this concentration of NaCl.  For 
size exclusion chromatography, the pooled fractions were spin concentrated in an 
Amicon Ultra Centrifugal filter device with a 10 kDa molecular weight cut-off filter 
(Millipore, Bedford, MA), to 0.5 mL, injected into the 2 mL capacity loop and then 
run in the buffer: 20 mM Tris-HCl (pH 7.4) and 300 mM NaCl, on the Fractogel 
EMD BioSEC-650(S) (Merck, UK) column with a flow rate of 1 mL/min.  WT 
CRYAB eluted between 30 - 45 min and R120G eluted between 30 - 48 min. 
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Ionic strength calculations. 
In Figure 2.13, the I of buffer 5 (0.0607 M) was calculated taking into account the 
conjugate base of Tris being electrostatically neutral and the only charges present 
being contributed from the weak acid dissociation products of Tris-H+ and Cl-; 
including the contributions from the Mg2+, Na+ and Cl- ions, whose I is calculated 
collectively.  The FWA was calculated to be 0.87 for pH 7.3 using the Henderson-
Hasselbach equation and pKa of 8.114: 
 
€ 
pH = pKa + log[A]/[HA] 
 
and the following: FWA = [HA]/([A] + [HA]).  Then the following equation was used 
just for the Tris species components (Tris-H+ and Cl-); where zi is equal to the charge 
and mi is equal to the concentration of the ion, giving a value of 0.0087 for the Tris 
species: 
 
€ 
I =1/2⋅ zi2 ⋅ mi ⋅ FWA∑  
 
The Mg2+, Na+ and Cl- ions used the above equation without the FWA component.  
The Tris and ion I values were then summed to give the overall I.  Below is a plot 
showing the relationship between I and pH for Tris-HCl buffers. 
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Figure A.1 PH-dependent ionic strength of 10mM Tris-HCl buffers. 
The above chart outlines the I for a 10mM Tris-HCl buffer, using the pKa of 8.114, 
minus other species and this is dependent upon concentration, as shown in the ionic 
strength calculation. 
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Statistical tests for chapter 2. 
This section shows the statistical results from the data obtained in chapter 2.  
Parametric two-sided, type-2 Student’s T tests or non-parametric Mann-Whitney U 
tests were carried out on the data.  For T test analysis, the data were pasted into 
Excel and initially normalised from an arcsine-root transformation since the 
proportions assessed from the gels are distributed binomially (Zar, 1996).  Two-sided 
tests were used since the observed values in one group were equally likely to be 
bigger or smaller than the mean in the other group.  A type-2 test was used assuming 
equal variances for the two groups.  The Shapiro-Wilk test was performed on the 
transformed data before the T test analyses to make sure that the data had been 
normalised, in the SPSS Statistics version 21 programme (IBM, US) (Barnard et al., 
2007).  The data were pasted into the programme and the Analyze > Descriptive 
Statistics  > Explore options selected.  The data were transferred to the Dependent 
List and the Descriptive statistics option was chosen with a confidence interval of 
95% for the mean.  The data were then processed using the Normality plots with tests 
and Histograms options.  The output file gave Shapiro-Wilk test results; with 
significance above 0.05 the data could be inferred to have a normal distribution.  
Below is one of the output tables for the first sample in Table A.2. 
 
 
Figure A.2 Shapiro-Wilk test result example. 
 
A Mann-Whitney U test was used on those data that weren’t successfully normalised 
after transformation, i.e. had a significance less than 0.05 from the Shapiro-Wilk test.  
The data were ranked in ascending order of magnitude and for those values that were 
the same these were given an average rank.   
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The total ranks were summed for each group and then the U value was calculated for 
each group, with an example for group A, using: 
 
UA = nA x nB + ((n(n+1))/2) - RA. 
 
Where nA and nB represent the total number of samples in group A and B 
respectively, n is equal to the number of observations in group A and RA has been 
given as an example of the sum total of ranks in group A.  UB is calculated using the 
same formula except RB is used instead of RA and n is the total number of 
observations in group B.  To calculate significance, the smallest U value was 
compared to critical values of U using a one-tailed test and α = 0.05 (Gravetter and 
Wallnau, 2009).  A U value smaller than the critical value achieved significance. 
 
nB  nA 1 2 3 4 5 
1   - - - - - 
2   - - - - 0 
3   - - 0 0 1 
4   - - 0 1 2 
5   - 0 1 2 3 
Table A.1 Critical U values.   
Values were obtained from published values, with nA representing the number of 
samples in group A and nB representing the number of samples in group B (Gravetter 
and Wallnau, 2009). 
 
For each test there is a null hypothesis, which states that there is no difference 
between the two group means and that they come from the same population.  The 
null hypotheses have been rejected when p<0.05. 
Overall these results show that CRYAB can reduce R239H filament-filament 
interactions, CRYAB inhibits a proportion of WT and R416W GFAP filament 
assembly and CRYAB has increased binding to filaments at 44 0C compared to 23 0C 
for the WT and mutant GFAP. 
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Table A.2 Filament-filament interactions of GFAP in the presence and absence 
of CRYAB through Tris assembly assessed from the Student’s T-test.   
P-values from arcsine-root transformed proportions of GFAP protein in supernatants 
from low speed sedimentation assays and two-sided, type-2 Student’s T-test analyses 
comparing those assembled with/without WT CRYAB are shown.  
 
 
 
 
 
 
 
 
Sample 
assembled 
Proportion 
of GFAP in 
supernatant 
Arcsine-root 
transformation 
(2 d.p.) 
F value 
(critical F 
value) 
p-value Significance at 
5% 
WT 0.85 1.17    
 0.9 1.25    
 0.88 1.22    
 0.94 1.32    
 0.9 1.25    
WT + 
CRYAB 
0.94 1.32    
 0.86 1.19    
 0.9 1.25    
 0.85 1.17    
 0.88 1.22 1.18 (9.6) 0.72 Not 
Significant 
R416W 0.096 0.32    
 0.021 0.15    
 0.2 0.46    
R416W + 
CRYAB 
0.57 0.86    
 0.33 0.61    
 0.11 0.34 2.64 (39) 0.30 Not significant 
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Table A.3 Filament-filament interactions of GFAP in the presence and absence 
of CRYAB through Tris assembly assessed from the Mann-Whitney U test.   
WT CRYAB reduces R239H filament-filament interactions as demonstrated by a 
smaller U value then the critical U value for the R239H + CRYAB sample. 
 
 
 
 
 
 
 
 
Sample 
assembled 
Proportion 
of GFAP in 
supernatant 
Rank Sum of 
Ranks 
U value 
(Critical U 
value) 
Significance 
R79C 0.82 2    
 0.79 1    
 0.84 3    
 0.91 9    
 0.9 6.5 21.5 18.5 (3)  
R79C + 
CRYAB 
0.95 10    
 0.9 6.5    
 0.9 6.5    
 0.88 4    
 0.9 6.5 33.5 6.5 (3) Not Significant 
R239H 0.066 3    
 0.057 2    
 0.05 1    
 0.072 4 10 16 (1)  
R239H + 
CRYAB 
0.45 7    
 0.55 8    
 0.36 6    
 0.2 5 26 0 (1) Significant 
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Table A.4 Filament-filament interactions of GFAP in the presence and absence 
of CRYAB through imidazole assembly assessed from the Student’s T test.   
P-values from arcsine-root transformed proportions of GFAP protein in supernatants 
from low speed sedimentation assays and two-sided, type-2 Student’s T-test analyses 
comparing those assembled with/without WT CRYAB are shown. 
 
 
Sample 
assembled 
Proportion of 
GFAP in 
supernatant 
Rank Sum of 
Ranks 
U value 
(Critical 
U 
value) 
Significance 
R239H 0.11 5.5    
 0.074 2    
 0.11 5.5    
 0.1 4 17 9 (1)  
R239H + 
CRYAB 
0.05 1    
 0.087 3    
 0.24 8    
 0.22 7 19 7 (1) Not 
Significant 
Sample 
assembled 
Proportion of 
GFAP in 
supernatant 
Arcsine-root 
transformation 
(2 d.p.) 
F value 
(critical F 
value) 
p-value Significance at 
5% 
      
WT 0.48 0.77    
 0.44 0.73    
 0.24 0.51    
WT + CRYAB 0.24 0.51    
 0.11 0.34    
 0.086 0.30 1.43 (39) 0.05 Significant 
R79C 0.66 0.95    
 0.84 1.16    
 0.81 1.12    
R79C + 
CRYAB 
0.85 1.17    
 0.87 1.20    
 0.88 1.22 25.23 (39) 0.14 Not significant 
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Table A.5 Filament-filament interactions of GFAP in the presence and absence 
of CRYAB through imidazole assembly assessed from the Mann-Whitney U 
test.   
 
Table A.6 Inhibition of assembly of GFAP through Tris assembly by CRYAB 
assessed from the Student’s T test.   
P-values from arcsine-root transformed proportions of protein in supernatants from 
high speed sedimentations and two-sided, type-2 Student’s T-test analyses are 
shown.  WT CRYAB inhibits WT GFAP assembly. 
 
 
 
 
 
 
 
Sample 
assembled 
Proportion of 
GFAP in 
supernatant 
Arcsine-root 
transformation 
(2 d.p.) 
F value 
(critical F 
value) 
p-value Significance at 
5% 
WT 0.09 0.31    
 0.06 0.25    
 0.13 0.36    
 0.09 0.30    
WT + 
CRYAB 
0.33 0.61    
 0.25 0.52    
 0.38 0.66 2.05 (39.2) 0.001 Significant 
R239H 0 0    
 0 0    
 0.02 0.14    
 0.12 0.35    
R239H + 
CRYAB 
0.01 0.10    
 0.02 0.14    
 0.05 0.23    
 0.04 0.20 8.64 (15.4) 0.63 Not significant 
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Table A.7 Inhibition of assembly of GFAP through Tris assembly by CRYAB 
assessed from the Mann-Whitney U test. 
CRYAB appears to reduce the amount of assembled mutant R416W GFAP material 
with p<0.05. 
 
 
 
 
 
 
 
 
 
 
 
  
Sample 
assembled 
Proportion of 
GFAP in 
supernatant 
Rank Sum of Ranks U value 
(Critical U 
value) 
Significance 
R79C 0.32 2    
 0.44 5    
 0.15 1 8 7 (0)  
R79C + 
CRYAB 
0.57 6    
 0.43 3.5    
 0.43 3.5 13 2 (0) Not 
significant 
R416W 0 2.5    
 0 2.5    
 0 2.5    
 0 2.5 10 16 (1)  
R416W + 
CRYAB 
0.14 8    
 0.01 5    
 0.03 6.5    
 0.03 6.5 26 0 (1) Significant 
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GFAP type 
assembled and 
temperature 
Proportion of 
CRYAB in pellet 
Arcsine-root 
transformation 
(2 d.p.) 
F value 
(critical F 
value) 
p-value Significance 
at 5% 
WT 23 0C 0.17 0.43    
 0.16 0.41    
 0.18 0.44    
 0.03 0.17    
 0.06 0.25    
WT 44 0C 0.71 1.00    
 0.37 0.65    
 0.39 0.67 2.63 (39) 0.008 Significant 
R79C 23 0C 0.12 0.35    
 0.14 0.38    
 0.07 0.27    
 0.07 0.27    
 0.11 0.34    
R79C 44 0C 0.7 0.99    
 0.41 0.69    
 0.45 0.74 9.44 (39) 0.001 Significant 
R239H 23 0C 0.23 0.50    
 0.06 0.25    
 0 0    
 0.20 0.47    
 0.15 0.39    
R239H 44 0C 0.89 1.23    
 0.84 1.16    
 0.47 0.76 1.58 (39) 0.004 Significant 
R416W 23 0C 0.14 0.38    
 0.12 0.35    
 0.19 0.45    
R416W 44 0C 0.43 0.72    
 0.36 0.64    
 0.55 0.84 3.79 (39) 0.006 Significant 
Table A.8 Binding of WT CRYAB to GFAP through Tris assembly at 23 and 44 
0C assessed from the Student’s T test.   
P-values from arcsine-root transformed proportions of WT CRYAB in pellets from 
high speed sedimentation assays and two-sided, type-2 Student’s T-test analyses are 
shown comparing the amount of pelleted WT CRYAB between 23 and 44 0C. 
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GFAP type 
assembled 
and 
temperature 
Proportion of 
CRYAB in pellet 
Arcsine-root 
transformation 
(2 d.p.) 
F-value 
(critical F 
value) 
p-value Significance 
at 5% 
WT 23 0C 0.26 0.54    
 0.13 0.37    
 0.14 0.38    
WT 44 0C 0.74 1.04    
 0.61 0.90    
 0.95 1.34 6.24 (39) 0.010 Significant 
Table A.9 Binding of WT CRYAB to GFAP through imidazole assembly at 23 
and 44 0C assessed from the Student’s T test.   
The p-value from arcsine-root transformed proportions of CRYAB co-pelleting with 
WT GFAP from high speed sedimentation assays and two-sided, type-2 Student’s T-
test analysis between 23 and 44 0C is shown. 	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Appendix of GFAP oligomer approximation chapter 3. 
A standard curve was derived from the standard protein ladder bands’ distances 
travelled on a gel versus their molecular weights, with values shown in the table 
below. 
Molecular Weight Standards (kDa) Distance Travelled (units) 
250 0.4 
130 0.8 
95 1.5 
72 2.2 
55 3.1 
36 4.8 
28 6 
17 9 
  Table A.10 Standard curve values.                                                                                                 
 
The distance travelled of the GFAP oligomer was equivalent to 0.5 units and this was 
used in the equation of the standard curve shown in Figure A.3 to give an 
approximate size of 220 kDa for the oligomer. 
 
Figure A.3 Denatured protein SDS-PAGE gel standard curve. 
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Appendix of statistical analyses chapter 3.1.3.2, section 2. 
Table A.11 There is a significant increase in binding of CRYAB to vimentin 
filaments formed with manganese ions at pH 6.9 compared to magnesium ions 
at pH 6.8 at 39 and 44 0C assessed from the Student’s T test.   
The amounts of CRYAB binding to vimentin filaments assembled at pH 6.9 with 
manganese ions compared to pH 6.8 with magnesium ions are shown. 
 
 
 
 
 
 
 
 
 
 
Sample 
assembled 
and 
conditions 
Proportion 
of CRYAB 
in pellet 
Arcsine-root 
transformation 
(2 d.p.) 
F value 
(critical F 
value) 
p-value Significance 
at 5% 
Vimentin 
39 0C Mn2+ 
0.1 0.32    
 0.16 0.41    
 0.12 0.35    
Vimentin 
39 0C Mg2+ 
0.059 0.25    
 0.068 0.26    
 0.093 0.31 1.87 (39) 0.052 Significant 
Vimentin 
44 0C Mn2+ 
0.2 0.46    
 0.15 0.40    
 0.12 0.35    
Vimentin 
44 0C Mg2+ 
0.085 0.30    
 0.096 0.32    
 0.103 0.33 12.60 (39) 0.049 Significant 
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Table A.12 There is no significant increase in binding of CRYAB to vimentin 
filaments formed with manganese ions at pH 6.9 compared to magnesium ions 
at pH 6.8 at 23 0C assessed from the Mann-Whitney U test.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 	  	  
Sample 
assembled 
Proportion 
of  CRYAB 
in pellet 
Rank Sum of Ranks U value 
(Critical U 
value) 
Significance 
Vimentin 
23 0C Mn2+ 
0.12 6    
 0.09 4    
 0.07 1 11 4 (0)  
Vimentin 
23 0C Mg2 
0.076 3    
 0.074 2    
 0.093 5 10 5 (0) Not Significant 
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Table A.13 There is no significant difference in binding of CRYAB to GFAP 
filaments formed with manganese ions at pH 6.9 compared to magnesium ions 
at pH 6.8 at 39 and 44 0C assessed from the Student’s T test.   
The amounts of CRYAB binding to GFAP filaments assembled at pH 6.9 with 
manganese ions compared to pH 6.8 with magnesium ions are shown. 
 
 
 
 
 
 
 
 
 
Sample Proportion 
of CRYAB 
in pellet 
Arcsine-root 
transformation 
(2 d.p.) 
F value 
(critical F 
value) 
p-value Significance 
at 5% 
      
39 0C Mn2+ 
GFAP 
0.14 0.38    
 0.15 0.40    
 0.1 0.32    
39 0C Mg2+ 
GFAP 
0.146 0.39    
 0.128 0.37    
 0.135 0.38 9.37 (39) 0.69 Not 
Significant 
44 0C Mn2+ 
GFAP 
0.31 0.59    
 0.2 0.46    
 0.4 0.68    
44 0C Mg2+ 
GFAP 
0.213 0.48    
 0.232 0.50    
 0.267 0.54 11.97 (39) 0.35 Not 
Significant 
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Table A.14 There is a significant difference in binding of CRYAB to GFAP 
filaments formed with manganese ions at pH 6.9 compared to magnesium ions 
at pH 6.8 at 23 0C assessed from the Mann-Whitney U test.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample 
assembled 
Proportion 
of CRYAB 
in pellet 
Rank Sum of Ranks U value 
(Critical U 
value) 
Significance 
23 0C 
Mn2+ 
GFAP 
0.1 7    
 0.08 5    
 0.13 8    
 0.09 6 26 0 (1)  
23 0C 
Mg2+ 
GFAP 
0.075 3    
 0.06 1    
 0.077 4    
 0.069 2 10 16 (1) Significant 
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Appendix of quantifications from chapter 3.1.3.3. 
Overall these results demonstrate that a drop in pH and an increase in temperature 
result in increased co-pelleting of CRYAB with GFAP, vimentin and desmin. 
 
Section 1 pH and temperature dependence of binding of CRYAB to GFAP, 
vimentin and desmin with addition prior to filament formation. 	  
Table values are shown as averages +/- their standard deviations. 
 
 % CRYAB 
pellet 
Mg2+ 23 0C 
% CRYAB 
pellet 
Mg2+ 39 0C 
% CRYAB 
pellet 
Mg2+ 44 0C 
Vimentin 14 +/- 3 22 +/- 1 28 +/- 2 
GFAP 15 +/- 4 38 +/- 1 40 +/- 2 
Desmin 54 +/- 2 64 +/- 14 47 +/- 19 
Table A.15 % binding of CRYAB to filaments in HEPES buffers at pH 6.3. 
 
 % CRYAB 
pellet 
Mg2+ 23 0C 
% CRYAB 
pellet 
Mg2+ 39 0C 
% CRYAB 
pellet 
Mg2+ 44 0C 
Vimentin 8 +/- 1 8 +/- 3 10 +/- 1 
GFAP 7 +/- 1 14 +/- 1 24 +/- 3 
Desmin 16 +/- 2 15 +/- 2 20 +/- 4 
Table A.16 % binding of CRYAB to filaments in HEPES buffers at pH 6.8. 
 
 % CRYAB 
pellet 
Mg2+ 23 0C 
% CRYAB 
pellet 
Mg2+ 39 0C 
% CRYAB 
pellet 
Mg2+ 44 0C 
Vimentin 8 +/- 4 7 +/- 2 8 +/- 6 
GFAP 7 +/- 5 11 +/- 3 15 +/- 3 
Desmin 10 +/- 2 12 +/- 1 11 +/- 1 
Table A.17 % binding of CRYAB to filaments in HEPES buffers at pH 7.3. 
  
224 
pH % CRYAB 
pellet 
Mg2+ 23 0C 
% CRYAB 
pellet 
Mg2+ 39 0C 
% CRYAB 
pellet 
Mg2+ 44 0C 
7.3 13 +/- 3 10 +/- 1 13 +/- 1 
6.8 11 +/- 3 13 +/- 2 16 +/- 2 
6.3 15 +/- 5 14 +/- 5 12 +/- 4 
Table A.18 % of CRYAB pelleting in HEPES buffers.  
 
Section 2 pH and temperature dependence of binding of CRYAB, to assembled 
GFAP filaments, at the same pH. 
 
 % CRYAB 
pellet 
Mg2+ 23 0C 
% CRYAB 
pellet 
Mg2+ 39 0C 
% CRYAB 
pellet 
Mg2+ 44 0C 
GFAP pH 6.3 17 +/- 2 29 +/- 3 34 +/- 4 
GFAP pH 7.3 4 +/- 3 6 +/- 1 11 +/- 2 
Table A.19 % binding of CRYAB to filaments in HEPES buffers at pH 6.3 and 
7.3. 
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Appendix of statistical analyses chapter 3.1.3.3. 
Table A.20 CRYAB interactions are significantly greater at pH 7.3 at 39 0C with 
addition of CRYAB before GFAP has formed compared to CRYAB addition 
after GFAP formation assessed from the Student’s T test.   	  	  	  	  	  
The data in Table A.20 and A.21 show p-values from arcsine-root transformed 
proportions of CRYAB protein in pellets from high speed sedimentation assays and 
two-sided, type-2 Student’s T-test analyses comparing the difference, at pH 7.3 at the 
same temperatures, of pelleted CRYAB to filaments either after being added to the 
filaments before or after they had assembled.  Table A.22 shows the data for pH 6.3. 
Sample Proportion 
of CRYAB 
in pellet 
Arcsine-root 
transformation 
(2 d.p.) 
F value 
(critical F 
value) 
p-value Significance at 5% 
pH 7.3      
23 0C 
CRYAB 
before 
0.05 0.23    
 0.037 0.19    
 0.131 0.37    
23 0C 
CRYAB 
after 
0.012 0.11    
 0.075 0.28    
 0.04 0.20 1.25 (39) 0.41 Not Significant 
39 0C 
CRYAB 
before 
0.15 0.40    
 0.09 0.30    
 0.09 0.31    
39 0C 
CRYAB 
after 
0.055 0.24    
 0.05 0.23    
 0.07 0.27 6.02 (39) 0.051 Significant 
  
226 
Table A.21 CRYAB interactions are not significantly greater at pH 7.3 at 44 0C 
with addition of CRYAB before GFAP has formed compared to CRYAB 
addition after GFAP formation assessed from the Mann-Whitney U test.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample 
assembled 
Proportion 
of GFAP in 
supernatant 
Rank Sum of Ranks U value 
(Critical U 
value) 
Significance 
44 0C 
CRYAB 
before 
0.16 5    
 0.18 6    
 0.12 3 14 1 (0)  
44 0C 
CRYAB 
after 
0.10 1.5    
 0.14 4    
 0.10 1.5 7 8 (0) Not 
Significant 
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Table A.22 CRYAB interactions are significantly greater at pH 6.3 at 39 0C with 
addition of CRYAB before GFAP has formed compared to CRYAB addition 
after GFAP formation assessed from the Mann-Whitney U test.   
 
 
 
 
Sample 
assembled 
Proportion 
of GFAP in 
supernatant 
Rank Sum of 
Ranks 
U value 
(Critical U 
value) 
Significance 
pH 6.3      
23 0C CRYAB 
before 
0.21 6    
 0.20 5    
 0.13 1 12 3 (0)  
23 0C CRYAB 
after 
0.18 3.5    
 0.15 2    
 0.18 3.5 9 6 (0) Not Significant 
39 0C CRYAB 
before 
0.39 6    
 0.38 4.5    
 0.38 4.5 15 0 (0)  
39 0C CRYAB 
after 
0.30 2    
 0.31 3    
 0.26 1 6 9 (0) Significant 
44 0C CRYAB 
before 
0.37 3    
 0.39 5    
 0.42 6 14 1 (0)  
44 0C CRYAB 
after 
0.30 1    
 0.38 4    
 0.33 2 7 8 (0) Not Significant 
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Appendix of the microrheology calculations for single bead trapping from 
chapter 4. 
For the rheology experiments carried out in Durham, MATLAB R2007b was used 
for calculating the passive frequency dependent viscosity values; the “modulus” 
script was run to derive the complex shear modulus:  
 
Initially the power spectral density was calculated, where the discrete Fourier 
transform is used on the bead positions relative to the camera frames, using the 
following discrete Fourier transform equation: 
 
N represents the total number of data points and y(j), j, and k are integers labeling the 
input/output data points. 
It then applied the following to fit a Lorentzian function to the data: 
 
This gave the power spectrum for data up to half the camera frame rate, from which 
the imaginary apparent and real apparent part of the transfer function were derived to 
give the complex transfer function: 
 
The imaginary apparent part is calculated from: 
 
T is the temperature in kelvin and kb is the Boltzmann’s constant. 
 
 
 
The real apparent part was calculated using the Kramers-Kronig relation: 
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The true responses were then derived from the apparent responses using: 
 
A(f) is the apparent response and k is the trap stiffness. 
 
The true responses were then put into the Stokes relation: 
 
G’’ was calculated as: (1/(6*Pi*bead radius (2*10-06)))*-(-α’’/(α’2 + α’’2)) and 
then subtraction of solvent viscosity.  The passive frequency dependent viscosity was 
then derived from G’’ (loss modulus) in the following equation: 
 
As for the analysis in Durham, the data at AMOLF used the complex transfer 
function α(f) (α’+ iα’’) to calculate the apparent G(f), using the generalised Stokes 
relation, with a as the bead radius.  The general operation formula for dividing 
complex numbers was applied to separate out the real and imaginary parts (Chow, 
2000):  
 
The following values were used: a= 1, b= 0, c= α’ and d= α’’. 
This derived α’ apparent as: α’/(α’2 + α’’2) and α’’ apparent as: -α’’/(α’2 + α’’2) 
(with α’ as the apparent real and α’’ as the apparent imaginary response values) to 
then separately derive G’ apparent and G’’ apparent respectively from the Stokes 
relation. 
Therefore G’ apparent was calculated:  
(1/(6*Pi*bead radius (10-06)))*(α’/(α’2 + α’’2)) 
and G’’ apparent was calculated: (1/(6*Pi*bead radius))*-(-α’’/(α’2 + α’’2)). 
G’ sample was then: G’ apparent sample- G’ apparent buffer. 
G’’ sample was: G’’ apparent sample- solvent viscosity (2*Pi*frequency*viscosity 
of water at 21 0C). 
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G’’ values for 1 mg/mL desmin in the presence and absence of WT CRYAB. 	  	  
	  
Figure A.4 G’’ values of desmin networks in the presence and absence of WT 
CRYAB show no difference at this concentration. 
Values represent the average of 9 microspheres for desmin + WT CRYAB and 5 
microspheres for desmin alone +/- one SD shown as error bars. 
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